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Methylation of the C-5 position of cytosine is a stable, heritable and reversible
epigenetic modification of DNA that is widespread in vertebrate animals, plants and
fungi. In vertebrates, it is predominantly involved in transcriptional repression, with
known roles in genomic imprinting, X inactivation and silencing of repetitive DNA.
The levels of DNA methylation in murine embryos undergo significant changes post-
fertilisation during an event known as epigenetic reprogramming. This phenomenon
has been widely investigated in the mouse and to a lesser extent in other vertebrate
species. The purpose of this study was to investigate DNA methylation in sheep
(Ovis aries), a species of renewed interest since the birth of a female sheep (Dolly)
produced by somatic cell nuclear transfer (SCNT). Significantly, it has been
hypothesised that the low success rates observed in SCNT may be related to
incomplete or inefficient reprogramming of DNA methylation patterns during early
stages of development.
The main components of the DNA methylation repression system are the cytosine
methyltransferases (maintenance (Dnmtl) and de novo (Dnmt3a and 3b)) and the
methyl-CpG specific transcription repressors (MeCPs or MBDs). Cloning of ovine
cDNA sequences, and expression analysis of genes encoding proteins involved in
DNA methylation, yielded insights into DNA methylation processes in early
development and also in adult tissues. In addition, techniques were developed to
analyse genomic DNA methylation levels in single preimplantation embryos, and
were also used to assess the effects of somatic cell nuclear transfer on DNA
methylation reprogramming.
The ovine homologues of DNA methyltransferases DNMT1, DNMT3A and
DNMT3B, and the methyl-CpG-binding protein MBD2, were cloned fully or
partially, using a combination of RT-PCR, cDNA library screening, and 5' RACE
methods. Analysis of predicted protein sequences demonstrated high levels of
conservation within and out with functional domains. Attempts to clone an oocyte-
specific form of DNMT1, known to exist in the mouse, were unsuccessful. Instead, a
form identical to that isolated from adult tissues was detected in oocytes. These
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results imply there is little or no oocyte-specific form of Dnmtl in sheep oocytes,
which may be indicative of species-specific differences during early epigenetic
reprogramming events. Analysis of DNMT1, DNMT3A and MBD2 expression in
adult tissues using Taqman RT-PCR, demonstrated similar patterns to those
observed in the human, where previously reported. Qualitative expression analysis of
DNMT1 expression in ovine oocytes and preimplantation embryos of various stages,
suggested comparable expression patterns to those observed in the mouse, with
depletion of maternal stores observed between the 1-cell and blastocyst stages.
Expression analysis of DNMT3A demonstrated a reciprocal increase between these
stages, and analysis of DNMT3B expression indicated a similar pattern, again
increasing at the blastocyst stage. MBD2 was not found to be highly expressed in
oocytes or blastocysts.
A methyl-sensitive PCR method, optimised for use in single oocytes and embryos,
was employed to assay DNA methylation levels of an ovine satellite sequence, and
an ovine SINE element. No significant changes were detected in the satellite
sequence of in vivo derived embryos between the 8-16 cell and blastocyst stages of
development, contrasting with the significant decrease in satellite DNA methylation
levels observed in the mouse. However, comparisons between in vivo, in vitro
fertilised (IVF) and SCNT blastocysts demonstrated significant differences, with the
IVF and SCNT embryos (both of which undergo equivalent periods of in vitro
culture) relatively undermethylated within the satellite and SINE element. In
addition, SCNT blastocysts demonstrated increased methylation levels relative to
their IVF counterparts within the satellite sequence, but not the SINE element,
suggesting sequence-specific reprogramming errors.
In conclusion, there is strong evidence of overall conservation of DNA methylation
mechanisms between sheep and mice however, there are subtle differences. In
addition, SCNT blastocysts appear to show aberrant reprogramming of methylation
patterns when compared to their normal counterparts. This may underlie the low
success rates observed in animal SCNT. Future work will build on these results,
investigating global methylation levels during preimplantation development of
normal and cloned embryos, and also determining the precise roles of ovine DNA
methyltransferases in methylation reprogramming.
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Due to a lack of clarity regarding gene nomenclature for farm animals, this thesis
uses the recommended human notation (http://www.gene.ucl.ac.uk/nomenclature/ )
(Dolling et al., 1997) when describing sheep or cow genes/transcripts and proteins.
To summarise, this involves the use of italicised capital letters for the gene/
transcript and non-italicised capital letters for the corresponding protein. Mouse
genes or transcripts will be referred to by lower case italicised symbols, with lower
case, non-italicised symbols for the protein.
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Thesis rationale
DNA methylation is a stable, reversible and heritable modification of DNA with
known involvement in a number of biological processes including genomic
imprinting, X-inactivation and silencing of repetitive DNA. In each of these
processes, it is thought to function to repress transcription. Dynamic changes in
DNA methylation patterns occur in murine preimplantation development, as part of
the epigenetic reprogramming process that resets gametic chromatin into a form that
will support fetal development. The extent of conservation of this reprogramming
event in other mammalian species is poorly understood. In addition, it has been
hypothesised that DNA methylation patterns may be reprogrammed incompletely in
embryos produced by somatic cell nuclear transfer (SCNT).
The aim of this thesis was to initiate characterisation of the DNA methylation
system in sheep and in particular, to investigate its dynamics in preimplantation
development. The methods used to analyse DNA methylation in normal
preimplantation development were then applied to compare the extent of





1.1 Epigenetic modification of DNA
The term "epigenetic" was coined to describe the inheritance of gene expression patterns
conferred not by the DNA sequence itself, but by mechanisms regulating the
transcription of DNA. The field of epigenetic study was initiated by Conrad
Waddington (1942), at a time when many scientists believed physical change in the
genome (e.g. the loss of unnecessary genes) was the causal factor for cellular
differentiation. He defined epigenetics as "the study of the processes by which genotype
give rise to phenotype". This definition remained untouched for several decades, until
Robin Holliday proposed two independent definitions encapsulating changes in gene
expression occurring at both the adult and developmental stages of growth (Holliday,
1987 & 1994). These terms were combined to form the current day definition of
epigenetics as the study of changes in gene function that are mitotically and/or
meiotically heritable and that do not entail a change in DNA sequence.
Since the initial musings of Waddington, mounting interest in epigenetics has led to the
identification of an increasing number of DNA or chromatin modifications and RNA
based mechanisms. These include the modification of DNA itself (DNA methylation;
reviewed by Bird, 2002), modification of histones (reviewed by Rice & Allis, 2001),
higher order chromatin stmcture (reviewed by Lyko & Paro, 1999; Grewal & Elgin,
2002) and RNA interference (Matzke et al., 2001). Most of these processes are
potentially 'epigenetic', but too little is known of their specific requirement in
developmental processes to determine whether they fulfil a crucial obligation of a true
epigenetic modification, heritability. However, one of these modifications is known to
be truly epigenetic in nature: DNA methylation. Of all of the known DNA regulatory
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mechanisms, DNA methylation has been most intensely investigated and is known to be
stable, reversible (Doerfler et al., 1998) and most importantly, clonally heritable (Bestor
& Verdine, 1994).
1.2 DNA methylation
DNA methylation is the covalent modification of DNA involving the addition of a
methyl group to the cyclic carbon 5 of a cytosine residue (m5C) and is a process
prevalent in both prokaryotic and eukaryotic organisms. The main role of DNA
methylation in prokaryotes is as part of the host defence system, where marking of the
bacterial genome with methylated cytosine protects the host genome from destruction by
its own restriction endonucleases (reviewed by Hubacek, 1992). DNA methylation is
also present in all four groups of eukaryotes (plants, animal, fungi and protists), albeit to
different extents. Most invertebrate species have moderate to high levels of m5C,
however, this is not true in all cases. The fruit fly, Drosophila melanogaster, contains
low levels ofm5C, predominantly at CpT residues (Lyko et al., 2000), and the nematode
worm (Caenorhabditis elegans) completely lacks detectable m5C (Simpson et al., 1986).
DNA methylation is known to be widespread in plants (reviewed by Martienssen &
Colot, 2001), with all species examined demonstrating high m5C levels. In the case of
fungi, some species present methylated genomes (Neurospora crassa, Candida albans)
whereas methylation is undetectable in close relatives such as Saccharomyces cerevisiae
(Selker, 1998; Russell et al., 1987; Proffit et al., 1984).
Vertebrate species demonstrate high levels of m5C, dispersed throughout the genome.
This contrasts with the distribution observed in invertebrate species, where methylation
patterns are generally restricted to non-coding regions. Even amongst vertebrate
species, substantial differences in methylation are detectable, for example, rRNA-
encoding genes are highly methylated in fish and amphibian species, but are relatively
undermethylated in mammals, birds and reptiles (Tweedie et al., 1997). It has been
proposed that the differential distribution of DNA methylation amongst vertebrates, and
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in eukaryotes in general, may reflect an evolutionary system for the implementation of
alternative DNA methylation functions (Colot & Rossignol, 1999).
In mammals, methylated cytosine residues are found predominantly adjacent to guanine
residues, within the so-called CpG dinucleotide. In a typical differentiated human cell,
70-80% of CpG dinucleotides are methylated, with most unmethylated CpG residues
residing in GC-rich regions termed CpG islands localised within the 5' regions of genes
(Bird, 1986). Approximately 60% of human genes are predicted to contain CpG islands,
a significant number of which remain unmethylated throughout development and in
adult tissues (Antequera & Bird, 1993). Recent studies in mice have also identified
methylated cytosine residing in CpA and CpT dinucleotides, although this appears to be
restricted to ES cells and the functional significance has not yet been determined
(Ramsahoye et al., 2000).
Extensive studies of CpG island methylation in the mouse has demonstrated its
involvement in a wide variety of biological processes including X-inactivation (Panning
& Jaenisch, 1996), genomic imprinting (Li et al., 1993), carcinogenesis (reviewed by
Baylin & Herman, 2000) and ageing (reviewed by Issa, 2000). There is also increasing
evidence that DNA methylation is required for the regulation of tissue-specific and
developmental stage-specific genes (Jackson-Grusby et al., 2001; Stancheva et al.,
2002). In each of the aforementioned processes, DNA methylation is likely to be
present in the capacity to repress transcriptional activity.
In addition, cytosine methylation occurs outwith CpG islands, predominantly to silence
transposable elements including SINE and LINE sequences, and intracisternal A particle
(IAP) elements (Liu et al., 1994; Woodcock et al., 1997; Walsh et al, 1998).
Presumably, this action is required to silence the promoters of these DNA elements, thus
preventing DNA damage by unconstrained transposition, the so-called 'genome defense'
model (Yoder et al., 1997). Centromeric satellite DNA is also normally highly
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methylated (Miller et al., 1974), most likely reflecting the highly repressed nature of
heterochromatic regions.
1.2.1 The establishment and maintenance of DNA methylation patterns
The methylation of DNA is catalysed by a family of enzymes known as the DNA
methyltransferases. These enzymes function through a highly conserved catalytic
domain containing a set of conserved sequence motifs. The enzyme utilises S-
adenosylmethionine (SAM) as a substrate, transferring a methyl group to carbon 5 of the
cytosine residue and creating a covalent modification of the DNA. Several DNA
methyltransferases with a demonstratable methylating function both in vitro and in vivo
have been identified in mammals. DNA methyltransferase 1 (Dnmtl) was the first to be
cloned in the mouse (Bestor et al., 1988), and is known as the 'maintenance
methyltransferase' due to its preference for methylating hemi-methylated DNA (Bestor
1992) The recognition and methylation of hemi-methylated DNA allows the clonal
maintenance of methylation patterns in newly replicated DNA. In addition, Dnmtl
protein has been shown to be localised at the replication focus (Leonhardt et al., 1992),
suggesting a direct coupling of DNA methylation with DNA replication. This notion is
further backed by the identification of a PCNA (proliferating cell nuclear antigen)
binding site within the Dnmtl protein sequence (Chuang et al., 1997).
The establishment of new methylation patterns is known generically as de novo
methylation, a process thought to be independent ofDnmtl activity and thus requiring a
different methyltransferase enzyme, or set of enzymes. The recent identification of four
novel mammalian methyltransferase genes provided potential candidates for this unique
role. One gene encodes the Dnmt2 protein, containing the conserved methyltransferase
motifs identified in both prokaryotic and eukaryotic methyltransferases (Yoder et al.,
1998). However, this protein has so far failed to demonstrate either maintenance or de
novo methylating activity in vitro and methylation levels in ES cells carrying a targeted
deletion ofDnmt2 demonstrate no reduction in methylation levels (Okano et al., 1998b).
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Dnmt3a and Dnmt3b are two closely related methyltransferase genes identified through
database homology searches for genes containing conserved methyltransferase motifs
and, in contrast with Dnmt2, have demonstrated methylating activity in vitro (Okano et
al., 1998a). More significantly, they did not show preference for hemi-methylated DNA
in experiments performed in vitro, raising the possibility that they were the long sought
after de novo methyltransferases. Indeed, further experiments confirmed that both
Dnmt3a and Dnmt3b are required for genome-wide de novo methylation (Okano et al.,
1999). Although Dnmt3a and Dnmt3b are now widely recognised as de novo
methyltransferases, the mechanisms by which they target specific DNA sequences
remains unknown.
A further gene belonging to the Dnmt3 family, Dnmt3L, was recently identified,
although the lack of methyltransferase motifs would suggest no direct role in the
methylation of DNA (Aapola et al., 2001). Interestingly, targeted disruption ofDnmt3L
in mice leads to a loss of maternal methylation imprints, implying Dnmt3L may be
indirectly involved in the establishment of DNA methylation patterns (Bourc'his et al.,
2001). Figure 1,1 demonstrates the structural relationships between all known
mammalian DNA methyltransferases.
In addition to Dnmt3L, there appear to be several other proteins with that are
inextricably linked with the maintenance or establishment of methylation patterns but
have no obvious methylating ability. The first was identified in the plant Arabadopsis
thaliana and named DDM1 (Decrease in DNA Methylation) and was shown to be
required for the maintenance of m5C mostly at repeated sequences (Vongs et al., 1993).
Sequence analysis of this gene demonstrated that it does not encode a DNA
methyltransferase, but instead encodes a member of the SNF2-like helicase family,
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Figure 1.1 The DNA methyltransferases of mammals.
Taken from Bestor (2000). All mammalian DNA methyltransferases contain the
canonical methyltransferase motifs within the C-terminal domain except Dnmt3L, which
is not thought to perform methylating activities in vivo. The N-terminal domain, which
is responsible for specific protein-protein interactions, varies between Dnmtl and the
Dnmt3 family, but is completely absent in Dnmt2.
Mutations in a second protein, ATRX, known to cause development abnormalities
including mental retardation, facial dysmorphism and a-thalassemia (Gibbons et al.,
1995) also demonstrated a similar epigenotype to DDM1 mutants in mice and humans,
with changes in DNA methylation pattern observed in several highly repeated sequences
(Gibbons et al., 2000). Interestingly, the ATRX protein, also a member of the SNF2-
like helicase family (McDowell et al., 1999), shares a highly conserved zinc finger
domain with the DNMT3 family of proteins (Aapola et al., 2000), raising the possibility
that various interactions between these proteins could occur to establish or maintain
sequence-specific methylation patterns. A third member of the SNF2-like helicase
family, Lsh (Lymphoid specific helicase; a misleading name as it is expressed
ubiquitously in mouse fetuses (Raabe et al., 2000)), was also recently shown to be
required for maintenance of normal methylation levels, particularly in repetitive DNA
sequences but also in single-copy genes including (3-globin, PgK-2 (phosphoglycerate
6
kinase) and the imprinted gene, HI9 (Dennis et al., 2001). As with ATRX, the apparent
developmental requirement for Lsh and sequence-specific loss of methylation, may
indicate a requirement for SNF-helicases in aiding the establishment of region-specific
methylation patterns at certain stages of development, perhaps by making the DNA more
accessible to DNA methyltransferases.
The processes of de novo and maintenance methylation are likely to be interlinked, with
individual DNA methyltransferases cooperating to establish and maintain methylation
patterns. This has been demonstrated in experiments expressing Dnmtl and Dnmt3a in
transgenic fruitflies (Drosophila melanogaster), a species with little detectable m5C and
thus arguably a good system for analysing in vivo function of DNA methyltransferases
(Lyko et al., 1999). Although this experiment ultimately demonstrated a non-tolerance
for DNA methylation and DNMT expression in fruitflies (resulting in a lethal
phenotype), interesting observations were made concerning the interaction of DNMTs.
Flies co-expressing Dnmtl and Dnmt3a demonstrated increased genomic m5C levels
when compared to flies expressing only Dnmt3a, suggesting significant cooperation of
the two enzymes to establish and maintain methylation patterns.
More recently, biochemical analyses of Dnmt3a in vitro have demonstrated a hemi-
methylating action of Dnmt3a (Yokochi & Robertson, 2002), creating a possible
scenario whereby Dnmtl recognises and completes the methylation of the double
stranded DNA template. This concurs with the previously described findings of Lyko et
al. (1999). The potential interactions between known DNA methyltransferases in
relation to the dynamics ofDNA methylation are summarised in Figure 1.2.
Although specific roles have been defined for each of the DNA methyltransferases
identified so far, for example, in establishing or maintaining methylation patterns, the
possibility cannot be excluded that these roles are interchangeable in certain
circumstances. Indeed, in cancer cells lacking a functional DNMT1 gene, genomic DNA
methylation patterns are stably maintained (Rhee et al., 2000), perhaps demonstrating an
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ability of DNMT3A or DNMT3B to recognise hemi-methylated DNA as a substrate.
Whether alternatative functions of DNMTs are observed solely as a result of cellular
transformation, or whether there is an inherent ability present in all cell types to switch
DNMT roles, remains unknown. In addition, the discovery of further mammalian DNA

















Figure 1.2 Dynamics of DNA methylation pattern
Adapted from Reik et al. (1999). De novo methyltransferases Dnmt3a and Dnmt3b are
generally thought to establish methylation patterns, which are subsequently maintained




As DNA methylation is associated with transcriptional repression, it follows that
demethylation would be linked to gene activation. Demethylation could arise gradually
via passive mechanisms, for example, by preventing maintenance methylation activities
through subsequent cell cycles (passive demethylation). Conversely, methyl groups
could be stripped from DNA, involving an enzymatic process (active demethylation).
The search for an enzyme capable of demethylating DNA (the so-called "demethylase")
has been a long and uphill struggle, with plenty of false starts and significant
controversy.
Several studies performed in the late 1980s and early 1990s demonstrated that active
demethylation can occur within tissue-specific genes (Razin et al., 1986; Paroush et al.,
1990; Saluz et al., 1988). The purification of an extract demonstrating active
demethylating properties was first reported by Jost (1993), and was isolated from
chicken nuclear extracts. Further analysis of the complex comprising the demethylating
activity demonstrated the presence ofboth RNA and proteins, and a preference for hemi-
methylated DNA (Jost et al., 1997). More precisely, the mode of action involves the
removal of methylated cytosine by m5C DNA glycosylase activity, a component of
which was later identified as a G/T mismatch DNA glycosylase (Zhu et al., 2000).
In 1996, a breakthrough in the search for a mammalian demethylase was apparent, with
the discovery of an RNA-associated enzyme activity in rat myoblast cells (Weiss et al.,
1996). However, further examination of this ribozyme-like demethylating activity
demonstrated no RNA component involvement (Swisher et al., 1998). In 1999, a second
report identifying a novel mammalian demethylase protein was released. This putative
demethylase was a truncated variant of the methyl-binding protein, MBD2, (named
MBD2B) and demonstrated the ability to cleave methyl groups from cytosine residues,
releasing methanol as a by-product (Bhattacharya et al., 1999). However, soon after the
reported identification of MBD2B as a mammalian demethylase, two independent
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publications emerged describing the presence of MBD2B within a transcriptional
repressor complex (Ng et al., 1999; Wade et al., 1999). As demethylation is often
associated with gene activation, not repression, the authors of the two 'repression'
reports sought to recreate the experiments demonstrating the demethylating activity of
MBD2B. Unfortunately, these experiments failed and combined with the observation of
unchanged global methylation levels in mice carrying a targeted deletion of MBD2
(Hendrich et al., 2001), the demethylating activity observed by Bhattacharya and
colleagues remains in doubt.
After years of experiments, the search for a mammalian demethylase is still in progress,
with attention returning to m5C DNA glycosylases. The recent identification of MBD4
as a human protein with G/T mismatch DNA glycosylase activity (Hendrich et al.,
1999a) provides a potential candidate. Analysis of recombinant MBD4 confirmed the
presence of DNA glyosylase activity, although in contrast with the chicken, this is
inhibited by the presence of RNA (Zhu et al., 2000). However, targets of this specific
mode of demethylation have yet to be defined and it is also unclear as to whether this
protein is involved in the large-scale demethylation events observed during early mouse
embryogenesis (discussed in section 1.4.4).
1.3 DNA methylation and transcriptional repression
Although the specific roles of DNA methylation in eukaryotic organisms vary
substantially, they share a common theme of transcriptional repression. Approximately
60-90% of the CpG dinucleotides within the mammalian genome are methylated (Bird,
1986), with the unmethylated CpG dinucleotides normally concentrated in CpG-rich
regions termed CpG islands (Bird, 1986). CpG islands tend to be localised within the
promoter regions of many RNA polymerase II transcribed genes (Antequera & Bird,
1993). There have been several models proposed over the years to describe how DNA
methylation may act to repress transcription; these are illustrated in Figure 1.3.
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The model currently most favoured is that of DNA methylation-mediated repression
through the recruitment ofmethyl-binding proteins and associated repression complexes
(Fig. 1.3c). The best described methyl-binding protein MeCP2, was first identified in
the late eighties (Meehan et al., 1989). This protein was shown to preferentially bind
methylated DNA (methyl-Cp-G), via the methyl-Cp-G binding domain (MBD). MeCP2
also contains a transcriptional repression domain (TRD) that interacts with the co¬
mpressor Sin3a, which in turn, binds histone deacetylase (Nan et al., 1998) ultimately
leading to the formation of a silent chromatin state.
Recently, several other methyl-binding proteins (MBD1, MBD2, MBD3 and MBD4)
have been identified, each containing the highly conserved methyl-CpG-binding domain
(Hendrich & Bird, 1998). All of these proteins, with the exception of MBD3,
demonstrate affinity for methylated DNA, but the precise roles of these proteins vary
significantly. MBD1 is involved in HDAC-associated transcriptional repression (Ng et
al., 2000), as are MBD2 and MBD3. There are also several reports suggesting MBD2
and MBD3 directly interact as components of the methylation-associated repression
complex (Hendrich et al., 2001; Zhang et al., 1999; Tatematsu et al., 2000).
Furthermore, Mbd2, alongside a second recently identified methyl-binding protein
named Kaiso, have been identified as part of the methylation-associated repression
complex initially identified as MECP1 (Ng et al., 1999; Prokhortchouk et al., 2001).
As mentioned previously, MBD4 has been identified as a thymine glycosylase, involved
in DNA repair of deaminated methylated CpG residues (Hendrich et al., 1999a). The
extent of involvement of the MBD-containing proteins in global transcriptional
repression has yet to be determined. Little is known of the sequences and genes










Figure 1.3 Possible modes of transcriptional repression by DNA methylation
(A) Direct repression: DNA methylation of CpG dinucleotides within the promoter
region prevents RNA polymerase II from passing through this region, halting
transcription. (B) DNA methylation prevents transcription factors (TF), or other
proteins associated with transcriptional activation, from binding to the promoter
region. (C) Methylated DNA recruits methyl-binding proteins, which in turn recruit
transcriptional repression complexes, such as the mSin3A/HDAC complex. This
leads to deacteylation of histone tails, and the formation of a compact, inaccessible
chromatin structure.
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An interesting observation demonstrating an additional level of complexity to the
methylation-mediated transcriptional repression mechanism was presented recently. The
DNA methyltransferase Dnmtl, was shown to associate with histone deacetylases
HDAC1 and HDAC2 (Fuks et al., 2000). This potentially allows the maintenance of
transcriptionally repressed chromatin during and immediately after replication. An
alternative interpretation suggests Dnmtl may require HDAC activity for it to function
correctly; chromatin remodelling may be required to allow Dnmtl access to the DNA.
A second paper demonstrated that this association was mediated by a co-repressor
named DMAP1 (DNMT-associated protein 1; Rountree et al., 2000). More recently, the
putative de novo methyltransferase, Dnmt3a, has also been found to associate with
histone deacteylase (Fuks et al., 2001) and is recruited by a sequence-specific DNA
binding factor, RP58. Furthermore, Dnmt3a is capable of transcriptional repression
independent of its methylating activity (Bachman et al., 2001: Fuks et al., 2001).
1.4 Specific roles of DNA methylation in gene silencing
Since the initial discovery of DNA methylation, several biological processes have been
identified in which DNA methylation plays a significant role in gene silencing. Some of
these roles are more well-defined, such as allele-specific silencing of imprinted genes,
whereas others remain controversial (tissue-specific gene silencing). Here, the nature of
DNA methylation involvement in a number of silencing processes is described.
1.4.1 Genomic Imprinting
Imprinted genes are by definition, those that are only expressed from one allele; either
the maternal or paternal allele. Genomic imprinting is a phenomenon found only in
placental mammals and is thought to be an evolutionary adaptation to address competing
parental contributions to embryo size and survival (the so-called 'parental conflict
hypothesis'; Moore & Haig, 1991). Imprinted genes have been identified and studied in
several species including the human and sheep; however, the most of our current
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knowledge about the mechanisms of genomic imprinting comes from experiments
performed using the mouse as a model species.
The epigenetic marks, or 'imprints', required for the regulation of imprinted gene
expression, are established in the germlines of each parent and transmitted to the embryo
after fertilisation (Latham, 1999). DNA methylation has properties that meet the full
requirements for the imprinting mark; it affects gene expression (Nan et al., 1998), it is
heritable (Bestor & Verdine, 1994) and is also reversible (Doerfler et al., 1998). DNA
methylation has been shown to be essential to imprinting (Li et al., 1993) as mice with a
targeted deletion of Dnmtl demonstrate inappropriate expression (biallelic expression,
or complete silencing) of a number of imprinted genes including HI9, Igf2 and Igf2r.
However, there is no clear indication of whether DNA methylation establishes the
imprinting mark, and differential methylation may be important in stabilising the imprint
and regulating gene expression rather than being the primary signal.
In imprinted genes, DNA methylation is generally localised within so-called
differentially methylated regions (DMRs). DMRs of imprinted genes are de novo
methylated or demethylated in a sex-specific manner during gametogenesis, establishing
the permanent methylation pattern (Obata & Kono, 2002). In addition, further allele-
specific alterations in methylation occur in some imprinted genes during embryogenesis,
maintaining imprinted control of gene expression at appropriate developmental stages
(Brandeis et al., 1993; Olek & Walter, 1997).
DNA methylation within a DMR can lead to either repression or activation of an
imprinted allele. For example, the maternally expressed murine Igf2r gene contains two
differentially methylated regions, one within the promoter, the second within intron 2
(Stoger et al., 1993). In the maternal allele, DMR1 remains unmethylated, whilst DMR2
is methylated, allowing transcription to occur from the maternal promoter. A reciprocal
pattern of methylation is observed on the paternal allele, with direct silencing of the
paternal promoter through methylation, and indirect silencing via the production of an
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antisense transcript from the unmethylated DMR2, extending into the promoter region
(Wutz et al., 1997; Lyle et al., 2000).
DNA methylation outwith DMRs can also play a role in the regulation of imprinted gene
expression. The mouse imprinted Igf2-H19 loci contains two reciprocally imprinted
genes that are co-ordinately regulated via a common imprinting control centre (reviewed
by Thorvaldsen & Bartolomei, 2000). This imprinting centre is differentially methylated
and serves to function as a CTCF-binding insulator (Szabo et al., 2000). When the
imprinting centre is unmethylated, CTCF can bind, preventing enhancers downstream of
H19 from interacting with the upstream Igf2 promoter. When this site is methylated,
CTCF cannot bind, and the enhancers are free to interact with the Ig/2 promoter (Hark et
al., 2000; Bell & Felsenfeld, 2000). This method of regulation is observed only in
endoderm; mesodermal-specific enhancers have yet to be identified and alternative
regulation strategies may be involved. Figure 1.4 summarises the different modes by
which DNA methylation can interfere with transcription at the Igf2-H19 locus, and also

























Figure 1.3 How differential DNA methylation can regulate allele-specific gene
expression in imprinted genes.
Igf2r: Methylation of the maternal DMR2 prevents production of an antisense transcript,
and allows uninhibited transcription from the unmethylated DMR1. The unmethylated
paternal DMR2 leads to the transcription of antisense RNA which proceeds into DMR1,
aiding the silencing of the paternal Igf2r allele.
Igf2-H19: When the Igf2-H19 imprinting centre is methylated, enhancers downstream
ofHI9 can act to stimulate transcription of the paternal Igf2 promoter. However, when
the imprinting centre is unmethylated, CTCF, an insulator protein, can bind to the site
and prevent access of the enhancers to the Igf2 promoter. The enhancers shown in this




DNA methylation is also involved in the regulation of X-inactivation, specifically as a
regulator ofXist (inactive X-specific transcript), a gene encoding an RNA that binds to,
and coats the X chromosome, thus contributing to X-inactivation (Brown et al., 1991;
Brown et al., 1992; Brockdorff et al., 1992). In the murine trophoblast, Xist expression
is imprinted, with differential methylation observed within the promoter region
(demethylated in male germ cells, methylated in female germ cells; Ariel et al., 1995;
Zuccotti & Monk, 1995). Xist is therefore expressed from the paternal X chromosome,
which ultimately leads to its silencing. However, X-inactivation is random in the fetus
proper, with either the maternal or paternally-derived X-chromosome inactivated. To
reinforce the idea that DNA methylation is necessary for X-inactivation, mice carrying a
mutated Dnmtl gene demonstrated aberrant patterns of Xist expression, leading to
inappropriate X-inactivation activities (Panning & Jaenisch, 1996). In addition to the
regulation of imprinted Xist expression, DNA methylation may also be required for the
regulation of CTCF binding within the Tsix (antisense counterpart ofXist responsible for
imprinted X-inactivation in the placenta) locus, controlling the access of enhancers to
the Xist promoter (Chao et al., 2002).
It should be noted that in humans, the regulation of X-inactivation appears to differ from
the mouse. X-inactivation is not imprinted in the human trophoblast, with random X-
inactivation occuring in both the fetus and trophoblast. Thus, the methods by which Xist
and Tsix expression is regulated, would be expected to differ. Indeed, human TSIX is
known to be truncated in comparison with its murine counterpart (Migeon et al., 2001).
The status of imprinted X-inactivation in other mammalian species is currently
unknown.
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1.4.3 Tissue-specific and developmental stage-specific expression
The reversible and stable nature of DNA methylation makes it an ideal mechanism for
the regulation of genes in a tissue-specific or developmental stage-specific manner.
Indeed, it was proposed in the 1970s that methylation and demethylation of specific
DNA sequences could regulate gene expression during mammalian development
(Holliday and Pugh, 1975; Riggs, 1975). DNA methylation has been shown to be
essential for normal development, as loss of maintenance DNA methyltransferase
(Dnmtl) activity results in embryonic lethality at gastrulation (Li et al., 1992).
However, it is not yet known whether embryonic death can be attributed to a widespread
disruption of methylation-associated gene-regulation during differentiation, since the
observed mis-expression of imprinted genes (Li et al., 1993) or active transcription of
endogenous retroviruses (Walsh et al., 1998) may be sufficient to prohibit normal
development. In fact, some believe that DNA methylation is only required for the
silencing of endogenous retroviruses, and that it silences genes only in specific
circumstances, namely imprinted genes and during X-inactivation (Walsh & Bestor,
1999).
Studies investigating the relationship between gene expression and promoter
methylation status have been performed in both tissues and the developing embryo,
however, these have proved somewhat inconclusive. For example, the mouse skeletal
a-actin promoter retains similar levels ofmethylation in expressing and non-expressing
tissues (Wamecke & Clarke, 1999). Furthermore, genes including the oxytocin receptor
(Oxtr; normally expressed in myometrium, endometrium, mammary gland and ovaries
(Kubota et al., 1996)) and Pax3 (expressed in limb precursors and the central nervous
sytem) were not found to be highly methylated in non-expressing tissues (Walsh &
Bestor, 1999). On the contrary, methylation of the human ApoA-I gene promoter is
found only in non-expressing tissues, consistent with a role in gene silencing (Shemer et
al., 1990). The different observations may reflect the use of alternative silencing
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mechanisms in tissue-specific gene regulation, although it should be noted that the
techniques used to analyse promoter methylation status in the aforementioned studies
only looked at limited CpG sites and may not be indicative of the entire promoter region.
It was not until recently that convincing evidence emerged, providing a link between
DNA methylation and developmental regulation of tissue-specific or stage-specific
genes. Studies using Xenopus laevis have demonstrated alterations in promoter
methylation in several genes, correlating with changes in developmental expression
patterns (Stancheva et al., 2002). The promoters of three genes known to be activated at
the midblastula transition (MBT; TFIIIA, Xbra and c-Myc II) were found to be
significantly demethylated, whereas repetitive sequences, and promoters of genes known
to be inactive at MBT, demonstrated no detectable changes in DNA methylation.
Furthermore, depletion of DNMT1 in Xenopus embryos led to observations of
inappropriate promoter methylation in genes required at MBT, and transcriptional
release of genes normally silenced at this stage. Although these experiments clearly
demonstrate a requirement for DNA methylation in developmental gene regulation in
Xenopus, experiments to determine whether this role is replicated in other species,
particularly mammals are evidently required.
A recent experiment investigating the requirement for DNA methylation in a
differentiated cell type provides additional evidence to support the hypothesis that DNA
methylation is required for tissue-specific gene regulation. Using murine fibroblast cells
carrying a conditional deletion of Dnmtl, Jackson-Grusby and colleagues (2001)
demonstrated that loss of Dnmtl activity resulted in the activation of many non-tissue-
specific genes. They also described a 10% overall increase in gene activation, including
two placental-specific genes, the B-cell surface antigen 3b, and a gene involved in
adipose differentiation. These results imply a role for DNA methylation in regulating
tissue-specific expression patterns, although the possibility that epigenetic disregulation
occurred as a consequence of an indirect mechanism, cannot be excluded.
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1.4.4 Cancer and ageing
Changes in genomic m5C content are often observed as a result of neoplasia. These
alterations are specifically manifested as a genome-wide hypomethylation (loss of
methylation) event (Goelz et al., 1985) and hypermethylation (increased methylation) of
gene-linked CpG islands (reviewed by Jones & Laird, 1999). Hypermethylation of
tumor-supressor gene promoter regions are seen in several cancers, including
retinoblastoma (RB gene) and renal cancer (von Hippel Landau (VHL) gene), providing
a substantial link between methylation and cancer (Stirzaker et al., 1997; Herman et al.,
1994). The extent of DNA methylation involvement in silencing tumour suppressor
genes has lead some to revise the 'two-hit hypothesis' to include DNA methylation as
one of the processes able to inactivate these genes and induce tumorigenesis (Jones &
Laird, 1999).
A gradual increase in CpG island methylation, alongside a general decrease in global
methylation levels, is also seen as a result of the ageing process (Issa, 2000). For
example, an age-related increase in methylation levels within the human oestrogen
receptor promoter has been reported, mirroring the inappropriate methylation known to
occur in colon cancer (Issa et al., 1994). In addition, the methylation status of the
imprinted gene IGF2, also undergoes age-related changes, with the differential
methylated region DMR1, switching from mono-allelic to biallelic methylation (Issa et
al., 1996). As with the changes in the human oestrogen receptor, the increased
methylation status of IGF2 also correlates with neoplastic transformation. These results




Mammalian development shares many common themes, but there are subtle differences
between species, including modes of implantation and placentation, the length of
gestation and the timing of key events such as compaction and gastrulation. Differences
observed at specific stages of development, including preimplantation and peri-
implantation development, most likely result from alternative gene expression and thus
thus may represent epigenetic differences. Here, a brief outline of events occurring
during post-fertilisation sheep development is described, highlighting the known
differences between ruminant, primate and rodent development at specific stages of
early development.
1.5.1 Pre-implantation development
The events of early (preimplantation) development in mammalian embryos are
morphologically similar, although differences in timing (summarised in Table 1.1) and
cell size are evident. In all species, the zygote undergoes several rounds of cell
cleavage, leading to the formation of a blastocyst and followed by attachment of the
embryo to the uterine wall. Initially, the mature oocyte is arrested at metaphase II of
meiosis, characterised by the formation of the polar body, with fertilisation subsequently
triggering the completion of the meiotic process. At this stage, the second polar body
(containing a haploid set of chromosomes) is extruded, and DNA synthesis of sperm and
egg chromosomes proceeds, forming the male and female pronuclei. When DNA
synthesis is complete, the pronuclei fuse and the first cell division is underway.
Subsequent cell divisions lead to the formation of 4, 8 and 16 cell embryos. At the 16-
cell stage in mouse (32-64 cell stage in sheep), the embryo becomes known as a morula,
characterised by cellular compaction and a fluid-filled cavity known as the blastocoel
(summarised in Figure 1.5 (i)).
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The blastocyst is distinguished by the compartmentalisation of two specialised cell-
types, a process initiated at the morula stage and signalling the onset of differentiation.
The inner cell mass (ICM) contains cells destined to form mainly embryonic tissues and
the remaining outer cells form the trophectoderm which contributes to the extra¬
embryonic tissues in subsequent stages of development. After further expansion of the
blastocoel cavity, the embryo 'hatches' out of the zona pellucida (a protein layer of
extracellular material deposited by the growing oocyte). From this point on,
considerable divergence of mammalian implantation and placentation mechanisms are
apparent.
Stage Sheep Mouse Human Cow Pig
2-cell D1 D1 D1.5 D1 DO.6-0.8
ZGA
4-cell D2 D1-2 D2-2.5 ZGA D2 D1 ZGA
8-cell D3 ZGA D2 D2.5 D3 ZGA D2.5
Morula D5 D3 D4 D4
(32-64 cells) (16-32 (16-32 cells) (32-64 cells)?
cells)
Blastocyst D6-7 D3.5 D6-7 D7 D5-6
(>100 cells) (64 cells) (>80cells) (>100cells)
Implantation D15 D4 D7-8 D22 D13
End of D145-155 D19-20 D252-274 D278-290 D112-115
Gestation
Table 1.1 Timing of specific developmental stages in the sheep, mouse, human
cow and pig
The day at which each species reaches the stage specified is expressed in terms of days
post conception (D=dpc). The approximate cell number at the formation of the morula
and blastocyst stages in each species is also highlighted. ZGA indicates the onset of
zygotic genome activation in each species. The table is a modified version taken from
Noden and DeLahunta, 1985).
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1.5.2 Implantation and placentation
In the mouse and human, the blastocyst invades the uterine endothelium almost
immediately after hatching, however, this is not the case in farm animals. The hatched
sheep, pig or cow blastocyst demonstrate a marked change in size and structure, with the
trophoblast elongating rapidly to reach a length of several centimetres by days 15, 16
and 17 of gestation respectively (highlighted in Figure 1.5(ii)). During the elongation
process, the embryo remains free in the uterus, and does not implant into the uterine wall
until around day 15 of gestation (an extensive overview of farm animal implantation can
be found in King et al, 1982). In the mouse and human, implantation is followed by
gastrulation and the subsequent differentiation of the ICM into the mesoderm, endoderm
and ectoderm, which in turn give rise to the embryo. In contrast, farm animals gastrulate
prior to implantation.
The modes of placentation observed in rodents and primates also differs significantly
from placentation in farm animals. In the mouse, the outer layer of trophectoderm cells
invades the uterine epithelium, basal lamina and endometrium, leading to the formation
of the placenta. The placenta subsequently further invades the uterus, with direct contact
occurring between the fetal trophoblast and maternal blood vessels. This form of
'invasive' placentation is known as hemochorial placentation and is also seen in humans
(rodent and primate placentation is reviewed by Enders & Welsh, 1993).
When the ruminant embryo reaches the time of implantation, the outer trophoblast cells
do not invade the maternal endometrium, but instead form attachments at specific sites
known as caruncles (as highlighted in Figure 1.5 (iii)). At these points of fetal-maternal
contact, specialised structures known as cotyledons then form from the chorioallantoic
membranes of the developing conceptus. The cotyledons and caruncles are jointly
known as placentomes and it is through these structures that most fetal nourishment is
obtained. This form of placentation is known as epitheliochorial placentation, and
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differs from hemochorial placentation as the placenta and uterus are separated by
maternal and placental epithelial layers. Epitheliochorial placentation is also seen in the
pig, although there are differences between the placentae of pigs and ruminants. An
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Attachment to uterine caruncles
Figure 1.5 Stages of preimplantation development, implantation and
placentation in the sheep and cow
Taken from Young et al., 1998a. (i) After fertilisation, the subsequent cleavage rounds
occur leading to the formation of the blastocyst. The timing of zygotic genome
activation (ZGA) is indicated, (ii) After the blastocyst hatches, the trophoblast elongates
forming a 'tapeworm-like' structure, implanting in the uterus at day 15. Gastrulation
occurs during elongation, prior to implantation, (iii) Sheep and sheep placentation is
non-invasive, with fetal-maternal contact localised at structures known as placentomes,





1.6 Reprogramming of DNA methylation patterns in normal
mammalian development
The reprogramming of gametic DNA methylation patterns during preimplantation
development is required for the formation of an epigenetically typical embryonic
genome capable of sustaining development. The dynamics ofDNA methylation patterns
during murine preimplantation development have been intensely investigated, with both
passive and active mechanisms believed to be involved in reprogramming. However,
the methylation reprogramming observed post-fertilisation is a continuation of events
initiated when the primordial germ cells (PGCs) of a day 10.5-11.5 mouse fetus enter the
genital ridge. At this time, the DNA of PGCs is rapidly demethylated, leading to the
erasure of all methylation imprints and re-activation of the inactive X in female germ
cells (Tada et al., 1998; Mann, 2001; Tarn et al., 1994). It is not yet known what
triggers the demethylation event or whether it is an active or passive process. During
later stages of gametogenesis, imprints are re-established (as discussed in section 1.4.1)
alongside a general increase in DNA methylation levels, with the sperm acquiring higher
levels of methylation in comparison to the oocyte (Sanford et al., 1987; Razin &
Shemer, 1995).
Shortly after fertilisation and prior to the first cell division, the murine paternal genome
undergoes widespread demethylation (Mayer et al., 2000; Oswald et al., 2000), a
process thought to be active in mechanism. Whilst the paternal genome is rapidly
demethylated, the maternal pronucleus in the fertilised embryo retains its methylation
status, and is passively demethylated during the first few embryonic cell divisions,
apparently by the failure to maintain methylation patterns (Rougier et al., 1998; Monk et
al., 1987). The differential methylation of maternal and paternal genomes is thought to
be linked to the establishment of methylation imprints in the zygote (Oswald et al.,
2000).
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One hypothesis explaining the rapid demethylation of the paternal pronucleus after
fertilisation may be linked to chromatin remodelling events occurring at this stage.
When the sperm first enters the oocyte, its DNA is packaged in protamines, forming a
highly compact chromatin structure. These protamines are progressively exchanged for
maternally-stored histones, between the point of sperm entry and the initial phase of
DNA replication (Nonchev & Tsanev, 1990). Thus, the maternal and paternal pronuclei
are significantly different in terms of gross chromatin structure at the onset of
development. During this time, the sperm DNA is rendered 'naked' for a short period,
which may be long enough for demethylating agents in the ooplasm to act upon the
unprotected DNA. This hypothesis could also account for the protection of the maternal
pronucleus (with previously acquired histones) from active demethylation. In addition
to this, parthenogenetic embryos do not demonstrate any demethylation post-activation,
strongly suggesting that the differences in paternal and maternal chromatin remodelling
may be the underlying cause of the observed differential demethylation events (Barton et
al., 2001). The passive loss of DNA methylation observed between the 2-cell and
blastocyst stage of development is likely to be a result of the retention of maintenance
methyltransferase, Dnmtl, in the cytoplasm of oocytes and early stage embryos (Carlson
et al., 1992; Cardoso & Leonhardt, 1999).
It should be noted that there are exceptions to the widespread demethylation events, for
example, some paternally derived sequences, such as the HI9 paternal allele, are
protected from the initial active demethylation (Olek & Walter, 1997; Tremblay et al.,
1997). The retention of high levels ofmethylation in IAP proviral repeats (Walsh et al.,
1998) and centromeric satellite sequences (Rougier et al., 1998) is also observed. As
Dnmtl is not thought to be active for most of preimplantation development, the activity
of the de novo methyltransferases Dnmt3a and Dnmt3b may be responsible for the
residual methylating activity occurring at this time. As these proteins have not been
assessed in preimplantation embryos as yet, it is not possible to relate the retention or
establishment of DNA methylation levels within specific DNA sequences to the activity
of these proteins, or to as yet unidentified molecules. After the gametic methylation
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patterns have been erased, they must be reprogrammed to allow successful development
of the embryo. This re-establishment of methylation patterns, known as de novo
methylation, may be performed by the putative de novo methyltransferases Dnmt3a and
Dnmt3b, (Okano et al., 1999) although the precise mechanisms of this process are
poorly understood.
The level of conservation of epigenetic reprogramming in other species was not
investigated until recently. Studies in two lower vertebrate species, Xenopus and
Zebrafish, failed to show any significant changes in global methylation levels during the
early stages of development (Stancheva et al., 2002; Macleod et al., 1999). The absence
of global demethylation in these two species is intriguing, although it is possible that
other forms of epigenetic reprogramming, such as chromatin remodelling, may be more
important in non-mammalian species. As neither frogs nor fish have imprinted genes,
and it has been proposed that post-fertilisation demethylation is required to re-set
methylation imprints (Oswald et al., 2000), this event may be strictly a mammalian
phenomenon.
Dean et al. (2001) have recently shown that methylation reprogramming is conserved to
a large extent in three other mammalian species; cow, rat and pig. Using indirect
immunoflourescence with an antibody directed against 5-Methyl Cytosine (5-MeC),
they demonstrated that active demethylation of the paternal genome occurs shortly after
fertilisation in each of these species. Methylation patterns were also analysed in later
stages of cow preimplantation development where passive demethylation of the maternal
genome was observed, although this did not extend to the blastocyst stage as occurs in
the mouse. The timing of de novo methylation appears to differ slightly in cow
embryos, occurring at the 8-16 cell stage, as opposed to after the blastocyst stage in the
mouse. Overall, the transient demethylation and early de novo methylation in the cow
embryo highlight mammalian species-specific differences in these reprogramming
events.
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Interestingly, two further papers analysing sequence-specific methylation in cow
preimplantation embryos both observed demethylation of euchromatic sequences
(including the BOV-B LINE), whilst heterochromatic sequences (including Satellite I
remained highly methylated (Bourc'his et al., 2001; Kang et al., 2001a). Furthermore,
demethylation extended into the blastocyst stage, with no early de novo methylation
observed. The discrepancies in observations between the three cow studies are
suprising, but most likely reflect the use of different methylation analysis techniques.
For example, Dean et al. used indirect immunofluorescent methods on whole embryos,
whereas Bourc'his et al. studied metaphase chromosome spreads. This may have
resulted in the preferential binding of the m5C antibody to different sequences, thus
accounting for the observed differences. Moreover, the bisulfite method utilised by
Kang et al. (2001a) analysed only specific sequences.
The differences observed between species in the timing of key events such as zygotic
genome activation (ZGA; the switch from maternal to zygotic control of development),
compaction, implantation and gastrulation, are most likely reflected in developmental
gene expression and presumably epigenetic processes. Firstly, the number of cells in
morulae or blastocysts differ between the embryos of various mammals, reflecting the
different timing of compaction. Secondly, the timing of implantation and embryonic
morphology at this stage is also highly different. Finally, the initiation of zygotic
genome activation (ZGA) occurs at different embryo stages, with significant active
transcription occurring at the 2-cell stage in mouse, the 4-cell stage in the human as
opposed to the 8-cell stage in the pig and the 8-16 cell stage in the sheep and cow
(Telford et al., 1990).
It is possible that DNA methylation is one such epigenetic mechanism involved in
regulating the timing of key events in pre- and peri- implantation development. If so, it
might be expected that variations in methylation reprogramming exist between
mammalian species, reflecting the differences in timing. As mentioned previously,
Dean and colleagues (2001) have shown that although active demethylation of paternal
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pronuclear DNA is conserved between several mammalian species, the precise
reprogramming events occurring beyond this stage (particularly for the cow) may differ
substantially from those seen in the mouse. However, as the functional role of DNA
methylation reprogramming observed during preimplantation development in processes
such as ZGA, compaction and blastocyst formation remains unclear, it is not possible to
say whether the observed differences in species-specific reprogramming underlie the
timings of key events during preimplantation development.
The reprogramming of DNA methylation patterns is not the only significant epigenetic
event occurring during preimplantation development. For example, in the mouse, the
male pronucleus demonstrates significantly higher levels of transcriptional activity in the
1 -cell embryo, (Ram & Schulz, 1993; Bouniol et al., 1995) representing differences in
chromatin structure and accessibility. Studies of histone acetylation in mouse 1 -cell
embryos demonstrated differences between the maternal and paternal pronuclei.
Hyperacetylated histone H4 was shown to be associated with paternal but not maternal
chromatin (Adenot et al., 1997), explaining the differential transcriptional activity
observed at this time. It is likely that further epigenetic modifications such as histone
methylation, are also involved in the control of transcriptional activity and thus the
regulation of timings of ZGA, compaction and implantation in mammalian development.
1.7 Somatic cell nuclear transfer
In vitro embryo technologies present major advantages in commercial agriculture,
assisted reproduction in humans and towards more efficient mouse embryo production
methods for scientific research. In humans, in vitro fertilisation (IVF) has been used
successfully since the 1970s to assist couples with fertility problems (review of assisted
reproduction technologies including IVF can be found in Menezo et al., 2000). More
specific techniques such as ICSI (Intra-Cytoplasmic Sperm Injection) have also been
developed (reviewed by Mansour, 1998). The state of embryo technologies in the
mouse has greatly enhanced the production of mice for research purposes with methods
29
such as superovulation (hormonal stimulation of oocyte release) allowing optimal
production of embryos.
In farm animals, artificial insemination and in vitro fertilisation potentially allows for the
improved selection and large-scale production of animals with desired genetic traits. In
addition, somatic cell nuclear transfer (SCNT), a more recently established embryo
technology, is a potentially valuable commodity for the production of genetically
modified animals for use as bioreactors, or as organ donors for xenotransplantation.
Recent advances have demonstrated the feasibility of these processes, with the
production of sheep expressing the human factor IX protein in milk (Schneike et al.,
1997) and cloned pigs and sheep carrying a targeted disruption of the alphal,3-
galactosyltransferase gene, encoding a major xenoantigen responsible for tissue rejection
when performing xenotransplantation (Dai et al., 2002; Denning et al., 2001).
Further to the aforementioned agricultural advantages, SCNT may also contribute to the
success of human stem cell therapies. It is envisaged that human adult cells could be
cloned, with ES cells produced from the resultant embryos and differentiated in vitro to
produce virtually any adult cell type. The resultant cells would be genetically identical
to the patient's and would thus remove any possibility of tissue rejection. Diseases such
as Parkinson's could be cured by the cloning of a 'healthy' cell type (e.g. skin
fibroblast), to create an embryo, and subsequent differentiation of embryonic ES cells
into dopaminergic cells. However, such research is in its infancy and currently limited
by the low success rates of cloning and inherent problems as described later in this
section. Furthermore, the ethical considerations of cloning research in humans,
particularly the generation of embryos solely for subsequent ES cell derivation, have
been widely debated and hence research is restricted by licensing. Consequently, the
use of surplus IVF and ICSI human embryos may be a more practical source of ES cells
for basic research at this time.
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Currently, the widespread application of livestock embryo SCNT-related technologies is
somewhat limited by the very low success rates, reflecting the high incidence of fetal
abnormalities and mortality (reviewed by Young & Fairbum, 2000). These may be
attributed to incomplete epigenetic reprogramming of somatic nuclei occurring after the
SCNT process. In addition to SCNT, in vitro embryo production techniques also suffer
inherent problems including low success rates and increased fetal size (often associated
with fetal mortality) when comparing in vitro produced embryos with their in vivo-
derived counterparts (Young et al., 2001).
Somatic cell nuclear transfer involves the transfer of genetic material from a
differentiated nucleus into an enucleated oocyte. The cell is either fused with, or
microinjected into the oocyte to initiate development. The first vertebrate nuclear
transfer, or 'transplantation' experiments were performed by Briggs & King (1952), in
order to determine whether differentiated cells could be reprogrammed to induce
development. Using the frog as a model (Rana pipiens), blastula nuclei were
transplanted into enucleated oocytes, and tadpoles obtained. Further experiments
demonstrated that the more advanced or differentiated the nucleus (using cells from a
post-gastrulation embryo), the lower the success rates of these transplantation
experiments (Briggs & King, 1957), prompting many to believe that reprogramming
highly differentiated nuclei was impossible. Almost a decade after the original
experiments were performed, it was discovered that differentiated intestinal cells derived
from Xenopus laevis larvae were indeed able to de-differentiate when transferred to an
enucleated oocyte, and sustain normal development to the tadpole stage (Gurdon, 1962).
After these initial successes, attention turned to mammalian nuclear transfer, with micro¬
injection techniques developed during the mid to late 1970s (Bromhall, 1975). Thus
followed almost twenty years of experimental optimisation of the nuclear transfer
technique, with little or no success. The persistent failures, combined with the discovery
that both the maternal and paternal genomes were required for normal development, led
some to believe mammalian cloning was impossible (McGrath & Solter, 1984; Barton et
31
al., 1984). However, this was not true, and success first came in the production of sheep
using a cultured embryonic cell line that had undergone several passages (Campbell et
al., 1996). The method utilised fused enucleated metaphase II (Mil) oocytes with
serum-starved donor cells arrested in the Go phase of the cell cycle, with subsequent
activation by electrical stimulation (outlined in Figure 1.6). Nonetheless, it wasn't until
the advent of Dolly, that the production of a clone from a fully differentiated cell (adult
mammary gland epithelial cell) was shown to be possible (Wilmut et al., 1997). Soon
after, the cloning ofmice from cumulus cell nuclei was reported, using a microinjection
technique for nuclear transfer rather than cell fusion (Wakayama et al., 1998). Many
successes in other mammalian species have followed in recent years, although success
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It is believed that the low success rates of SCNT can be mostly attributed to the failure
of the oocyte to completely reprogramme somatic nuclei in order to sustain normal
embryonic development. In addition to reprogramming errors (discussed in section 1.7),
there are several elements of the SCNT procedure itself, which may significantly reduce
the potential for successful development and ultimately lead to failure of the SCNT
process (these are highlighted in Figure 1.6). The processes which may introduce
additional errors are also common to other in vitro embryo production technologies used
routinely in sheep and cattle. For example, the source of oocytes used as the recipient
could affect the success of SCNT depending on their existing developmental capacity
prior to enucleation. As SCNT requires large numbers of recipient oocytes (>100) to
gain only a few live offspring, the harvesting of naturally ovulated oocytes is not a
practical option in large animals. Instead, either superovulation or in vitro maturation of
oocytes is commonly used.
In vitro maturation (IVM) of oocytes consists of the collection of oocytes from abattoir
slaughtered sheep or sheep ovaries and subsequent culture in vitro. Typically, only
follicles of 2-5 mm are aspirated (purportedly containing the most developmentally
competent oocytes) and the oocytes are subsequently matured for 24 hours in TCM199
medium supplemented with serum, FSH (follicle stimulating hormome), LH (luteinising
hormone) and oestradiol (Walker et al., 1996). This encourages oocyte development to
the metaphase II stage of meiosis, the stage at which mature oocytes are normally
released from the ovary. Superovulation involves the hormonal stimulation of ovaries
with GnRH (gonadotrophin-releasing hormone), FSH and LH to release larger than
normal numbers ofmeiotically matured oocytes over a short period of time (reviewed by



















































Figure 1.6 Somatic cell nuclear transfer (SCNT) in sheep
The stages of the nuclear transfer process from oocyte collection to the production of live
offspring are outlined. Possible reasons for the low success rates of SCNT, including inefficient
reprogramming and effects of oocyte source or in vitro culture, are highlighted in red.
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In vivo, oocyte competence is gained gradually, as the oocyte develops within the
follicle. This involves the acquisition of mRNA transcripts and proteins required for
control of the initial stages of development. In addition, modifications are made to both
DNA and RNA during the final stages of oocyte maturation. For example, mRNA
transcripts found in the growing oocyte have shorter than normal polyA tails, inhibiting
translation and are only adenylated when translation is required (reviewed by Gandolfi
& Gandolfi, 2000). Furthermore, DNA methylation imprints are established at different
stages of oocyte growth (Obato & Kono, 2002). A key methylation modifier, Dnmtlo,
is also known to be present abundantly in mature mouse oocytes. This is a truncated,
oocyte-specific isoform of Dnmtl predominantly localised in the cytoplasm of mature
oocytes and preimplantation embryos (Mertineit et al., 1998; Carlsson et al., 1992).
However, in earlier stages of oocyte growth, Dnmtl is found in the nucleus and during
later stages is dispersed into the periphery of the ooplasm until localised in a cortical
shell (Mertineit et al., 1998). Some of the oocytes acquired by superovulation or in vitro
maturation could be relatively immature in terms of cytoplasmic content, or even
possibly derived from mildly atretic follicles. This could in theory, lead to a
heterogeneous pool of oocytes being used as recipients in SCNT experiments, with
varying extents of incomplete methylation imprints, untranslatable mRNA transcripts
and inappropriate localisation ofDnmtlo.
A second potential source of problems could arise from in vitro culture of SCNT
embryos. The same culture system used for in vitro fertilised embryos is used to culture
fused SCNT embryos to the blastocyst stage. Serum free media is favoured (e.g.
synthetic oviduct fluid containing amino acids and sheep serum albumin (SOFaaBSA)),
as exposure to sera has been shown to contribute to the fetal growth and developmental
abnormalities collectively termed as 'Large Offspring Syndrome' (LOS; Young et al.,
1998a). This phenotype has been reported in cattle and sheep produced by IVM, IVF
and in vitro culture, as well as somatic cell nuclear transfer (SCNT; reviewed by Young
& Fairburn, 2000). The precise mechanisms or specific factors involved in the induction
of this phenotype remain undetermined. However, aberrant methylation of an imprinted
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gene, the insulin-like growth factor II receptor (IGF2R), has been reported in sheep
fetuses with fetal overgrowth (Young et al., 2001). It is possible that inappropriate DNA
methylation of other imprinted genes, or other DNA sequences, may also contribute to
this phenotype in in vitro produced or SCNT embryos. Although the use of serum-free
media generally leads to the production of apparently healthy offspring (De Sousa et al.,
2001), it cannot be ruled out that this method of embryo culture has no effect on
epigenetic status whatsoever.
It should also be noted that the cells used to provide donor nuclei could potentially be
epigenetically altered by culture or serum-starvation prior to SCNT. Epigenetic defects
in imprinted genes (Igf2, HI9, Igf2r and U2afl-rsl) have been observed as a result of
ES-cell culture, leading to the mis-expression of developmentally important genes in
embryos derived from these cells (Dean et al., 1998). The effects of serum-starvation on
sequence-specific epigenetic status have been analysed in fetal fibroblasts, with no
change in methylation levels observed within Satellite I DNA pre- and post- semm
starvation (Kang et al., 2001a). However, it possible that some genes or sequences may
be more susceptible to epigenetic modification in culture, and thus other epigenetic
changes may have remained undetected.
1.8 Epigenetic reprogramming in cloned embryos
The successful production of animals by nuclear transfer has demonstrated that highly
methylated and differentiated somatic nuclei can be sufficiently reprogrammed to
sustain embryonic development (reviewed by Solter, 2000). However, the extent to
which epigenetic reprogramming is conserved in cloned embryo development is only
beginning to be examined (reviewed by Fairburn et al., 2002) and inefficient or partial
epigenetic reprogramming may be responsible for the low birth rates and developmental
abnormalities often seen as a result of the nuclear transfer process (reviewed by Young
& Fairburn, 2000). One aspect of interest is the ability of the enucleated oocyte to
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recognise and reprogramme methylation patterns of somatic nuclei or other epigenetic
modifications
There are a number of epigenetic processes that may be affected by the SCNT process.
In the 'normal' situation, maternal factors stored in the oocyte cytoplasm modify
paternal and maternal DNA differentially, whereas in cloned embryos, the same factors
have to modify a single, highly differentiated somatic nucleus. Most is known about
DNA methylation changes occurring post-fertilisation in mouse development, including
the differential demethylation of paternal and maternal genomes (Mayer et al., 2000;
Oswald et al., 2000) and the maintenance and establishment ofmethylation imprints (El-
Maari et al., 2001; Olek & Walter, 1997; Tremblay et al., 1997). The dynamic changes
occurring at this time signify DNA methylation as a candidate process to analyse in
SCNT embryos.
Another significant epigenetic change occurring after fertilisation is the protamine-
histone exchange (as discussed section 1.6). Also mentioned previously (section 1.6)
was the possibility that active demethylation of the paternal pronucleus observed after
fertilisation may be aided by the temporary cytoplasmic exposure of unpackaged
paternal DNA during histone-protamine exchange. In fused SCNT 1 -cell embryos, the
DNA of somatic nuclei is already packaged into somatic histones, and these may not be
exchanged to the same extent as protamines (Bordignon et al., 2001). If only a fraction
of the DNA is exposed to demethylating agents at this stage, somatic DNA methylation
patterns may be maintained, with detrimental effects to later stages of embryonic
development.
Further epigenetic modifications such as histone acetylation and histone methylation
may also be difficult to reprogramme in SCNT embryos. Interference from the large
quantity of proteins associated with a transcriptionally active somatic nucleus may also
contribute to reprogramming problems in cloned embryos. However, little is known of
general histone modifications in the preimplantation embryo, thus the reprogramming of
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DNA methylation remains the most easily examined modifications in cloned embryos at
this time.
To address this specific issue, several investigations have been reported recently,
analysing the conservation ofmethylation reprogramming events during cloned embryo
development. Dean et al. (2001) analysed demethylation events in cloned sheep
embryos. Interestingly, the initial demethylation event appeared to be conserved in
cloned 1 -cell embryos, with loss of methylation in the somatic donor cell nucleus
observed shortly after fusion with the enucleated oocyte. Further demethylation was
observed at the 2-cell stage at which point demethylation ceased, an event followed by
spurious de novo methylation in many 4-8 cell stage embryos.
The observations ofDean et al. (2001) demonstrated that methylation reprogramming in
somatic nuclei is partially conserved in cloned embryos, with different extents of
inappropriate methylation seen in individual embryos. However, more detailed
information on which sequences are aberrantly methylated in cloned embryos is required
to further understand the observed phenotypes and low success rates of cloning. A
second investigation using the m5C antibody on metaphasic chromosome spreads
addressed this question, analysing euchromatin and heterochromatin specific regions in
normal and cloned cow blastocysts (Bourc'his et al., 2001). When compared to their
normal counterparts, cloned cow blastocysts demonstrated increased levels of
methylation in centromeric heterochromatin, but comparable levels in euchromatin. In
agreement with Dean et al. (2001), this study also demonstrated inefficient passive
demethylation during the initial embryonic cell divisions, although contrarily, they failed
to observe the 'active' demethylation of somatic nuclei after fusion.
Methylation analysis of specific DNA sequences has also been performed using bisulfite
treatment and subsequent restriction analysis in cloned cow and porcine embryos (Kang
et al., 2001a; Kang et al., 2001b). Analysis of the Satellite I DNA sequence (a major
constituent of centromeric heterochromatin) in normal and cloned cow blastocysts
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demonstrated increased methylation levels in significant numbers of cloned embryos.
Analysis of another repeat sequence in cow cloned embryos, the Bov-B LINE (which
normally undergoes demethylation during cow preimplantation development) again
demonstrated inefficient reprogramming, with the methylation status remaining
unchanged between the 4-8 cell and blastocyst stages. Surprisingly, cloned porcine
embryos do not appear to show highly aberrant patterns of methylation, with most
cloned blastocysts retaining similar methylation levels to their normal counterparts in the
centromeric satellite and the PRE-1 SINE DNA sequences.
Overall, these findings present a picture of partial, but incomplete methylation
reprogramming in many cloned embryos. Possible reasons for the lack of complete
reprogramming include the inability of the oocyte to efficiently reprogramme highly
methylated and differentiated somatic nuclei. However, as the somatic donor nuclei of
cloned cow embryos appear to be demethylated shortly after activation (Dean et al.,
2001), the oocyte is able to at least partially reprogramme methylation patterns of the
somatic nuclei. A second explanation resides within the somatic nucleus, as
inappropriate expression and nuclear localisation of somatic Dnmtl in the embryonic
nucleus may be introduced from within the donor cell nucleus. As the normal mouse
zygote retains Dnmtl in the cytoplasm, the introduction of somatic Dnmtl could result
in maintenance of methylation levels either significantly, or partially, thus contributing
to the aberrant epigenotype observed in cloned embryos. Alongside Dnmtl, a whole
host of other DNA methylation associated proteins (including de novo
methyltransferases, DNMT-interactors or methyl-binding proteins) perhaps not normally
found in the early embryo, could also lead to aberrant methylating activity. Finally,
altered methylation levels in cloned embryos could also arise from the early expression
of DNA methyltransferases (or indeed other methylation-associated proteins) caused by
spurious transcriptional activation of the donor cell nucleus.
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1.8.1 Consequences of inefficient methylation reprogramming
Certain fundamental questions pertaining to the specific roles of DNA methylation in
development must be addressed before the observations of aberrant methylation
reprogramming can be interpreted confidently. For example, are methylation errors in
heterochromatic sequences, such as satellite DNA, detrimental to normal development?
Undermethylation of minor satellite DNA is observed in patients suffering with ICF
syndrome (conferred by mutations in the human DNMT3B gene), contributing to a range
of developmental abnormalities. And to what extent is aberrant reprogramming
tolerated in embryos? It is well known that methylation errors in imprinted genes can be
directly linked to the mis-expression of these developmentally important genes, thus
perturbing normal development (reviewed by Reik & Walter, 2001). Erroneous
expression of this particular subset of genes has been widely postulated as a potential
contributory factor to the overgrowth phenotypes observed in cloned animals. It has
been suggested that cloned embryos may tolerate a certain extent of inappropriate
reprogramming (Rideout et al., 2001) as cloned mice with aberrant expression of
imprinted genes appear developmentally normal (Humpherys et al., 2001). It is clear
that further studies investigating the long-term effects of aberrant methylation of other
developmentally regulated genes and repetitive DNA sequences acquired during pre-
and postimplantation development are required to elucidate the functional significance.
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1.9 Thesis aims and objectives
The purpose of this study was to investigate DNA methylation in sheep, in particular, its
dynamics during the early stages of embryo development. As DNA methylation has not
previously been investigated extensively in sheep, isolation and characterisation of
components of the DNA methylation repressor system (DNA methyltransferases and
methyl-CpG-binding proteins) was initially required. This would allow analysis of
sequence homology of these components between several mammalian species, and also
to understand the requirement for these proteins in adult sheep tissues by assessing
expression levels. Preliminary characterisation of methylation dynamics in normal
sheep preimplantation development and events in cloned (SCNT) embryos were then
able to be performed for the first time
Specific aims
1. To clone sheep homologues of genes encoding DNA methyltransferases and
the methyl-CpG-binding protein, MBD2 and to evaluate their conservation
with mouse and human homologues.
2. To investigate expression levels of these genes in adult sheep tissues.
3. To determine whether an oocyte-specific form of DNMT1 exists in sheep
oocytes.
4. To determine expression patterns of DNMT1, DNMT3A and DNMT3B genes
in sheep and mouse oocytes and preimplantation embryos.
5. To optimise techniques for DNA methylation analysis of specific sequences
in single oocytes and embryos, and analyse changes in methylation levels
between different stages of sheep preimplantation development.
6. To determine whether DNA methylation of specific sequences is equivalent




2.1 Materials and equipment
Abgene. London, UK: Thermo-Start® PCR mastermix, 0.5ml thin-walled PCR tubes.
Ambioit (Europe) Ltd. Huntingdon, Cambridgeshire, UK: OuantumRNA Classic II
18S standards
Amersham Pharmacia Biotech UK Ltd. Little Chalfont, Buckinghamshire, UK:
SeeDNA™, Multiprime DNA labelling kit, Hybond-C Nitrocellulose filters, Hybond N+
membrane, [a-32P]dCTP radiolabeled nucleotide, film, Rapid-hyb buffer, Hyperfilm™
MP, First-Strand cDNA Synthesis Kit, 20% SDS (USB).
Applied Biosystems. Warrington, Cheshire, UK: ABI PRISM® 7700 Sequence
Detection System, Taqman probe synthesis, ABI PRISM™ Optical 96-Well Reaction
Plates, MicroAmp® Caps, TaqMan® Universal PCR Master Mix, TaqMan® Ribosomal
RNA Control Reagents.
BDH. Poole, Dorset, UK: Molecular Biology Grade Agarose, sodium chloride,
magnesium sulphate, gelatine, EDTA, sodium phosphate, tri-sodium citrate, Tris base,
boric acid, sodium hydroxide.
Beckman Coulter Inc. Fullerton, CA, USA. Beckman J2-21M/E refrigerated
centrifuge.
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BD Biosciences Clontech UK. Basingstoke, Hampshire, UK: SMART™ RACE cDNA
amplification kit.
BIO-RAD. Hercules, California, USA: Multi-Analyst software.
DIFCO. West Molesey, Surrey, UK: Yeast extract, Bactotryptone, Casamino acids.
Greiner Labortechnik. Frickenhausen, Germany. 15ml centrifuge tubes, 50ml
centrifuge tubes.
Hettich-Zentrifugen. Tuttlingen, Germany: MIKRO 22R refrigerated benchtop
centrifuge, MIKRO 20 benchtop centrifuge.
Hybaid Ltd. Teddington, Middlesex, UK: Touchdown thermal cycler, Multiblock
System (MBS), RiboLyser™ Cell Disrupter, RiboLyser™ GREEN Kit.
Invitrogen. Groningen, The Netherlands: lOmM dNTP's, TOPO-TA Cloning® kit,
Agar.
Kendro Laboratoryproducts (Sorvall). Connecticut, USA: Sorvall RC-3B refrigerated
centrifuge.
Konica Medical Imaging Inc .New Jersey, USA: SRX 101A Film processor.
Life Technologies Ltd. Paisley, UK. 1 Kb Plus DNA ladder.
MWG Biotech. Milton Keynes, UK: Sequencing service, oligonucleotide synthesis.
New England Biolabs (UK) Ltd. Hitchin, Hertfordshire, UK. Hha I restriction enzyme,
Sss I (CpG) methylase.
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Novagen Inc. Madison, Wisconsin, USA: Pellet Paint™ Co-precipitant.
QIAGEN Ltd. Crawley, West Sussex, UK: QIAquick Gel Extraction Kit, QIAprep
Plasmid Miniprep kit, QIAprep Lambda Midiprep kit, RNeasy Miniprep kit,
QIAshredder columns.
Roche Diagnostics Ltd. Lewes, East Sussex, UK: Eco RI, Xho I, Bam HI and Hind III
restriction enzymes, Taq Polymerase, Expand HiFi Taq polymerase.
Sigma-Aldrich Company Ltd. Poole, Dorset, UK: Gel loading solution, Proteinase K,
Denhardt's solution, 10X MOPS buffer, Ethidium Bromide, Maltose, Formamide,
Ampicillin, casein hydrolysate.
Stratagene. La Jolla, CA, USA: Adult Sheep lung cDNA (Unizap) library, SOLR
competent cells, XLl-blue MRA (P2) competent cells, UV Stratalinker™ 1800.
UVPInc. Upland, California, USA: High performance transilluminator.
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2.2 Buffers and Media
All buffers and solutions described below were made up by H.F apart from 10X TBE,
20X SSC, LB medium and LB agar, which were prepared by M.Hutchison and S.Ewart
(Roslin Institute (R.I.)).
10X TBE: 0.9 M Tris-borate (BDH)
0.02 M EDTA (BDH)
pH 8.0
20X SSC buffer: 3 M NaCl (BDH)
0.3 M Sodium Citrate (BDH)
pH 7.0
Hybridisation buffer: 50% Formamide (Sigma)
5 X SSC (R.I.)
0.01 M EDTA (BDH)
5x Denhardt's solution (Sigma)
0.05 M NaPCL (BDH; pH 7.0)
1% SDS (UBS)
DNA extraction buffer A: 75 mM NaCl (BDH)
25 mM EDTA
pH 8.0





LB Medium (1 litre): Bactotryptone (DIFCO) 10.0 g
Yeast extract (DIFCO) 5.0 g
NaCl 10.0 g
pH7.0








NZY Medium (1 litre): Casein hydrolysate (Sigma) 10.0 g
NaCl 5.0 g
Yeast extract 5.0 g
MgS04.7H20 (BDH) 2.0 g
pH7.0
































250 gg/ml Proteinase K
NaCl
MgS04.7H20




2.3.1 In vitro fertilised/cultured (IVF) embryos
All stages of in vitro oocyte maturation, fertilisation and embryo culture were performed
by Mr. J. Gardner and Dr. J. McCracken (Roslin Institute (R.I)). A detailed protocol is
described in Walker et al., 1996. Immature oocytes were obtained from abattoir-derived
ovaries, and the semen pellets were provided by a Texel ram (a kind gift from Edinburgh
Genetics). At various stages between 1-cell and blastocyst embryos were selected and
subsequently stored at -80°C in 1 pi culture medium.
2.3.2 In vivo derived embryo collection
In vivo produced embryos were collected from superovulated and naturally-mated
Scottish Blackface ewes. Embryo collections were performed by members of the Large
Animal Unit (R.I) under strict accordance with Home office regulations. Embryos were
selected at various stages between 1-cell and blastocyst stages and stored at -80°C in 1
pi culture medium. Mouse oocytes and preimplantation embryos were collected from
superovulated and naturally-mated mice (B6D2F1) by Mrs M. McGarry (R.I.).
2.3.3 Somatic cell nuclear transfer (SCNT)
Nuclear transfer experiments were performed by Dr. J. McCracken and Mr. W. Ritchie
(R.I). A detailed protocol is described in De Sousa et al., 2001. Recipient oocytes were
collected from superovulated Scottish Blackface ewes. Donor cells were from a fetal
fibroblast cell line B1WF1P5, prepared by Mrs. P. Ferrier (R.I.), and serum starved for 5
days prior to nuclear transfer. Embryos were selected at various stages between 1-cell
and blastocyst stages and stored at -80°C in 1 pi culture medium.
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2.3.4 Tissue samples
Tissue samples for RNA extraction were collected from a Poll Dorset ewe by members
of the Large Animal Unit (R.I).
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2.4 General Methods
2.4.1 Polymerase chain reaction (PCR) methods
2.4.1.1 Standard PCR
PCR reactions were performed in 25 pi volumes containing lx PCR reaction buffer
(Roche Diagnostics; final magnesium [Mg2+] concentration 1.5-2.5 mM depending on
primers used), ImM dNTP's (Invitrogen), 1U Taq polymerase (Roche Diagnostics), 250
nM each of forward and reverse primer, dT^O and 1-5 pi of template. PCR reactions
were performed on either the Hybaid Touchdown thermal cycler, or the Hybaid Multi-
block system. Cycling conditions were dependent on primer pairs and template
concentration. Specific annealing temperatures, magnesium conditions and PCR
programs used for the various primer sets used can be found in Table 2.1. PCR program
conditions can be found in Table 2.2. Sequences of all primers used in this study can be
found in Table 2.3
2.4.1.2 Hotstart PCR
The Thermo-Start® PCR mastermix (ABgene) was utilised when hotstart PCR was
required to increase specificity. PCR reactions were performed in 25 pi reaction
volumes containing 12.5 pi 2x PCR mastermix (final [Mg2+] concentration 1.5 mM; 0.8
mM dNTPs, 1U Thermo-Start® Taq polymerase), 250 nM each of forward and reverse
primers, dH^O and 1-5 pi template DNA. Cycling conditions were the same as standard
PCR (Tables 1 & 2), except for the initial 94°C denaturing cycle, which was held for 15
minutes to allow for the incremental activation of the Thermo-Start® Taq polymerase.
Specific cycling conditions for the various primer sets can be found in Table 2.1 and
Table 2.2.
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Primer Pair Annealing OptimalMg2+ PCR
Temperature concentration program
CO (mM)
MTRA1F/R 57 2.5 SI
HDNMT3AF/R 60 1.5 SI
DNMT3B2F/R 55 1.5 SI
DMTF/R 56 1.5 SI
MBDF/R 58 2.5 SI
*18SF/R 60 1.5 S2
RX15C/13A 60 2.5 SI
BOVBF/R 58 1.5 TH1
OVSAT1AF/R 62 1.5 TH1
SHE2/SOMDT2 59 2.5 TH2
SOMDT1/SOMDT2 59 2.5 TH2
MOE1/MSER 59 2.5 TH2
MSE1/MSER 59 2.5 TH2
Table 2.1 Optimal PCR conditions for specific primer sets.
The table shows the optimal Magnesium concentrations and annealing temperatures for
all standard primers used in this study. PCR programs are described in Table 2.2.
* QuantumRNA Classic II 18S primers (Ambion).
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PCR No. of Denaturing Annealing Extension
Program cycles
°C rnin:sec °C min:sec t min:sec
SI l 94 5:00 - -
40 94 0:30 55-62 0:30 72 0:45
1 - - 72 5:00
S2 1 94 5:00 - -
30 94 0:30 55-62 0:30 72 0:45
1 - - 72 5:00
TH1 1 94 15:00 - -
*40 94 0:30 55-62 0:30 72 0:45
1 - - 72 5:00
TH2 1 94 15:00 - -
40 94 0:30 55-62 0:30 72 0:45
1 - - 72 7:00
Table 2.2 PCR programs
Specific cycling conditions for PCR programs described in this study. Annealing
temperatures are specified in Table 2.1. 'S' programs are standard PCR programs
utilising Roche Taq Polymerase, 'TH' programs are Hot start PCR programs, using
Thermo-Start® PCR mastermix.
* Cycle numbers for quantitative MS-PCR using program TH1 are described in 2.4.12
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Table 2.3 Primer sequences
All primers used in this study were designed using the 'Prime' application of GCG10,
or the web-based Primer 3 program, and synthesised by MWG Biotech (UK)
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2.4.2 Gel electrophoresis protocol
A 20 pi aliquot of PCR reactions/restriction enzyme digests was mixed with 3 pi loading
dye (Sigma) and electrophoresed in a 1.5-2% agarose (BDH) gels using IX TBE
containing 0.2 pg/ml ethidium bromide (Sigma) at 8-9 Vcm"1. PCR products were
visualized on a UV transilluminator and the image recorded using a video camera
system linked to the Multi-analyst software program (BIO-RAD) and gel images were
edited in Microsoft Photo Editor Version 3.01. If necessary, band intensities were
increased/decreased using the brightness or contrast tools of Photo Editor, but changes
were made across the entire gel image, not in single lanes. To quantify PCR products,
band intensity was measured using the Multi-Analyst Software.
2.4.3 Subcloning and sequencing of PCR products
Single band PCR products to be sequenced were cut from the agarose gel and purified
using the QIAquick Gel Extraction kit (QIAgen) as per manufacturers instructions. The
PCR products were then subcloned into the pCR2.1-TOPO vector using the Invitrogen
TOPO TA cloning kit, as per manufacturers instructions. Recombinant plasmids were
identified using blue-white screening, and 5-10 single white colonies picked for DNA
miniprep. The single colonies were grown overnight in a shaking incubator in 3 ml LB
broth supplemented with Ampicillin (Sigma; 100 pg/ml), at 37°C. Plasmid DNA was
subsequently isolated from the minicultures using the QIAprep plasmid DNA miniprep
kit (QIAGEN) as per manufacturers instructions. An aliquot of 1-2 pi of the resultant
plasmid DNA was digested with EcoR I (see 2.4.4) and run on a 1.5-2% gel (see 2.4.2)
to confirm insert identity. Approximately 5-10 pg of miniprep DNA was then ethanol
precipitated (see 2.4.5) and the pellet sent to MWG Biotech UK for sequencing. Single
strand sequencing was performed using either the Ml3 universal or reverse primers.
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2.4.4 Sequence analysis
The raw data of all sequences generated was checked by analysis of the sequence
chromatograms; any sequence of poor quality data was removed. Ambiguous regions of
sequence were re-sequenced by MWG Biotech, performing both primer design and
sequencing of specified region. For inserts longer than 1.5 kb, sequencing was
performed in 500-600 bp reads. Primer walking was employed to gain complete
sequence for the insert. The 500-600 bp sequence reads were assembled into a single
contiguous sequence using the Staden Sequence Analysis Package. Analysis and editing
of generated sequences was performed using the Genetic Computer Group (GCG)
Wisconsin Sequence Analysis Package (Version 10 for Unix). Pairwise sequence
alignments were generated using the 'Gap' application, and multiple sequence
alignments were generated using the 'localpileup' application. Default settings were
used in all cases. Multiple sequence alignments were displayed and shaded using the
GeneDoc Multiple Sequence Alignment Editor and Shading Utility Version 2.6.001.
The Shade options were set to 'Conservation mode', 'Shade to 4 levels' and 'Enable
similarity groups'.
2.4.5 Restriction enzyme digestion
Restriction enzyme digestion of DNA was normally performed in a 20 pi volume
containing 500 ng-1 pg DNA, 10U restriction enzyme and 2 pi of the appropriate 10X
buffer. Incubation was generally performed for 2-4 hr at 37°C. Enzymes were obtained
from either Roche or New England Biolabs.
2.4.6 Ethanol Precipitation
To precipitate DNA, 0.1 volumes of 3 M sodium acetate (pH 5.0) and two volumes of
100% ethanol were added to the DNA sample and then frozen at -70°C for 30 min. The
DNA sample was then centrifuged at 19280 RCF (Relative Centrifugal Force) for 30
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min (MIKRO 22R benchtop refrigerated centrifuge; Hettich Zentrifugen), then the
supernatant removed. The pellet was washed using 500 pi of 70% ethanol and the pellet
was centrifuged at 19280 RCF for 20 min. The supernatant was removed and the DNA
pellet air-dried at room temperature. The DNA pellet was subsequently resuspended in
a suitable volume ofwater.
2.4.7 cDNA library screen
The cDNA library screen was performed using a commercially prepared adult sheep
lung cDNA library packaged in the Uni-ZAP® XR vector (Stratagene).
2.4.7.1 Plating of Phage
A fresh stock of XLl-blue MRF (Stratagene) was prepared by inoculating 50 ml LB
broth (supplemented with lOmM MgSCL and 0.2% maltose) with a single colony of
these bacteria. The culture was grown overnight, until it reached an optical density of
0.5 at 600nm. The bacteria were pelleted at 483 RCF (Beckman J2-21M/E refrigerated
centrifuge) for 10 min, and resuspended in lOmM MgSCL to an optical density of 0.5 at
600nm.
During preliminary experiments, the XLl-blue MRF bacteria were mixed with various
dilutions of the bacteriophage cDNA library to ascertain the dilution required to gain
approximately 50000 pfu/plate. The bacteriophage/bacteria mixture was incubated for
20 min at 37°C; 6.5 ml molten top agarose (47°C) was then added and poured onto large
(150 mm) NZY agar plates. Plates were incubated for approximately 8 h, or until the
plaques showed confluent growth. Once confluent phage density was obtained, 10 large
NZY plates were prepared as described for the primary screen. Plates were refrigerated
for 2 h to prevent the top agar from sticking to the nitrocellulose filters in later steps.
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2.4.7.2 Plaque lifts
Hybond C Nitrocellulose filters (150 mm; APBiotech) were transferred to the NZY plate
for 2 min and both filters and plates were marked for orientation using an ink-filled
syringe. Duplicate lifts were performed where two filters were subsequently transferred
onto phage infected NZY plates for 2 mins and 5 mins respectively. After transfer,
filters were denatured by submerging in 1.5 M NaCl/0.5 M NaOH for 2 min, then
neutralised for 5 min in 0.2 M Tris-HCl (pH 7.5)/2X SSC. Filters were subsequently
blotted on Whatman 3MM paper, then baked at 80°C for 2h. After baking, filters were
wetted with 2X SSC prior to hybridisation.
2.4.7.3 Hybridisation
Filters were prewashed at 50°C in 100 ml pre-wash solution containing 5X SSC, 2%
SDS and 1 mM EDTA (pH 8.0), in a rotisserie hybridisation oven (also used for
subsequent hybridisation and post-hybridisation washes). The pre-wash solution was
removed and 10 ml hybridisation buffer (see 2.2) was added for pre-hybridisation.
Filters were prehybridised at 43°C for 1-2 h.
Typically, 100-250 ng of PCR product was used as the DNA probe (PCR product cut
out from gel and purified using QIAprep Gel Extraction kit following the manufacturers
instructions). The PCR product was labelled with [a-32P] dCTP radiolabeled nucleotide
(APBiotech) using the Multiprime™ DNA labelling system (APBiotech) as per
manufacturers instructions, then purified using the Nick™ column (APBiotech) as per
manufacturers instructions. The labelled probe was denatured at 95°C for 5 min, then
cooled on ice. Sufficient denatured probe (1 million counts per ml) was added to 10 ml
fresh hybridisation buffer (see 2.2) in the bottle containing the filters. Hybridisation was
performed overnight at 43°C.
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2.4.7.4 Post-hybridisation washes
The hybridisation buffer was removed and the following washes performed:
1st wash: 5 min at room temperature, shaking gently, with 200 ml of 2X SSC + 0.5%
SDS
2nd wash: 200 ml of 0.5X SSC + 0.1% SDS at 60°C for lh.
3rd wash: 200 ml of 0.1X SSC + 0.1% SDS at 60°C for lh.
4th wash: as 3rd wash.
After the final wash, filters were prepared for exposure by blotting dry, then wrapping in
SaranWrap™ with care to avoid trapping air bubbles. Filters were placed against
Flyperfilm™ MP in an autoradiography cassette and exposed at -70°C. The exposed
film was developed using the automated film processor. Positive signals on the film
were aligned with the corresponding plate using the ink orientation marks. Positive
clones were subsequently isolated as an agar plug, and stored in 0.5 ml SM buffer at 4°C
for use in secondary screen.
2.4.7.5 Secondary screen
The bacteriophage were diluted accordingly in order to gain a moderate covering of
plaques on the phage infected NZY plates, with plaques well separated. Plaque lifts,
hybridisation and washes were performed as described previously (2.4.7.2; 2.4.7.3;




The bacteriophage were diluted in order to gain isolated plaques. Plaque lift and
hybridisation steps were repeated as described before. Positive plaques were isolated
and stored in SM buffer at 4°C until required for pBluescript phagemid excision.
2.4.7.7 Excision of pBluescript phagemid
Fresh stocks of XLl-blue MRF and SOLR bacteria (Stratagene) were prepared by
inoculating 50 ml LB broth with a single colony. The cultures were grown overnight,
until it reached an optical density of 0.5 at 600 nm. The bacterial cultures were then
spun down at 483 RCF (Beckman J2-21M/E refrigerated centrifuge) for 10 min, and
resuspended in 10 mM MgSCL to an optical densityof 1.0 at 600nm.
To excise the pBluescript phagemid containing the 'positive' cDNA insert from the
positive lambda vector, 125 pi of the lambda phage stock was incubated with the fresh
200 pi XL1 blue MRF' bacteria (OD6oo = 1-0), 125 pi SM buffer and 1 pi ExAssist
helper phage (3.75 pfu/ml; ExAssist phage were provided with the Stratagene cDNA
library) at 37°C for 15 min. After incubation, 3 ml of LB broth was added to the tube
and then incubated for 2-3 h at 37°C with shaking, followed by a further incubation at
65°C for 20 min. The tube was then centrifuged at 2296 RCF (Sorvall RC-3B
refrigerated centrifuge) for 20 min and the supernatant decanted into a sterile 15ml
centrifuge tube. To plate the excised phagemids, 200 pi of the fresh SOLR cells (OD600
= 1.0) was added to 10 pi of the phage supernatant and incubated at 37°C for 15 min.
The bacteriophage/SOLR mixture was then plated onto pre-warmed LB-Amp plates and
incubated at 37°C overnight. 10 single colonies per initial bacteriophage clone were
subsequently picked from the plates and DNA was prepared using the QIAprep plasmid
DNA miniprep kit (Stratagene) as per manufacturers instructions.
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2.4.8 Rapid amplification of 5' cDNA ends (5' RACE)
5'RACE was performed to gain additional 5' DNMT1 cDNA sequence, after sequence
analysis of the cDNA library screen products. The 5'RACE method was performed
using the Clontech SMART RACE kit, as per manufacturers instructions. Prior to 5'
RACE, RNA was extracted from tissue or oocytes, as described 2.4.11.1; 2.4.11.2,
















Figure 2.1 The Clontech SMART RACE cDNA amplification protocol.
First-strand synthesis is primed using a gene-specific primer (replacing oligo(dT) primer
shown in figure). After reverse transcriptase reaches the end of the mRNA template, it
adds several dC residues. The SMART II Oligonucleotide anneals to the tail of the
cDNA and serves as an extended template for the reverse transcription (RT).
After first-strand cDNA synthesis, rapid amplification of cDNA ends (SMART RACE
PCR) was performed using a gene-specific primer and the universal primer mix (specific
to the SMART II oligonucleotide) provided with the kit. Gene-specific primers were
required to have an annealing temperature of 65-70°c, to be compatible with the
(g)
universal primer mix. Touchdown PCR was performed using the Advantage 2 PCR
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Kit (Clontech) provided with the SMART RACE kit, as per manufacturers instructions.
Touchdown PCR increases sensitivity and reduces background (or non-specific bands)
by initially creating stringent PCR conditions (high annealing temperature) optimal for
amplification of gene-specific products only. As the PCR progresses, annealing
temperatures are decreased gradually, relaxing conditions, and allowing further
amplification of the enriched gene-specific target. Touchdown PCR conditions are
described in Table 2.4











Table 2.4 PCR conditions used for 5' RACE PCR.
The touchdown PCR program starts with high specificity reflected in the high annealing
temperature. With subsequent stages of the PCR, the conditions are relaxed, allowing
accumulation of the specific PCR products.
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2.4.9 DNA extraction from tissues and cultured cells
Approximately 100 mg of tissue was homogenised in 5 ml DNA extraction buffer A (see
2.2) using a Polytron homogeniser. After homogenisation, 5 ml of DNA extraction
buffer B (see 2.2) and 1 pg Proteinase K were added, and the homogenate was incubated
overnight at 37°C on a slow shaking tray. The DNA was subsequently isolated using a
standard phenol:chloroform extraction method. One volume of phenol was added and
the solution mixed well, followed by addition of 1 volume of chloroform: isoamyl
alcohol (24:1). After thorough mixing, the solution was centrifuged at 2296 RCF
(Sorvall RC-3B refrigerated centrifuge) for 20 min. The aqueous layer was
subsequently isolated, and the phenokchloroform extraction repeated. After the second
isolation of the aqueous layer, a final extraction was performed using 1 volume of
chloroform:isoamyl alcohol (24:1), and the thoroughly mixed solution was centrifuged
as described for the previous step. The aqueous phase was again isolated, and 0.2
volumes of 10 M ammonium acetate and 2 volumes of ice-cold 100% ethanol were
added. The solution was shaken gently until the DNA precipitated out of solution. The
DNA was removed, and washed in 70% ethanol, prior to drying at 37°C. DNA was
resuspended in 50-100 pi dFhO according to desired use.
To extract DNA from cultured cells, the QIAgen DNeasy kit (QIAgen) was used, as per
manufacturers instructions. Frozen cell pellets were used as the starting material, and
DNA was eluted in 100 pi of dFhO. The QIAgen DNeasy kit was also used for the
isolation of DNA from sperm, with a number of modifications made to the protocol.
Briefly, 100 pi of Buffer X2 (see 2.2) was added to 100 pi of sperm, with the DTT and
Proteinase K added to buffer X2 just prior to use. The sample was incubated at 55°C for
1 hour, with inversion of the tube occasionally to ensure the contents dispersed
thoroughly. When the sample was dissolved, 200 pi of Buffer AL (provided in Dneasy
kit) and 200 pi of ethanol were added to the sample. The mixture was subsequently
pipetted onto a DNeasy mini column, and the column centrifuged at 6290 RCF for 1
minute. The flow-through was discarded and the DNeasy column placed into a new 2
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ml collection tube. Then 500 pi of Buffer AW1 (provided in DNeasy kit) was added and
the column centrifuged as before. Again, flow-through was discarded, and the DNeasy
column placed in a fresh collection tube. To wash the DNA a final time, 500 pi of
Buffer AW2 (provided in DNeasy kit) was added to the DNeasy column, and the column
was subsequently centrifuged at 6290 RCF for 3 mins. The DNeasy column was placed
in a 1.3 ml centrifuge tube and 100 pi of dH20 was pipetted directly onto the DNeasy
column membrane. The DNA was eluted by centrifugation at 6290 RCF for 1 minute.
2.4.10 Single embryo methylation analysis
2.4.10.1 DNA extraction from single oocytes or embryos
The tube containing the single embryo in 1 pi culture medium was freeze-thawed three
times. Freezing was performed at -80°C for periods of 20-30 min, with the embryos
defrosted at room temperature between subsequent freezes. The embryo was
subsequently digested with Proteinase K (0.1 pg) at 50°C for lh. Prior to ethanol
precipitation, Proteinase K activity was heat-killed at 80°C for 20 min. DNA was
ethanol precipitated using either 2 pi SeeDNA™ co-precipitate (APBiotech) or Pellet
Paint™ (Novagen) in a standard sodium acetate/ethanol precipitation with the following
specifications: 100% ethanol wash was performed at 22130 RCF (MIKRO 22R
benchtop refrigerated centrifuge) for 1 h; 70% ethanol wash was performed at 22130
RCF for 30 min. The DNA pellet was resuspended in 6 pi dH20.
2.4.10.2 Digestion of single embryo DNA
DNA from single oocytes/ embryos was divided into two aliquots of 3 pi. One aliquot
was digested with Hha I restriction endonuclease (New England Biolabs) in a 19 pi
digestion reaction containing 20U Hha I, IX NEBuffer 4 and IX BSA for 2 h at 37°C.
A further 20U Hha I was added after two hours (to ensure complete digestion of DNA)
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and incubated for an additional two hours. Enzyme activity was subsequently heat-
killed at 65 °C for 20 min. The second DNA aliquot was incubated in a 20 pi digest
reaction containing IX NEBuffer 4 and IX BSA for 4 h at 37°C, followed by a 65°C
incubation for 20 min.
2.4.10.3 Methyl-sensitive PCR
PCR reactions were performed in a 25 pi volume containing: 1 X PCR buffer (Roche
diagnostics; final concentration. 1.5mM), 200 pM dNTP's (Invitrogen), 250nM each
primer, 1U Taq DNA polymerase (Roche diagnostics) and either 2 pi Hha I digested or
undigested DNA, or control template. Thermal cycler conditions for specific primers
can be found in Table 2.5.
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Primers/embryo No. of Denaturing Annealing Extension
stage cycles
°C min:sec °C minrsec °C min:sec
Ovsatla/blastocyst 1 94 15:00 - -
19 94 0:30 62 0:30 72 0:45
1 - - 72 7:00
Ovsatla/morula 1 94 15:00 - -
21 94 0:30 62 0:30 72 0:45
1 - - 72 7:00
Ovsatl a/8-16 cell 1 94 15:00 - -
22 94 0:30 62 0:30 72 0:45
1 - - 72 7:00
Ovsatla/oocyte 1 94 15:00 - -
24 94 0:30 62 0:30 72 0:45
1 - - 72 7:00
Bovb/blastocyst 1 94 15:00
24 94 0:30 58 0:30 72 0:45
1 - - 72 7:00
Table 2.5 PCR conditions for primers used in methyl-sensitive PCR.
The table indicates the cycling conditions used for each primer pair at different
developmental stages.
2.4.10.4 In vitro CpG methylation of plasmid DNA
One pg of plasmid DNA was incubated for 1-2 h at 37°C in a reaction mixture
containing IX SAM, IX NEBuffer 4 and 5U Sss I methylase (NEB), made up to 20 pi
with water. Sss I methylase activity was subsequently heat-killed at 65 °C for 20 min,
prior to restriction enzyme digestion.
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2.4.11 RNA extraction and cDNA synthesis
2.4.11.1 Tissues and cultured cells
RNA was extracted from tissues using the Hybaid Ribolyser™ system combined with
the QIAgen RNeasy kit (QIAgen). The Ribolyser™ technology combines the use of
silica and ceramic beads (within the Ribolyser™ tube) with high speed twisting and
shaking movements. Friction generated by the collision of these beads allows disruption
of the tissue, producing a lysate suitable for subsequent RNA extraction. Briefly, lOOmg
tissue was placed in a Ribolyser™ tube containing l .8 ml RNeasy buffer RLT. The tube
was then placed in the Ribolyser™ and subjected to a 30 sec pulse of high-speed motion,
sufficient to disrupt the cells. One third of the lysate (600pl) was used in the subsequent
RNA extraction, using the QIAgen RNeasy kit as per manufacturers instructions. For
RNA extraction from pelleted fibroblast cells, the cells were lysed using the
QLAshredder kit (according to manufacturers instmctions). RNA extraction from the
lysed cells was then continued as for tissues, using the QIAgen RNeasy kit. An optional
DNase digestion step was performed (according to maunfacturers instrictions) using a
DNase kit specifically supplied for use with the QIAgen RNeasy kit. RNA was reverse
transcribed using the First strand cDNA synthesis kit (APBiotech) as per manufacturers
instructions, starting with 1 pg of total RNA and using the random hexamer (pd(N)6)
primer for cDNA synthesis.
2.4.11.2 Single oocytes and embryos
RNA was extracted from single oocytes or preimplantation embryos using the QIAGEN
QIAshredder kit and RNeasy Mini kit as per manufacturers instructions. RNA was then
ethanol precipitated using Pellet Paint™ coprecipitant (Novagen) as per manufacturers
instructions. The RNA was resuspended in 8 pi DEPC-treated H2O. Reverse
transcription was performed immediately after RNA extraction using the First-Strand
cDNA Synthesis kit (APBiotech) as per manufacturers instructions, using the random
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hexamer (pd(N)6) primer for cDNA synthesis. Embryo and oocyte eDNA was stored at
-20°C after preparation.
2.4.12 Taqman® RT-PCR
The Taqman® assay, used in conjunction with the ABI PRISM® 7700 Sequence
Detection System (Applied Biosystems), provides a highly sensitive method for
quantification ofmRNA (Heid et al., 1996). By combining fluorogenic probes with the
5' exonuclease activity of Taq polymerase, real-time monitoring of PCR product




Figure 2.2 The Taq polymerase extends the forward and reverse primers (highlighted as
solid black horizontal lines) as normal. The fluorogenic gene-specific probe (red solid
horizontal line)has a reporter (R) dye at the 5' end and a quencher (Q) dye at the 3' end.
The gene-specific probe anneals to the template between the primers. When the primer
extension reaches the probe, the taq exonuclease activity cleaves the reporter dye from
the probe. The reporter dye is then released from the quencher, producing a fluorescent
signal. As the amount of PCR product generated in each cycle increases, a proportional
amount of flourescence is released.
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PCR product accumulation is measured as an increase in fluorescence signal detected by
the sequence detection software. The fluorescence of the reporter dye is normalised to a
passive reference dye included in the PCR mastermix; this is necessary to correct for any
fluctuation in fluorescence due to discrepancies in concentration or reaction volume.
The PCR cycle at which a statistically significant increase in fluorescence is observed is
described as the Ct value, or 'threshold cycle', and correlates with the beginning of the
exponential phase of the PCR. The Ct value is the predictive target quantification value.
Figure 2.3 shows the typical graphical output of a Taqman® reaction, demonstrating how
Ct values are obtained.
Cycle number
Figure 2.3 Taqman® real-time PCR graphical output. The threshold cycle (Ct) is
calculated as the point when significant increases in reporter dye fluorescence (Rn) are
observed, rising above the 'background' emission intensity noise. The level of
background noise is determined by the emission intensity in the No Template Control
(NTC).
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2.4.12.1 Relative quantification of gene expression using the Taqman
Assay
For analysis of gene expression in adult tissues, it was decided to use 18S ribosomal
RNA (rRNA) as an endogenous control. Due to the abundant nature of 18S rRNA in
adult tissues, a separate tube method was performed instead of multiplex PCR, to avoid
primer competition within a single PCR reaction. The comparative Ct method quantifies
gene expression relative to a 'calibrator' tissue, after normalisation of expression against
endogenous gene 18S rRNA. In order to validate this method of quantification, it is
important that the gene-specific and 18S rRNA primers both amplify target cDNA with
the same efficiency. This is achieved by assessing the Ct values over a range of cDNA
dilutions. As 18S rRNA is more abundant in tissues than mRNA transcripts, a different,
or 'more dilute' range of cDNA dilutions can be used in order to conserve cDNA stocks.
This is an acceptable practice for this method of quantification, although it remains
essential that the intervals between dilutions remain constant between the two primer
sets when evaluating relative efficiency. For example, a range of dilutions 1:10, 1:50
and 1:100 may be used for the gene-specific primers, and for 18S rRNA, dilutions of
1:100, 1:500, 1:1000 would be equivalent. By plotting the log of input (cDNA dilution
factor) against the difference in Ct values (ACt; gene-of- interest Ct value minus 18S
rRNA Ct value), equally efficient primers will demonstrate a slope of <0.1. If a slope of
>0.1 is observed, 18S primer concentrations can be reduced to limit the primer
efficiency to an appropriate level. Once confirmation of equal primer efficiencies is
obtained, gene expression can be quantified using the AACt equation:
2 - AACt
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When analysing gene expression in a range of tissues, expression values are first
normalised against the relative 18S rRNA level (ACt). A calibrator tissue is then
chosen, usually the tissue with the lowest level of gene expression (or highest ACt value)
and is designated the lx sample. The calculation of AACt involves subtraction by the
ACt calibrator value; for example if heart tissue is the calibrator value, then all tissues
will subtract the heart ACt value from their own ACt value. The calculation 2 ~ AACT is
then completed, and the tissue gene expression levels are expressed as a '« fold' increase
relative to the calibrator (lx) tissue. The standard deviation of the difference in Ct
values (ACt) is calculated from the standard deviations of the 'gene-of-interest' and 18S
values. The calculation is given below:
For each tissue analysed;
51 is the standard deviation of the gene-of-interest replicate Ct values.
52 is the standard deviation of the 18S replicate Ct values.
2.4.12.2 Taqman® PCR method
To quantify gene expression in tissues, we used the Real Time Quantitative PCR
(Taqman® PCR, Applied Biosystems) method utilising the ABI 7700 Sequence Detector
(Applied Biosystems). Gene-specific Taqman® primers and probes were designed using
Primer Express® software (Applied Biosystems; default parameters). Triplicate
reactions were prepared containing 12.5 pi of 2X Universal PCR Mastermix (containing
AmpliTaq Gold), 2.5 pi each of 3-9 pM (final concentration 300-900 nm) forward and
reverse gene-specific primers or 2.5pl each of 0.25-0.50 pM (final concentration 25-50
nm) 18S forward and reverse primers, 2.5 pi of 2 pM (final concentration 200 nm) gene-
specific/18S Taqman® probe, 2.5pl dH20 and 2.5 pi cDNA. Reactions were performed
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in a MicroAmp® Optical 96-Well Reaction Plate (Applied Biosystems) and the wells
were sealed using MicroAmp® Optical Caps (Applied Biosystem). The initial UNG
digestion was performed at 50°C for 2 min, followed by activation of the AmpliTaq
Gold at 95°C for 10 min. Thermal cycling then proceeded with 40 cycles of 95°C for 15
sec and 60°C for 1 min. Primer sequences and primer/probe concentrations optimised









DTI probe AAACTTCGTCTCCTTCAAGCGCTCCATG 200
DT3AF CGGCCAGTGCCCTCG 900
DT3AR CCTGCAATGATCTCTCCATCG 900
DT3A probe AGAGTCCCTTGCGGGCAGGATTG 200
DT3BF CTCTTGTCGCCAACCTTCA 900
DT3BR ATTACTCACGCCCCAAGGA 900
DT3B probe TGGCCACCACGTTCTCAAACATC 200
MD2F GCAACCAGTAACCAAAGTCACA 900
MD2R TGTAGCCTGTTGTCCCAGAA 900
MD2 probe CCCACAGAGAATGAATGAACAGCCA 200
18SF - 50/*25
18SR - 50/*25
18S probe - 200
Table 2.6 Taqman primer/probe sequences and optimal PCR conditions.
Primer and probe sequences are described for all gene-specific sets; the 18S primer and
probe sequences (Applied Biosystems 'ribosomal RNA control reagents') are not
disclosed by the manufacturer. Optimal primer and probe concentrations are also
described; these conditions allow for relative quantification of gene expression using the
'Comparative Ct' method.
* 18S rRNA primers were used at a final concentration of 25 nm when used in separate
tube quantification ofDNMT3A expression
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Chapter 3
Cloning and sequence analysis of the sheep DNA
methyltransferase DNMT1 coding regions
3.1. Introduction
DNA methyltransferase 1 (Dnmtl) was, until recently, the only DNA (cytosine-5)
methyltransferase identified in vertebrate tissues. The Dnmtl gene and encoded protein
have been studied extensively in the mouse, and also in humans and other vertebrate
species, albeit to a lesser extent. The mouse Dnmtl gene spans 56 Kb of genomic DNA,
is organised into 39 exons and encodes a protein of 1502 amino acids. The human gene
is similarly organised, except for the presence of an additional intron (Margot et al.,
2000).
Since the initial identification, the structure and function of mouse Dnmtl has been
widely investigated. The presence of ten sequence motifs observed in prokaryotic 5-
cytosine DNA methyltransferases was detected in the mouse protein (Lauster et al.,
1989; Posfai et al., 1989), six of these motifs are highly conserved between all DNA
cytosine-5 methyltransferases. These motifs encode the enzymatic domain of Dnmtl,
and play different roles in the catalysis ofDNA methylation. These include interactions
such as the folding together of motifs I and X to form the AdoMet (S-Adenosyl-
Methionine; the substrate for Dnmtl) binding site. Motif IV contains the Pro-Cys
dipeptide catalytic active site, motif VI contains a glutamyl residue required for
protonation of the cytosine target, and motif IX is involved in maintaining the target
recognition domain structure (located between motifs VIII and IX; Motif interactions are
reviewed in Bestor & Verdine, 1994).
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The catalytic domain of Dnmtl is found at the C-terminus of the protein, and is one of
three postulated structural compartments (Margot et al., 2000). The other two
compartments are the N-terminal domain, containing several functional domains of
interest, and a central domain, with poorly characterised function. Figure 3.1
demonstrates the structural compartmentalisation of Dnmtl and highlights known
functional domains of interest.
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Figure 3.1 The 'Tri-partite' structure of Dnmtl. Taken from Margot et al., 2000.
A schematic representation of the three distinct regions (Parts A, B & C) of the mouse
Dnmtl protein. Part A represents the N-terminal domain, part B represents the central
domain, and part C represents the catalytic domain. Known functional domains and
amino acids of interest are indicated in the diagram; relative exon positions are
highlighted above the protein domains. Key: PCNA (Proliferating cell nuclear antigen),
NLS (Nuclear localisation signal), RFTS (Replication foci targeting sequence), PBHD
(Poly-bromol protein homology domain), TRD (Target recognition domain).
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As mentioned previously, the C-terminal region ofDnmtl encodes the catalytic domain,
and demonstrates similarities with bacterial Type II DNA cytosine methyltransferases
(Bestor, 1988). However, it is the large N-terminal region that differentiates mouse
Dnmtl from bacterial and other vertebrate methyltransferases. The Dnmtl N-terminus
has been suggested to be responsible for conferring a number of specialised functions
through its many domains including the preferential recognition of hemi-methylated
DNA (Bestor et al., 1992).
The functions of these domains have been mainly characterised using various deletion
mutants. The domains include the Replication-fork Targeting (RFT) domain,
responsible for targeting Dnmtl to sites of newly synthesised hemi-methylated DNA
(Liu et al., 1998; Leonhardt et al., 1992). Upstream of the RFT domain lies the Nuclear
Localisation Signal (NLS), responsible for the import of Dnmtl into the nucleus
(Leonhardt et al., 1992). The Zinc binding domain (Bestor, 1992) lies adjacent to the
Polybromo-1 Protein Homologous Domain (PBHD), so-called due to the sequence
homology with the Poly-bromo-1 protein (Nicolas & Goodwin, 1996). The function of
this domain has so far remained undefined. Protein binding sites identified within the N-
terminal domain include the PCNA and Dnmtl-associated protein I (DMAP1) binding
sites. PCNA is a component of DNA replication protein complexes and is thought to
interact with Dnmtl at the replication fork (Chuang et al., 1997). DMAP1 is involved in
the recruitment of histone deacetylase complexes to Dnmtl (Rountree et al., 2000).
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3.1.1 Sex-specific promoters of Dnmtl
All forms of Dnmtl found in mouse somatic cells and tissues are the result of
transcriptional initiation from exon 1. In germ cells, alternative forms of Dnmtl protein
are produced by initiation of transcription from sex-specific promoters (Mertineit et al.,
1998). In oocytes, an alternative first exon, exon lo (somatic exon 1 was designated by
Mertineit et al. as exon Is; and the 'sperm-specific' exon as lp), leads to the initiation
of translation from ATG4 in exon 4, forming a truncated Dnmtlo protein. Dnmtlo is
extremely abundant in mature oocytes where it is localised at the cytoplasmic periphery
of the cell, and is thought to be the sole form of Dnmtl found in oocytes and
preimplantation embryos (Mertineit et al., 1998). In pachytene spermatocytes,
transcription is driven from the exon lp (p = pachytene) promoter and translation of
Dnmtl from this transcript leads to a grossly truncated protein, due to the presence of
multiple short open reading frames within exon lp. Figure 3.2 demonstrates the
genomic organisation of the mouse Dnmtl, indicating sex-specific exons. The figure
also shows mRNA products generated from the somatic and sex-specific exons,
indicating the effect of alternative promoter use.
The function of sex-specific Dnmtl proteins has been the source of much speculation.
Dnmtlp is undetectable in spermatocytes, with Mertineit et al. (1998) suggesting this is
due to the expected truncated nature of the protein. However, the 'sperm-specific'
Dnmtl isoform can be translated in other tissues, specifically skeletal muscle, despite the
presence of the multiple short reading frames (Aguirre-Arteta et al., 2000). This gives
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Figure 3.2 Genomic organisation of the mouse Dnmtl gene.
Taken from Bestor, 2000. (a) The genomic locations of sex-specific and somatic exons
lo, Is and lp in the mouse Dnmtl gene are indicated by red boxes. Alternate splicing of
these exons and start codons are also highlighted in the diagram, (b) The figure
describes the Dnmtl protein products of sex-specific splicing, highlighting the effects.
The dark horizontal bars indicate open reading frames; short vertical bars indicate ATG
initiation codons.
The abundant nature and unusual localisation ofDnmtl o in oocytes and preimplantation
embryos is certainly intriguing, in particular, the unusual localisation of Dnmtlo when
compared to the somatic form, Dnmtls. Dnmtls is first observed around the time of
implantation, and is abundant in the nuclei of somatic cells and tissues. On the contrary,
Dnmtlo is found exclusively in the cytoplasm of preimplantation embryos, with the
exception of the 8-cell stage, where it has been observed by immunodetection to enter
and subsequently exit the nucleus (Carlson et al., 1992). The reason for this stage-
specific nuclear localisation was recently determined through experiments involving
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targeted deletions of Exon lo of the mouse Dnmtl gene. Mice with homozygous
deletions demonstrated methylation errors within certain imprinted genes (Howell et al.,
2001). Thus, it appears Dnmtlo is responsible for maintaining DNA methylation
patterns within specific imprinted genes solely during the 8-cell stage of development.
The presence of sex-specific Dnmtl proteins in other vertebrate species so far remains
undetermined. A study ofXenopus laevis oocytes demonstrated the abundant presence
of somatic Dnmtl but did not rule out the possibility of an oocyte-specific form (Shi et
al., 2001). However, Xenopus do not have imprinted genes, so may well not require a
protein with such specialised activity. Studies of other vertebrate species known to have
imprinted genes are clearly required.
The DNA methyltransferase genes have not previously been cloned or characterised in
sheep. The aim of this particular study was to isolate the complete cDNA sequence
encoding sheep DNMT1 in order to assess conservation of cDNA and protein sequences
between sheep, humans and mice, and also to determine whether an oocyte-specific
DNMT1 exists in sheep. Isolation of the DNMT1 coding region will also allow
expression analysis to be performed in adult sheep tissues and preimplantation embryos,
to unravel the role of DNA methylation in sheep development. This chapter describes
the experiments performed to obtain the full-length DNMT1 cDNA sequence, the
subsequent cDNA sequence analysis and protein prediction, and finally, attempts to
identify a sheep oocyte-specific form ofDNMTL
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3.2 Results
3.2.1. Generation of partial sheep DNMT1 cDNA clones by RT-PCR
Sequence alignments of human and mouse DNMT1 cDNA sequences (NM001379;
X14805) were generated using the 'Gap' application (default parameters) of GCG10.
Primers specific to DNMT1 were designed from the human sequence in regions seen to
be highly conserved between the mouse and human. Table 3.1 lists the primers used
and the location within the source sequence. Pooled dl25 fetal heart and kidney cDNA
was used as the template in a standard PCR reaction performed as described 2.4.1.1.
PCR products were then electrophoresed on a 2% ethidium stained agarose gel as
described 2.4.2. PCR products of expected size (130 bp) were observed and
subsequently cloned and sequenced (as described 2.4.3) to confirm identity.
Gene Primer Direction
ofprimer




DNMT1 MTRA1F Forward NM001379 3936-3956
MTRA1R Reverse NM001379 4066-4047
Table 3.1 PCR primers used to amplify partial DNMT1 cDNA sequence in sheep.
Primer sequences are given in Table 2.3
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3.2.2. Isolation of a DNMT1 cDNA clone from an adult sheep lung cDNA
library
The partial cDNA clone generated by RT-PCR corresponding to the sheep DNMT1
sequence was subsequently used to probe an adult lung sheep cDNA library (obtained
from Stratagene). The cDNA library screen was performed as described 2.4.7. The
primary screen identified two positive clones, designated 4 and 6, which were re-plated
for the secondary screen. After the secondary screen, several positive plugs were
identified on the plates derived from clone 6; clone 4 appeared to be a false positive as it
failed to demonstrate binding with the DNMT1 probe in the second round of library
screening. These single plaque colonies were isolated and PCR analysis performed
using the MTRA1 primer set as an additional control. PCR products were
electrophoresed on a 2% ethidium bromide stained agarose gel (as described 2.4.2). The
results of this PCR are demonstrated in Figure 3.3. A single clone, 6.3a, was chosen for
further analysis. Excision of the pBluescript plasmid (containing the cDNA fragment)
from the Uni-ZAP® XR vector was subsequently performed (as described 2.4.7.7) and
plasmid DNA minipreps were established from 10 single colonies for clone 6.3 (as
described 2.4.3). PCR analysis using the MTRA1 primer set was again performed to
check insert identity of the minipreps. PCR products were electrophoresed on a 2%
ethidium bromide stained agarose gel (as described 2.4.2), results are shown in Figure
3.4. An EcoR l/Xho I double digest was also performed to release the insert from the
pBluescript vector, and simultaneously estimate insert size for each clone. Digests were
electrophoresed on a 1% ethidium bromide stained agarose gel (as described 2.4.2),
results are shown in Figure 3.5
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Figure 3.3 PCR analysis of positive plugs isolated after the secondary DNMT1
cDNA library screen.
Bacteriophage clone DNA was amplified using MTRA1 primers. Lanes 1-6 represent
PCR products amplified from clones 6.1a, 6.1b, 6.2a, 6.2b, 6.3a and 6.3b respectively.





Figure 3.4 PCR analysis of DNA minipreps established from the Uni-ZAP® XR
clone 6.3a
DNA minipreps were screened using the MTRA1 primers to confirm identity of the
clones. Lanes 1-8 show PCR products amplified in minipreps prepared from 8 single
colonies. DNA marker sizes (Lane 9; 1Kb Plus DNA ladder (Life Technologies)) are





Figure 3.5 EcoR I/A'ho I digestion of DNA minipreps established from Uni-ZAP®
XR clone 6.3a.
Lanes 1-8 represent minipreps 1-8 respectively, DNA marker sizes (Lane 9; 1Kb Plus
DNA ladder (Life Technologies)) are indicated to the right of the gel image.
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A single miniprep originating from clone 6.3a, with an insert of approximately 4.2 Kb,
was ethanol precipitated and sequenced (as described 2.4.6; 2.4.3). In total, 4243
nucleotides of sequence corresponding to the sheep DNMT1 cDNA sequences were
obtained. The sheep DNMT1 cDNA sequence corresponded to the nucleotides 1185-
5428 of the human DNMT1 sequence (Accession No. NM001379), including the PolyA
tail, but lacking the first 1 Kb of the coding region.
3.2.3 Cloning the 5' regions of the sheep DNMT1 cDNA sequence
A further 1-1.5 Kb of 5' sequence was required to gain the full length DNMT1 cDNA
clone (known to be approximately 5.2 Kb in the mouse; 5.4 Kb in the human). It was
decided to use a 5' RACE technique to clone the remaining sheep DNMT1 cDNA
sequence from adult tissue (heart) RNA. Parallel attempts were made to clone 5'
regions of an oocyte-specific sheep DNMT1, using pooled oocyte RNA as the starting
material instead of heart RNA.
An oligonucleotide, RACE Y, was designed within the initial 250 bp of the sheep
DNMT1 cDNA clone, in order to generate only DNMT1 -specific cDNA during the
modified 5' RACE reverse-transcription process. A control forward primer, RACE X,
and an additional reverse primer, RACE Z, were also designed to provide a control for
analysis of cDNA synthesised during later stages of the RACE protocol, allowing a
method of confirming the specific presence ofDNMT1 cDNA. Figure 3.6 demonstrates
the positions of the RACE primers in the DNMT1 sequence.
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1 ACGAGTGAAG ATGAAAAGGA GGAGAAGAGA CGCAGAACTA CATACAGAGA
51 ACTAACTGAG AAGAAAATGA CTCGAACCAA AATAGCAGTG GTGTCCAAGA
^
RACE X
101 CCGATCCTCC GAAGTGCACC GAGTGCTTGC AGTACCTGGA CGACCCCGAG
151 CTGAGATACG AGCAACACCC CCCTGATGCG GTGGAAGAGA TACAGATACT





Figure 3.6 Sequence location of RACE primers designed to amplify 5' regions
of sheep DNMT1
Nucleotide 1 corresponds to the first nucleotide of the DNMT1 cDNA library screen
clone (corresponding to nucleotide 1185 of the human DNMT1 cDNA sequence).
Primer RACE Y, highlighted in blue/purple (purple text indicates overlapping sequence
with the RACE Z primer), is the gene-specific primer used to amplify the oocyte and
somatic specific 5' ends of the sheep DNMT1 after the modified (SMART) reverse
transcription protocol. The same primer was used to detect DNMT1 products in the
post-cDNA synthesis PCR. The primer sequence highlighted in green is the control
forward primer RACE X. When RACE X is used in conjunction with RACE Z
(highlighted in red/purple), a product of 103 bp is generated allowing detection of
DNMT1 transcripts within the RACE cDNA population.
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3.2.3.1 Isolation of the sheep somatic DNMT1 5' cDNA sequence
The RACE Y primer was used in the reverse transcription of total RNA isolated from
heart tissue (as described 2.4.11.1) or pooled oocytes (as described 2.4.11.2) following
the SMART RACE protocol (as described 2.4.8). After synthesis of modified heart and
oocyte cDNA, PCR was performed using the RACE Y primer in conjunction with the
Universal primer mix (provided in SMART RACE kit), containing a primer specific to
the additional 'SMART II oligo' sequence at the 5' end of the cDNA, with conditions
described in 2.4.8. PCR products were electrophoresed on a 1.5% ethidium bromide
stained agarose gel (as described 2.4.2) and PCR products of approximately 1.3 Kb and
0.7 Kb were detected for heart cDNA (designated HI.3). A PCR product of 1.3 Kb was
also detected for oocyte cDNA, alongside two smaller products of 0.7 Kb and 0.5 Kb
(designated Oocl.3, OocO.7 and OocO.5 respectively). The results are shown in Figure
3.7. A second PCR was performed on the PCR products as an additional confirmation,
using RACE Y and RACE X primers, as described in 2.4.1.2. PCR products were
electrophoresed on a 2% ethidium bromide stained gel as described in 2.4.2, the results
are shown in Figure 3.8. PCR products HI.3, Oocl.3 and OocO.7 were then subcloned
and sequenced (as described in 2.4.3).
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Lane 1 2 3 4 1 2
Figure 3.7 RACE PCR products amplified from heart and oocyte cDNA
(A) Lane 1 contains a negative (no template) PCR control. Lane 2 contains RACE PCR
products of 1.3 Kb and 0.7Kb (indicated by arrows) generated from modified heart
cDNA, Lane 3 demonstrates a failure to amplify DNMT1 -specific RACE PCR products
from modified oocyte cDNA. DNA marker sizes (lane 4) are indicated to the right of
the gel image.
(B) The PCR was repeated for oocyte cDNA, using a higher cycle number. Lane 1
contains a negative (no template) PCR control. Lane 2 contains the three RACE PCR
products (1.3 Kb, 0.7 Kb and 0.5 Kb) generated from modified oocyte cDNA. RACE
PCR product sizes are indicated to the right of the gel image.
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Figure 3.8 PCR analysis of products isolated by 5' RACE using internal
primers. Lanes 2-5 contain PCR products amplified from RACE PCR products HI.3,
Oocl.3, OocO.7 and OocO.5 respectively. Lane 1 is a positive control PCR amplified
from kidney cDNA. DNA marker sizes (lane 6) are indicated to the right of the gel
image.
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The sequencing results confirmed all PCR products isolated and subcloned after the 5'
RACE experiment were DNMT1 cDNA sequences. After sequence editing, an extra 990
bp of 5' DNMT1 cDNA sequence were found to have been cloned by this method. The
990 bp HI.3 PCR product sequence was joined to the existing sheep DNMT1 cDNA
sequence, giving a total of 5233bp. The complete edited sheep DNMT1 sequence can be
found in Appendix I. Pairwise alignments of the entire cloned sheep cDNA sequence
with the human and mouse DNMT1 cDNA sequences were performed using the 'Gap'
application (default parameters) of the Wisconsin Package Version 10.2 (GCG10). The
sequence identity between the sheep and human DNMT1 cDNA was found to be
relatively high overall (86%), but slightly lower when comparing the sheep and mouse
cDNA sequences (75% homology), with the 3' portion of the sequence being the most
highly conserved between species. The pairwise sequence comparison of sheep/human
and sheep/mouse DNMT1 cDNA sequences can be found in the Appendix I. The
complete sheep DNMT1 cDNA clone sequence was translated using the 'Translate'
application (default parameters) ofGCG10, and an open-reading frame was identified in
frame 1. The open reading frame started at nucleotide 54 and terminated at a stop codon
(TAG) located at nucleotides 4887-4889. A multiple sequence alignment was
performed using the Tocalpileup' program (default parameters) on GCG10, comparing
the sheep DNMT1 protein with the known human (Accession No. NP001370) and
mouse (Accession No. NP034196) DNMT1 protein sequences. Shading was added
using the Genedoc program (default settings). Figure 3.9 shows the multiple alignment
of the protein sequences. Analysis of the sheep DNMT1 protein sequence demonstrated
the presence of highly conserved functional domains including a cysteine-rich domain,
proliferating cell nuclear antigen (PCNA) binding site, the replication foci targeting
sequence, and the methyltransferase motifs (catalytic domain).
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3.2.3.2 Analysis of sheep oocyte DNMT1 cDNA sequences
Comparison of cDNA sequences containing predicted exons 1-4 of the HI.3 (somatic)
and Oocl.3 (oocyte) sequences, with known exons 1-4 of mouse somatic and oocyte-
specific DNMT1, was performed by multiple sequence alignment (Localpileup;
GCG10). The multiple sequence alignment is demonstrated in Figure 3.10 demonstrate
that the heart and oocyte DNMT1 sequences shared high levels of homology with the
mouse somatic form of DNMT1. However, the DNMT1 sequence derived from sheep
oocytes demonstrated no similarity whatsoever with the alternative exon 1 of the mouse
oocyte-specific form.
After sequence editing, the 0.7 Kb PCR product derived from oocyte cDNA (OocO.7)
appeared to be a truncated form, with identical sequence to nucleotides 735-1232 of the
edited sheep DNMT1 sequence. A similar size product was also observed after RACE
PCR on heart cDNA, suggesting the presence of truncated cDNAs possibly due to the
inappropriate binding of the Smart II oligonucleotide primer during PCR steps. In
support of this argument, the 0.7Kb PCR product amplified in heart cDNA disappeared
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3.2.4 Investigation of DNMT1 isoforms in sheep and mouse oocytes.
To confirm the presence of the somatic DNMT1 in sheep oocytes, and to rule out
possible contamination of oocyte RNA prior to RACE experiments, a PCR-based assay
was designed. A method that would allow specific exon-detection was designed by
using primers within exon 1, (the exon which differs in mouse somatic and oocyte-
specific forms ofDNMT1 (primer SOMDT1)), exon 2, (which should amplify all forms
ofDNMT1 (primer SHE2)) and a reverse primer in exon 3 (primer SOMDT2). Primer
SOMDT2 was designed for use with both SOMDT1 and SHE2 primers, with all primers
sharing a similar annealing temperature. Figure 3.11 demonstrates the predicted exon
boundaries within the 5' region of the sheep DNMT1 cDNA sequence, and exon-specific
primer sites. In parallel, a similar experiment was designed for the mouse DNMT1
sequence. Primers were designed for somatic and oocyte-specific exon 1 (MSE1 and
MOE1 respectively) and a reverse primer (MSER) was also designed within exon 3.
This was to confirm previous data demonstrating oocyte-specific DNMT1 is the only
form ofDNMT1 in mouse oocytes and preimplantation embryos (Mertinet et al., 1998).
To determine whether sheep oocytes contained the same form of DNMT1 as somatic
tissues, a PCR was performed using either SOMDT1/SOMDT2 or SHE2/SOMDT2
primer pairs with pooled oocyte cDNA as the template (as described 2.4.1.2). The
SHE2/SOMDT1 primer pair, which in theory detects all forms ofDNMT1, was used as a
positive control. A second PCR was also performed using MOE1/MSER and
MSE1/MSER primer pairs, using pooled mouse oocyte cDNA as template (as described
2.4.1.1), All PCR products were subsequently electrophoresed on a 2% ethidium
bromide stained agarose gel (as described 2.4.2), results are shown in Figures 3.12 and
3.13. The intensity of the SOMDT1/SOMDT2 PCR product demonstrated considerable
amounts of somatic DNMT1 transcripts in sheep oocytes, confirming the previous
observation of identical forms ofDNMT1 in oocytes and heart tissue. The second PCR,
analysing specific exon presence in mouse oocyte cDNA demonstrated no detectable
somatic DNMT1, with the oocyte-specific form being the only form present.
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All DNMT1 PCR products generated in this particular experiment were digested with a
sequence-specific restriction enzyme (Apo I), to confirm identity (as described 2.4.5).
Furthermore, the sheep-specific PCR primers failed to amplify the correct size PCR
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Figure 3.12 Detetection of DNMT1 in sheep oocytes and heart tissue using exon-
specific primers.
Lanes 2-6 represent PCR products generated using SHE2/SOMDT2 primers, lanes 7-11
contain PCR products generated using SOMDT1/SOMDT2 primers. Lanes 3-4 and 8-9
are PCR products amplified from heart cDNA. Lanes 5-6 and 10-11 are PCR products
amplified from pooled oocyte cDNA. Lanes 2 and 7 are negative (no template) PCR
controls. DNA marker sizes (1 Kb plus DNA ladder, Invitrogen) are indicated to the
right of the gel image.




Figure 3.13 Detetection of oocyte- or somatic-specific DNMT1 in mouse oocytes
and heart tissue.
Lanes 1-5 show PCR products generated using the MSE1/MSER primer combination,
and lanes 6-10 show PCR products generated using the MOE1/MSER primer pair.
Lanes 1/7 are negative controls, lanes 2-3/8-9 are products generated from heart tissue,
lanes 4-5/10-11 contain PCR products generated from oocyte cDNA. DNA marker sizes
(lanes 6 and 12) are indicated to the right of the gel image.
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3.4 Discussion
A 4.2 Kb cDNA clone partially encoding sheep DNMT1 was isolated from an adult
sheep lung cDNA library. A further 1 Kb of cDNA sequence comprising the 5' region
of the somatic form of sheep DNMT1 was cloned using a 5' RACE technique. In total,
5233 bp of sheep DNMT1 cDNA sequence was obtained. After sequence editing,
pairwise alignments were generated comparing sheep DNMT1 with the human and
mouse DNMT1 cDNA sequences. The sheep cDNA sequence shares greater homology
with the human sequence (86%) than the mouse cDNA sequence (77%). Translation of
the sheep DNMT1 sequence from the first methionine residue (nucleotide position 54)
identified a long open reading frame terminating with the stop codon (TAG) at
nucleotide position 4887. This open reading frame potentially encodes a protein of 1611
amino acid residues with a predicted molecular weight of 182 kDa. In addition to the
translated regions, the cDNA clone contained 53 bp of 5' UTR and 346 bp of 3' UTR
sequence, including the polyA tail.
It is possible that further 5' UTR DNMT1 cDNA sequences exist in the sheep, as the 5'
RACE method used to clone these regions cannot guarantee attainment of complete
cDNA sequences for several reasons. Firstly, to gain complete 5' UTR sequences, the
RNA used for cDNA synthesis has to be of the highest quality. Standard procedures
were strictly adhered to with respect to the collection and storage of tissues for RNA
extraction, but even this cannot prevent some degradation of the RNA. Secondly, the
RACE method itself may form slightly truncated products if the reverse transcriptase
activity terminates prematurely (before the end of the RNA template). The additional
sequence likely to be gained by further attempts at 5' RACE or other cloning methods
would be negligible regions of further 5' UTR cDNA sequence, and in the context of
this study, adequate DNMT1 sequence information was already attained.
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Multiple sequence alignment comparing the predicted sheep protein sequence with the
known human and mouse protein sequences was performed. The predicted sheep
DNMT1 protein shares high levels of homology with the human and mouse proteins,
particularly within functional domains. The region demonstrating the highest levels of
homology is the carboxy terminal, specifically the methyltransferase motifs. Eight of
the ten methyltransferase motifs present in prokaryotic cytosine methyltransferases are
highly conserved between the sheep, human and mouse, and display identical sequence
homology. One of these highly conserved methyltransferase motifs, motif IV, contains
the proline-cysteine dipeptide (the catalytic site). Although the N-terminal region of
DNMT1 is not as highly conserved as the C-terminal region between species, high levels
of homology are apparent within functional domains. These include the cysteine-rich
(Zn binding) domain and the replication foci targeting domain. Protein binding sites for
PCNA and DMAP1 also retain high levels of homology between the three mammalian
species.
The predicted protein sequence for sheep DNMT1 is clearly highly homologous with
human and mouse protein sequence, and would therefore be expected to perform similar
functions. Analysis of the protein would be required to confirm this, including
measurement of protein size and assessment of its activity in vitro. The predicted size of
DNMT1 could be confirmed by western blot analysis, and assays can also be performed
to investigate the specificity of methyltransferases for hemi-methylated or unmethylated
substrates. However, it would be unlikely to discover completely different functions of
sheep DNMT1 when it is so similar to other mammalian forms ofDNMT1.
In addition to isolation of the somatic form of sheep DNMT1, parallel attempts were
made to clone an oocyte-specific DNMT1. The oocyte-specific form of DNMT1
identified in the mouse is identical to the somatic form, except for an alternative first
exon (exon lo). Using 5' RACE on pooled oocyte RNA, a 1 Kb cDNA was amplified
corresponding to the 5' region of the DNMT1 cDNA sequence. However, closer
inspection of the cDNA sequence demonstrated 100% homology with the 5' region
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amplified from somatic tissue. To rule out the possibility of contamination of the pooled
oocyte RNA source, an exon-specific PCR was designed. Primer sites were designed in
exon 1 (to amplify somatic form only), exon 2 (to amplify ALL forms ofDNMT1) and a
reverse primer in exon 3. The exon-specific PCR performed on pooled oocyte cDNA
confirmed the presence of 'somatic' DNMT1 in sheep oocytes. A similar exon-specific
PCR was designed to amplify the mouse Dnmtl as previous experiments confirming the
existence of the mouse oocyte-specific Dnmtl (Mertineit et al., 1998) did not
specifically analyse Dnmtl isoforms in mature oocyte RNA. The PCR showed that
there was no somatic form ofDnmtl in pooled mouse mature oocytes.
The species-specific differences observed here are intriguing. Although the existence of
an sheep oocyte-specific DNMT1 cannot be ruled out, it is clear that it is not the sole
form of DNMT1 found in sheep oocytes. Additional attempts were made to clone an
'oocyte-specific' DNMT1 in sheep using the primers used to amplify the mouse form.
The reverse primer of this pair is highly homologous with the sheep DNMT1 sequence in
exon 2. However, even when conditions were made less stringent, such as reducing
primer annealing temperature and altering the magnesium concentrations, no PCR
product was observed in sheep oocytes. Attempts to quantify the amount of somatic-
specific DNMT1 in sheep oocytes were difficult on account of the differences observed
in primer efficiencies and so were not continued. Moreover, it was decided it would be
more informative to analyse presence or absence of DNMTlo at the protein level.
Unfortunately, time limitations prevented this particular experiment from being carried
out.
The significance of the differences observed between the two species is unclear. The
mouse is the only known species expressing DNMTlo, however, there are no reports of
investigations performed in other vertebrate species except Xenopus. Xenopus does not
appear to have an oocyte-specific form ofDNMT1, with significant amounts of somatic
DNMT1 observed in Xenopus eggs. The apparent lack of DNMTlo in Xenopus may
not be significant, as this species does not have imprinted genes; the subset of genes
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methylated by Dnmtlo in the mouse at the 8-cell stage of development (Howell et al.,
2001). In contrast, evidence for genomic imprinting in the sheep is strong, and allele-
specific gene expression of IGF2, IGF2R, MEST (Feil et al., 1998) H19 (Hagemann et
al., 1998) DLK1, GTL2, DAT, PEG11, antiPEGll and MEG8 (Charlier et al., 2001)
have been reported. In addition, a more detailed study of sheep IGF2 imprinting was
recently undertaken, demonstrating 'imprinting' characteristics (developmental switch to
biallelic expression in the liver; sex-specific differences in recombination rates) shared
with the human IGF2 gene (McLaren & Montgomery, 1999).
Of note, a database search was initiated to investigate the presence of an oocyte-specific
exon in other mammalian species known to have imprinted genes, to identify sequences
sharing homology with the oocyte-specific exon lo. Although the entire human
chromosome 19 (the location of the human DNMT1 gene) is available for nucleotide-
based searches, no sequence demonstrating homology with the mouse exon lo was
identified. It is possible, however, that any exon lo sequences may differ significantly
between species, or an alternative method of regulation may exist.
If the sheep does not express an oocyte-specific DNMT1, then it is unclear as to what the
effect may be on imprinted gene methylation during preimplantation development. The
unusual localisation and nuclear import/export of mouse DNMTlo may be essential for
maintenance of imprinted gene methylation in the mouse, but is this the case in other
mammalian species? One fundamental question needs addressing prior to drawing
conclusions. If sheep do not express an oocyte-specific DNMT1, is the somatic form of
DNMT1 able to perform a similar role? The mouse Dnmtlo is a truncated protein,
lacking the first 3 exons of the somatic form. This difference in N-terminal regions is
clearly important for the specialised properties of oocyte and somatic forms ofDnmtl.
Also worthy of note, is a study in which the truncated form of Dnmtl protein was
isolated in a screen for proteins binding annexin V (Ohsawa et al., 1996). This protein
has been postulated to be involved in the sequestration ofDnmtlo at the periphery of the
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cytoplasm in mature oocytes (Mertineit et al., 1998). In addition, annexin V has also
been shown to undergo inducible nuclear localisation (Barwise and Walker, 1996). As
the N-terminal of somatic Dnmtl is extended in comparison with Dnmtlo, binding with
annexin V may be prevented. Indeed, DNMTlo has recently been shown to colocalise
with Annexin V in mouse oocytes (Doherty et al., 2002). Another protein whose
binding may be altered by the alternative N-terminal regions of Dnmtlo is DMAP1.
The DMAP1 binding site is located within the N-terminal region of somatic Dnmtl
(amino acid residues 1-130), and may be prevented in the truncated Dnmtlo if a
significant section of the binding site is absent.
Unfortunately, it appears that the 'oocyte specificity' of the truncated Dnmtl protein is
not as clear-cut as previously suggested. The Dnmtl protein shown to bind Annexin V
in the initial screening study was a truncated form (similar to Dnmtlo) found in the brain
of a dl 7 rat (Ohsawa et al., 1996; cDNA sequence accession no. D64060). A search of
the GenBank database also yielded a second rat Dnmtl cDNA sequence isolated from rat
brain, encoding the same truncated form of Dnmtl (Accession No. AF116345). The
two isoforms identified in the rat brain were not identical, with different sequences 5'
prime of exon 4. Multiple sequence alignment generated from the two rat brain Dnmtl
cDNA sequences alongside the oocyte and somatic forms ofmouse Dnmtl demonstrated
no homology between the rat Dnmtl sequences and exon lo of the oocyte-specific form
of Dnmtl. Comparison of the rat Dnmtl sequences with the somatic form of Dnmtl
demonstrated homology commencing from either exon 2 or exon 4. The sequence
alignment is presented in Figure 3.14. As the predicted protein sequences for both of
these isoforms initiate at the same ATG codon as the 'oocyte-specific' Dnmtl, it is
likely that this truncated form may be generated by several possible routes of alternate
splicing and not solely the result of exon lo usage.
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As the N-terminal regions of the oocyte-specific Dnmtlo appear to encode unique
localisation and specific methylating properties, and somatic DNMT1 is the abundant
form of DNMT1 in sheep oocytes, then the cytoplasmic localisation observed in mouse
oocytes and preimplantation embryos may not be replicated. Instead, localisation may
be observed throughout the cytoplasm and nucleus. The consequences of nuclear
localisation in terms ofmethylation reprogramming are significant.
In the mouse, exclusion ofDnmtl from the nucleus during preimplantation development
correlates with the passive demethylation of the genome observed at this stage. If the
nuclei of sheep oocytes (and consequently preimplantation embryos) contain significant
amounts of DNA methyltransferase activity, demethylation may not be observed to such
an extent, if at all, in sheep preimplantation development. Furthermore, the presence of
DNMT1 in the nucleus during preimplantation development would potentially allow for
the continual maintenance of imprinted gene methylation, eliminating the need for a
specialised DNMT1 with stage-specific localisation abilities. This would represent very
different reprogramming mechanisms occurring in two mammalian species.
Methylation reprogramming has been investigated to a small extent in the cow {Bos
taurus; a ruminant species closely related to sheep) and both active and passive
demethylation occurs post-fertilisation (Dean et al., 2001). In contrast to mice, however,
de novo methylation occurs at the 8-16 cell stage, demonstrating significant differences
in reprogramming between species. It would be very interesting to establish whether the
cow also expresses the somatic form of DNMT1 in oocytes, or whether the mouse is
unique in its unusual method ofDNA methylation regulation in embryos.
Still, the possibility of an oocyte-specific DNMT1 in sheep cannot be ruled out. It must
be remembered that so far, only the somatic DNMT1 transcripts have been detected in
sheep oocytes, and it may be possible that they are not translated. However, the
presence of somatic DNMT1 in sheep oocytes demonstrates significant species-specific
differences with further implications for methylation reprogramming in preimplantation
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development. Further work is clearly required to determine the specific localisation of
somatic (or oocyte) specific forms of DNMT1 in sheep oocytes and preimplantation
embryos.
Overall, the cloning ofDNMT1 in sheep reported here, will allow further analysis of the
functions of this protein in sheep. Expression analysis of DNMT1 in adult tissues and
preimplantation embryos will allow insights into the roles DNMT1 of in sheep
development, and is described in chapter 5. Furthermore, in situ analysis of DNMT1
mRNA and immunolocalisation of the protein in preimplantation embryos could also be
used to explore the role of this gene in sheep development.
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Chapter 4
Cloning and sequence analysis of the sheep de novo
methyltransferases DNMT3A and DNMT3B
4.1 Introduction
De novo methylation is the modification of completely unmethylated DNA and is
thought to be the process involved in establishing genomic DNA methylation
patterns during early development. The first mammalian DNA cytosine-5
methyltransferase to be identified was Dnmtl, a protein predominantly involved in
maintaining methylation patterns, although it does encode some residual de novo
methylating activity (Lei et al., 1996). The existence of separately encoded DNA
methyltransferases solely involved in establishing methylation patterns, was first
realised after observations of persistent de novo methylating activity in ES cells
carrying a targeted deletion of Dnmtl (Lei et al., 1996). The race to clone these
novel DNA methyltransferase genes led to the recent identification of Dnmt2,
Dnmt3a and Dnmt3b (Yoder et al., 1998; Okano et al., 1998a); all encoding proteins
homologous with bacterial cytosine-5 methyltransferases. Dnmt2, a protein related
to pmtlp of fission yeast (S.pombe), was almost instantly ruled out as a de novo
methyltransferase. Firstly, the protein failed to demonstrate any CpG methylating
activity in vitro, and secondly, ES cells carrying a disrupted Dnmt2 did not show any
alterations in global methylation levels (Okano et al., 1998b).
Dnmt3a and Dnmt3b are thought to be more realistic candidates for mammalian de
novo methyltransferases for several reasons. Firstly, in vitro expression of Dnmt3a
and Dnmt3b demonstrated methylating activity, and furthermore, demonstrated no
preference for hemi-methylated substrates (Okano et al., 1998a). In addition,
Dnmt3a and Dnmt3b are also highly expressed in undifferentiated ES cells, but
downregulated in adult tissues, suggesting developmental roles (Okano et al.,
1998a). Dnmt3a is a protein of 908 amino acids, encoded by a 4192 bp transcript
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(Okano et al., 1998a). The Dnmt3b cDNA sequence is of a similar size (4195 bp),
but is alternatively spliced to produce proteins of 859 aa (Dnmt3bl), 840 aa
(Dnmt3b2) and 777 aa (Dnmt3b3; Okano et al., 1998a).
The Dnmt3 family of proteins share a very similar C-terminal domain, along with a
cysteine-rich region. The C-terminal regions ofDnmt3a and Dnmt3b are not closely
related to the one seen in Dnmtl, suggesting different prokaryotic 5-methyl cytosine
ancestors (Xie et al., 1999). Furthermore, the cysteine rich region does not share
homology with the Dnmtl cysteine-rich region (Zn-binding domain), but is very
similar to a domain found in the ATRX protein, known to be a member of the
SNF2/SWI family of chromatin remodelling proteins (Picketts et al., 1996). The
Dnmt3a and Dnmt3b N-terminal regions demonstrate significant differences (less
than 30% sequence homology) between the two proteins (Xie et al., 1999). The N-
terminal regions may encode different roles for the two proteins, possibly mediated
by different protein-protein or protein-DNA interactions. Figure 4.1 highlights the
structural differences between the two proteins.
Genetic analysis of Dnmt3a and Dnmt3b has demonstrated essential roles for these
proteins in development. Mice carrying a targeted deletion of Dnmt3b die at mid-
gestation whilst mice carrying a targeted deletion of Dnmt3a die shortly after birth
(Okano et al., 1999). Furthermore, the specific roles of Dnmt3a and Dnmt3b in
development have also been investigated. Analysis of the mice carrying a targeted
deletion ofDnmt3b demonstrated a failure to methylate centromeric satellite minor
repeats (Okano et al., 1999), and a high percentage of humans suffering with the
genetic disorder ICF (Immunodeficiency, Centromeric instability, and Facial
anomalies) carry mutations in the DNMT3B gene (Hansen et al., 1999; Xu et al.,
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Figure 4.1 Structural comparison of Dnmt3a and Dnmt3b protein domains.
Adapted from Okano et al., 1998a. The cysteine rich region ofDnmt3a and Dnmt3b
proteins are highlighted in grey, the five most highly conserved methyltransferase
motifs are represented by black rectangles (numbered). Splice sites in Dnmt3b2
(amino acids 362 to 383) and Dnmt3b3 (amino acids 362 to 383 and 749 to 813) are
also indicated in the diagram. The N-terminal regions of Dnmt3a and Dnmt3b are
highlighted in red (Dnmt3a) and blue (Dnmt3b) to demonstrate the differences in
protein sequence.
In addition to its known role in CpG methylation, there is increasing evidence
suggesting a role for Dnmt3a in the methylation of non-CpG cytosine residues
(predominantly CpA dinucleotides) during mouse development. Non-CpG
methylation has been observed in ES cells (Ramsahoye et al., 2000), and has also
been demonstrated in the mouse neurofibromatosis type 1 gene (Nfl) during post-
fertilisation stages of development (Haines et al., 2001). Dnmt3a is known to be
responsible for the non-CpG methylation in ES cells (Ramsahoye et al., 2000), but
as there is no data available for Dnmt3a expression in mouse preimplantation
embryos and oocytes, it is difficult to ascertain whether it may be involved in
methylation of theNfl or other genes.
A closely related protein, Dnmt3L, has recently been shown to be essential for the
establishment of imprinted gene methylation in mouse oocytes (Bourc'his et al.,
2001). Dnmt3L is very similar to both Dnmt3a and Dnmt3b, containing the cysteine
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rich domain shared with the ATRX protein, but it lacks the conserved
methyltransferase motifs present in other members of the Dnmt3 family (Aapola et
al., 2000). Recent experiments investigating the precise role of the oocyte-specific
Dnmtl (Dnmtlo) have demonstrated that it is not responsible for establishing
imprinted gene methylation in oocytes and therefore another methyltransferase must
be involved. (Howell et al., 2001) As Dnmt3L itself cannot methylate genes it is
possible that it may cooperate with Dnmt3a or Dnmt3b (perhaps via interaction of
the shared cysteine rich domain) to establish methylation marks of imprinted genes
in mouse oocytes.
The importance of methylation reprogramming in mouse development, and the
apparent requirement for de novo methyltransferases Dnmt3a and Dnmt3b in normal
development is clear. As one of the main aims of this study is to investigate DNA
methylation and methylating activities occurring during sheep preimplantation
development, the de novo methyltransferase genes are key candidates for analysis.
The expression patterns of these genes have not been studied in the mouse
preimplantation embryo but their expression in ES cells, coupled with the high
levels of non-CpG methylation observed in early stage mouse embryos, would
suggest significant roles at this stage of development.
This study describes the initial cloning and sequence analysis of the sheep DNMT3A
and DNMT3B genes. Coding regions of the DNMT3A and DNMT3B genes were
cloned using a combination of RT-PCR and cDNA library screening. After
verification of cDNA clone identity, sequence analysis was performed and
comparisons made with the known human and mouse cDNA and protein sequences
to assess levels of conservation between the three species.
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4.2 Results
4.2.1 Generation of partial sheep DNMT3A and DNMT3B cDNA clones
by RT-PCR
Primer sequences specific to DNMT3A were obtained from Robertson et ai, 1999.
Pairwise sequence alignments of the human (Accession no. AF176228) and mouse
(Accession no. NM_010068) DNMT3B cDNA sequence were generated using the
'Gap' application (default parameters) of GCG10. Primers were designed in a
region of the human cDNA sequence seen to be highly conserved between the
human and mouse and present in all Dnmt3b splice variants. Table 4.1 lists the
primers used to amplify DNMT3A and DNMT3B cDNA, and the locations within the
human DNMT3A or DNMT3B cDNA sequence. Heart or liver cDNA derived from
dl25 fetal tissue was used as the template and a standard PCR reaction performed
(as described 2.4.1.1). In addition, PCR reactions using 500 ng genomic DNA as
template were also performed, to determine whether the DNMT3A or DNMT3B
primers spanned intronic regions. PCR products were electrophoresed on a 2%
ethidium bromide stained agarose gel (as described 2.4.2), results are shown in
Figure 4.2, PCR products of expected size (DNMT3A 280 bp; DNMT3B 101 bp)
were observed and subsequently cloned and sequenced (as described 2.4.3) to
confirm identity. Amplification of genomic DNA using the HDNMT3A primers
produced a larger PCR product of 1.2 Kb, indicating the primers span an intronic
region of approximately 0.9 Kb. The PCR product observed as a result of
amplification of genomic DNA with the DNMT3B2 primers was the same size as the
RT-PCR product, indicating the primers do not span an intron.
Ill






DNMT3A HDNMT3AF Forward AF067972 2282-2303
DNMT3A HDNMT3AR Reverse AF067972 2561-2539
DNMT3B DNMT3B2F Forward AF176228 2269-2290
DNMT3B DNMT3B2F Reverse AF176228 2369-2350
Table 4.1 Table of DNMT3A and DNMT3B primer design information.
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Figure 4.2 Partial sheep DNMT3A and DNMT3B cDNA clones generated by
RT-PCR.
(A) Lane 1 is a negative PCR control with no template. Lanes 2 and 3 are PCR
products amplified from dl25 fetal heart and liver cDNA respectively. Lane 4 is a
PCR product amplified from genomic DNA. DNA marker sizes (Lane 5; I Kb Plus
DNA ladder (Invitrogen)) are indicated to the right of the gel image.
(B) Lane 2 is a negative PCR control with no template. Lanes 3 and 4 are PCR
products amplified from dl25 fetal heart and liver cDNA respectively. Lane 5 is a
PCR product amplified from genomic DNA. DNA marker sizes (Lane 1; I Kb Plus
DNA ladder (Invitrogen)) are indicated to the left of the gel image.
112
4.2.2 Isolation of a DNMT3A cDNA clone from an adult sheep lung
cDNA library
The partial sheep DNMT3A cDNA clone generated by RT-PCR was used to probe
an adult lung sheep cDNA library obtained from Stratagene (as described 2.4.7).
The primary screen identified a positive clone, designated 9, which was re-plated for
the secondary screen. After the secondary screen, a positive signal corresponding to
six single plaque colonies (designated 9a-9f respectively) were identified. These
single plaque colonies were isolated and PCR analysis performed using the
HDNMT3A primer set as an additional control. The results of this PCR are
demonstrated in Figure 4.3. A single clone, 9D, was chosen for further analysis.
Excision of the pBluescript plasmid (containing the cDNA fragment) from the Uni-
ZAP XR vector was subsequently performed (as described 2.4.7.7) and plasmid
DNA prepared from 8 single colonies for clone 9D (as described 2.4.3). PCR
analysis using the HDNMT3A primer set was performed to check insert identity of
the plasmid DNA, and an EcoR 1/Xho I double digest was also performed to release
the insert and simultaneously ascertain insert size for lambda clone 9D, results are
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Figure 4.3 PCR analysis ofDNMT3A positive plugs.
Lane 1 is a minus template control, Lane 2 is a positive PCR control using liver
cDNA as template. Lanes 3-4 and 6-9 represent the PCR products amplified from
'positive' plugs 9a-9f respectively. DNA marker sizes (lane 5; 1 Kb Plus DNA
ladder, Invitrogen) are indicated to the right of the gel image.













Figure 4.4 EcoR VXho I digestion of DNA minipreps established from Uni-
ZAP® XR clone 9D.
Lanes 1-5 and 7-11 represent minipreps 1-8, DNA marker sizes (lane 6; 1 Kb Plus
DNA ladder, Invitrogen) are indicated to the right of the gel image.
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A single plasmid DNA miniprep originating from the 9D clone, with an insert of
approximately 2 Kb, was ethanol precipitated and sequenced (as described 2.4.6;
2.4.3). A total of 1850 nucleotides of sequence corresponding to the sheep
DNMT3A cDNA sequence were obtained and can be found in Appendix II.
Pairwise alignments of the cloned sheep cDNA sequence and the human or mouse
DNMT3A cDNA sequences were performed using the 'Gap' application (default
parameters) on GCG10. The sheep DNMT3A cDNA sequence was found to be
highly conserved (94%) when compared to the human homologue (Accession No.
AF067692. The pairwise alignment of sheep and human or mouse DNMT3A cDNA
sequences can be found in Appendix II. The sheep DNMT3A cDNA sequence was
subsequently translated using the translate application in GCG10, and an open
reading frame identified in frame 1. This open reading frame terminated at a TAA
stop codon located at nucleotides 1427-1429. Multiple protein sequence alignment
was performed as described in Chapter 3, comparing the human (Accession No.
NP072046), mouse (Accession No. NP031898) and sheep protein sequences.
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4.2.3 Sequence analysis of a partial sheep DNMT3B cDNA clone.
The partial DNMT3B cDNA clone generated by RT-PCR (refer to 4.2.1) was used as
a probe to screen the adult lung cDNA library (as described 2.4.7). Several attempts
to isolate a larger DNMT3B cDNA clone using this strategy failed. As the failure
may have been due to inefficiency of the probe (perhaps due to the small size of the
probe), library screening was performed using the full-length mouse Dnmt3b cDNA
(a kind gift from Dr I. Stancheva, University ofEdinburgh). Again, several attempts
using this method were unsuccessful. Poor representation of the DNMT3B cDNA in
the library, perhaps due to low expression in the adult sheep lung, may have been
one reason the library screen failed, therefore, an alternative strategy was devised.
Additional primer pairs were designed over regions seen to be homologous in the
human and mouse, however, attempts to amplify DNMT3B specific PCR products
failed. Ultimately, it was decided to cease attempts to clone a larger partial
DNMT3B cDNA clone due to time constraints.
The lOlbp of DNMT3B cDNA sequence amplified by RT-PCR corresponded to
nucleotides 2269-2369 human DNMT3B sequence (Accession No.AF176228). Due
to the high levels of homology shared by DNMT3A and DNMT3B at the nucleotide
level, it was necessary to confirm the identity of the partial sheep 'DNMT3B'
sequence by comparison with both genes. After removal of primer sequences,
multiple sequence alignment of the remaining 59 bp of sheep DNMT3B sequence
and the human DNMT3B and DNMT3A cDNA sequences (shown in Figure 4.6) was
performed using the 'localpileup' application (default parameters) of GCG10.
Pairwise alignment of the 59 bp sheep DNMT3B sequence with the human DNMT3B
and DNMT3A cDNA sequences demonstrated 92% and 81 % homology respectively,
increasing confidence in the identification of the cDNA sequence as DNMT3B. The
59 bp of sheep DNMT3B cDNA sequence were subsequently translated using the
'Translate' application of GCG10. Pairwise sequence alignment of the predicted
sheep DNMT3B protein sequence with the known human DNMT3B protein
sequence (Accession No. N0008823) was performed using the 'Gap' application
(default parameters) ofGCG10. The protein sequences were highly conserved, with
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31/32 amino acids being identical. The alignment ofDNMT3B protein sequences is



























Figure 4.6 Alignment of the sheep DNMT3B cDNA sequence with human
DNMT3B and DNMT3A sequences.
Multiple sequence alignment was performed using the docalpileup' application
(default parameters) ofGCG10.
Sheep 1 LLNYSRPKEGEDRPFFWMFENWAMKVGDKRD 32
I I I I I I I I I M I I I I I I I I I I II I I I I I I I I
Human 671 LFFEFYHLLNYSRPKEGDDRPFFWMFENWAMKVGDKRDISRFLECNPVM 720
Figure 4.7 Alignment of the known sheep and human DNMT3B protein
sequences. Pairwise protein sequence comparison was performed using the Gap




Partial clones encoding the sheep de novo methyltransferases DNMT3A and
DNMT3B have been isolated in sheep for the first time. A 1.85 Kb clone
corresponding to the 3' region of DNMT3A was cloned through a combination of
RT-PCR and cDNA library screening. Pairwise sequence alignments of the sheep
cDNA sequence with the human or mouse DNMT3A sequences were generated,
demonstrating very high levels of homology with both the human (94%) and mouse
(89%) sequences. The cDNA sequence was translated and an open reading frame
identified, terminating at nucleotide 1427 (stop codon TAA). The predicted sheep
DNMT3A protein sequence was compared with the human and mouse protein
sequences and was found to be highly homologous, with 473 out of 475 amino acid
residues (99% homology) identical to the human and mouse sequences. The
predicted protein sequence encodes the catalytic domain, containing the five highly
conserved methyltransferases motifs, and the cysteine-rich domain within the N-
terminal region.
The high level of conservation of DNMT3A between species is very interesting.
Between the mouse and human DNMT3A protein sequences, the N-terminal domain
is very highly conserved, (95%), more so than the N terminal regions of the mouse
and human DNMT1 protein (79%). As the predicted protein sequence of the clone
isolated from the sheep lung cDNA library only represents the C-terminal and N-
terminal regions in close proximity to the catalytic domain, it is difficult to say
whether the protein is completely conserved between sheep and other mammalian
species. However, the high levels of conservation between the known DNMT3A
sequences observed overall, signifies an important role for DNMT3A in mammals.
Indeed, it is known to be essential for normal development in the mouse (Okano et
ah, 1999), although its specific roles have not been clearly determined.
Attempts to clone DNMT3B in sheep resulted in a partial clone containing 59
nucleotides of novel sequence. cDNA library screening was performed to gain a
larger cDNA clone using the small DNMT3B PCR product as a probe, but this
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approach failed repeatedly. Further efforts to gain a larger clone included screening
the cDNA library with the complete mouse Dnmt3b cDNA sequence, and designing
additional PCR primers, but all of these experiments were unsuccessful. Failure of
the library screening may have been due to poor representation ofDNMT3B cDNA
within the sheep adult lung cDNA library. Indeed, further experiments
demonstrated that DNMT3B was undetectable in several adult tissues including lung,
although it was found to be expressed in dl25 fetal tissues (reported in Chapter 5).
Additional attempts to clone further regions of DNMT3B using alternative PCR
primers and dl25 fetal tissue cDNA also failed, suggesting a possible lack of
homology between the sheep and human or mouse DNMT3B sequences.
The small region of DNMT3B isolated in sheep demonstrated high levels of
homology with the human sequence at both nucleotide and amino acid level,
although it is not possible to determine whether this is indicative of the entire
sequence. A comparison of the sheep DNMT3B and human DNMT3A cDNA
sequences was also performed, as the two genes are known to share high levels of
DNA sequence homology in the human. Although high levels of homology were
observed between the sheep DNMT3B and human DNMT3A sequences (81%), this
was lower than that observed between the sheep and human DNMT3B cDNA
sequence (92%). This observation increased confidence in the verification of the
sheep clone as DNMT3B encoding sequence.
Overall, DNMT3B appears to be the least conserved between species of the known
functional DNA methyltransferases, with only 73% nucleotide sequence identity
between the human and mouse DNMT3B cDNA sequences. This compares to 79%
sequence identity between human and mouse DNMT1 cDNA sequences, and 89%
sequence identity between human and mouse DNMT3A cDNA sequences. This may
partially explain why the sheep DNMT3B cDNA clone has remained so difficult to
isolate.
In addition to cloning DNMT3A and DNMT3B, the de novo methyltransferases with
known methylating activity, it would have been valuable to clone the sheep
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homologue of the closely related DNMT3L gene. However, as DNMT3L was only
recently identified (Aapola et al., 2000), and the report describing its initial isolation
and characterisation was only available during the latter stages of this study, it was
deemed to be too late to initiate a new study. Moreover, DNMT3L is not expressed
in adult mouse or human lung tissue (Aapola et al., 2000; Aapola et al., 2001),
therefore a strategy of cDNA library screening using the lung cDNA library (the
only sheep cDNA library commercially available) would not have been feasible.
As with DNMT3B, DNMT3L does not appear to demonstrate very high levels of
sequence identity between species. A comparison of the human DNMT3L cDNA
sequence and a partial mouse Dnmt3L sequence, demonstrated only 69% nucleotide
sequence identity, which is lower than that seen between the human and mouse
DNMT3B cDNA sequences. This observation would suggest potential difficulties in
cloning the sheep homologue of DNMT3L, similar to those experienced whilst
cloning DNMT3B. Nevertheless, given its importance in the establishment of DNA
methylation marks in imprinted genes in mouse germline, attempts should certainly
be made to clone DNMT3L and to assess its role in sheep development in the future.
The identification and substantial cloning of DNMT3A in sheep has demonstrated
high levels of conservation of this protein between species and has also generated
substantial sequence to facilitate further analysis of its roles in sheep development.
In contrast, only a small region of DNMT3B was cloned in sheep, but sufficient
sequence was obtained to confirm its identity. Although it would have been of
interest to clone a larger region ofDNMT3B, sufficient sequence was determined for
expression analysis in sheep development, a primary interest of this thesis, which is
discussed in the following chapter.
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Chapter 5
Expression of DNA methyltransferase genes in sheep
tissues and preimplantation embryos
5.1 Introduction
The expression patterns of DNA methyltransferase genes in human and mouse
tissues have been well characterised, though less is known about events during
preimplantation development, particularly for the putative de novo
methyltransferases DNMT3A and DNMT3B. In the human, DNMT1 is expressed
ubiquitously in most adult tissues (Yen et al., 1992), reflecting its role in
maintaining methylation patterns during DNA replication and cell division.
DNMT3A is also expressed ubiquitously in adult tissues, although at slightly lower
levels than DNMTl, and DNMT3B transcripts are detected at low levels in
comparison to both DNMTl and DNMT3A (Xie et al., 1999). In adult mouse
tissues, DNA methyltransferases demonstrate expression patterns similar to those
seen in the human, with ubiquitous expression of Dnmtl (Bestor et al., 1988) and
downregulation of Dnmt3a and Dnmt3b in most adult tissues relative to levels in
undifferentiated ES cells (Okano et al., 1998a). It is worthy of note, that
inappropriate upregulation of these three DNA methyltransferases is often associated
with cellular neoplasticity (Robertson et al., 1999; Kanai et al., 2001).
The initial discovery that DNA methylation levels change significantly during
mouse preimplantation development (Monk et al., 1987) led to almost immediate
investigation of Dnmtl protein level and localisation in oocytes and preimplantation
embryos (Monk et al., 1991; Carlson et al., 1992), however, analysis of Dnmtl
mRNA levels was largely ignored. Dnmtl protein levels are exceptionally high in
124
oocytes, with 15000-fold more Dnmtl compared to fibroblasts cells (Carlson et al.,
1992). Dnmtl levels then decline gradually during preimplantation development,
with blastocysts retaining one quarter of the amount seen in oocytes (Carlson et al.,
1992). Dnmtl protein also undergoes strict regulation of cellular localisation during
preimplantation development, to aid the correct reprogramming of methylation
patterns at this time (Carlson et al., 1992; Cardoso & Leonhardt, 1999)
Previous studies of de novo methylation have focused on the role of the de novo
methyltransferases Dnmt3a and Dnmt3b during postimplantation development.
Mice carrying targeted disruptions of these genes died either at mid-gestation
(Dnmt3b) or four weeks post-partum (Dnmt3a; Okano et al., 1999). Furthermore,
Dnmt3a~'", Dnmt3b" ~ double mutant homozygous embryos were abnormally small,
demonstrated a failure to form somites and died before dll.5. As the phenotype in
double mutant homozygous mice was considerably more severe than either the
Dnmt3a or Dnmt3b single mutant homozygotes, these proteins evidently have
overlapping functions during embryogenesis. Although Dnmt3a and Dnmt3b have
been shown to be essential for normal post-gastrulation development, any possible
requirement in preimplantation embryos remains undetermined.
DNA methylation patterns are dynamic during the early stages of mouse
development, and regulation of DNA methyltransferase genes is required to ensure
that gamete specific methylation patterns are erased and subsequently re-established
to support embryonic growth and differentiation. At a time when the majority of
methylation patterns are being reprogrammed, imprinted genes often maintain or
establish methylation patterns post-fertilisation (Tremblay et al., 1997; Chaillet et
al., 1991; El-Maarri et al., 2001). The mechanism by which this de novo or
maintenance methylation occurs during oocyte maturation and preimplantation
development still remains undetermined. Bisulfite analysis of the maternal imprint
at the Snrpn locus in oocytes carrying a targeted deletion of the oocyte-specific
Dnmtl exonlo, ruled out DNA methylation by Dnmtl, as DNA methylation was
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maintained (Howell et al., 2001). It is possible that either of the two de novo
methyltransferases (Dnmt3a or Dnmt3b) may be involved in this process, and
analysis of Dnmt3a and Dnmt3b expression in oocytes may help determine any
possible roles. Indeed, a closely related protein, Dnmt3L has been shown to be
required for the establishment of maternal imprints (Bourc'his et al., 2001), and
could possibly interact with either Dnmt3a or Dnmt3b.
Imprinted genes are not the only DNA sequences that are de novo or continually
methylated during preimplantation development. In the mouse, centromeric satellite
DNA and IAP repeats retain high levels of methylation during the initial stages of
preimplantation development (Rougier et al., 1998; Walsh et al., 1998). As Dnmtlo
is actively retained in the cytoplasm during the first 3 cell divisions (Carlson et al.,
1992; Cardoso & Leonhardt, 1999), another DNA methyltransferase must be
responsible for any methylating activity occurring at this time. Again, expression
analysis of Dnmt3a and Dnmt3b may help to determine whether these genes are
required for the methylation of specific DNA sequences during the early stages of
preimplantation development.
In previous chapters, the cloning and sequence characterisation of sheep DNMT1,
DNMT3A and DNMT3B cDNA sequences was described, with high levels of
conservation observed. The aim of this particular study was to investigate the
expression patterns of DNMT1, DNMT3A and DNMT3B in adult sheep tissues, and
also to determine their presence in sheep oocytes and preimplantation embryos.
This is the first reported study of DNMT3A and DNMT3B expression in mammalian
preimplantation development. In addition, the levels of DNMT1, DNMT3A and
DNMT3B expression were analysed in cultured fetal fibroblast cells, the cells used
as donor cells in somatic cell nuclear transfer (SCNT) experiments described in
Chapter 7. As Chapter 3 demonstrated different DNMT1 isoforms in sheep and
mouse oocytes with potentially significant consequences for methylation
reprogramming, expression of the Dnmtl, Dnmt3a and Dnmt3b genes was also
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analysed in mouse oocytes and preimplantation embryos, in order to investigate any
species-specific differences.
5.2 Methodology
For quantitative analysis of DNMT1, DNMT3A and DNMT3B gene expression in
adult tissues and fibroblast cells, Taqman® real-time PCR was used. The Taqman®
chemistry, methodology and methods ofRNA quantification are outlined in Chapter
2 (2.4.12). The method employed for this particular study allows quantification of
RNA relative to a 'calibrator' tissue sample; the equation used to calculate relative
expression levels of the DNMT genes is shown below.
2 ■ AACt
When analysing gene expression in a range of tissues, expression values were first
normalised against the relative 18S level (ACt). A calibrator tissue is then chosen,
usually the tissue with the lowest level of gene expression (or highest ACt value) and
designated the lx sample. The calculation of AACt involves subtraction by the ACt
calibrator value; for example if heart tissue is the calibrator, then all tissues will
subtract the heart ACt value from their own ACt value.
For the analysis ofDNMT1, DNMT3A and DNMT3B transcript levels in oocytes and
preimplantation embryos, single oocytes or embryos were used rather than pooled.
This allowed for the detection of biological variation within a group of embryos of
the same stage; a particularly useful molecular tool when comparing heterogeneous
embryos derived from embryo technologies. Although in this particular study, time
limitations prevented gene expression comparison in embryos derived from different
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embryo production methods, existing techniques permitting gene expression
analysis in single blastocysts (Young et al., 1998b) were optimised for use in earlier
stage in v/vo-derived embryos and oocytes.
It was initially hoped that Taqman® methodology could be employed to analyse
DNMT1, DNMT3A and DNMT3B transcript levels in single sheep or mouse oocytes
and preimplantation embryos. However, given the specified requirement for
relatively high levels of expression (PCR exponential phase must be between 18 and
32 cycles) and the small amount of starting material, it was not possible to quantify
transcript levels using this technique. Instead, a method allowing simultaneous
comparison of DNMT1, DNMT3A and DNMT3B transcript levels in oocytes and
preimplantation embryos of various stages was employed.
To validate the detection or absence of gene-specific transcripts in oocytes and
embryos, 18S was used as an internal control for the cDNA integrity and PCR
process. As 18S is itself subject to changes in gene expression levels throughout
preimplantation development (Bilodeau-Goeseels & Schultz, 1997), as are other
housekeeping genes, a perfect internal reference for comparing DNMT levels
between different stages is not available. The RT-PCR method was designed so that
amplification of all genes (DNMT1, DNMT3A, DNMT3B and 18S) at all embryo
stages was performed simultaneously and PCR products were electrophoresed on the
same agarose gel. Thus individual stage-specific variations in transcript levels
could be compared between different genes. The method also allowed comparison
of expression patterns for any one specific gene in the mouse and sheep.
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5.3 Results
5.3.1 Expression of DNMT1 in adult tissues and fetal fibroblast cells
To quantify DNMT1 expression in adult tissues and fetal fibroblast cells, Taqman®
real-time RT-PCR was used. The 'Comparative Ct' method of relative
quantification (described in 2.4.12) was employed, with 18S acting as the
endogenous control. Primers and probe specific to the sheep DNMT1 cDNA
sequence were designed (as described 2.12.3) and can be found in Table 2.6. For
the template, RNA was extracted from heart, liver, kidney, lung, ovary and spleen
tissue and 1 pg of each tissue RNA sample was subsequently reverse transcribed (as
described 2.4.11.1). RNA was also extracted from pelleted fetal fibroblast cells and
lpg of RNA was reverse transcribed (as described 2.4.11.1) In parallel, lpg of each
tissue/cell RNA sample was carried through the reverse transcription procedure,
minus the reverse transcriptase enzyme, and designated as the tissue 'no RT
control'. Any amplification from these samples in subsequent PCR reactions would
be from DNA, and thus the no RT control acts as a measure of significant DNA
contamination. In addition, a blank 'no sample control' was simultaneously carried
through all RNA extraction/reverse transcription steps to ensure reagents and plastic
consumables were not contaminated.
A preliminary Taqman® PCR using the DNMT1 -specific primers and probe was
performed to check the no RT controls were not significantly contaminated in
relation to the relative cDNA sample, and also to check the no sample control for
general contamination. The Taqman® PCR was performed (as described 2.12.3)
with optimal DNMT1 primer/probe conditions as described in Table 2.6. Template
was either the no sample control, or a 1:10 dilution of tissue cDNA stock (PCR
optimised for this amount to conserve cDNA stocks) or corresponding tissue no RT
control. The Taqman® PCR was optimised for a 1:10 cDNA dilution to ensure all
DNMT and MBD2 genes could be analysed within a single tissue cDNA sample. A
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'no template control' was also performed to verify the contamination-free status of
the Taqman® PCR reagents. The average Ct values for the triplicate reactions
performed for each sample were calculated and are demonstrated in Table 5.1. The
no template control (NTC) and no sample control (NSC) displayed Ct values of 40,
indicating no amplification of PCR products after 40 cycles, and hence
demonstrating no contamination of tissue samples occurred during RNA
extraction/cDNA synthesis steps or the subsequent PCR. Most of the no RT
samples demonstrated Ct values of <40, indicating DNA contamination of the RNA
samples, despite DNase treatment (see Table 5.1). As the differences between no
RT samples and cDNA samples of respective tissues were significant (6-10 cycles
difference), and each cycle represents a 2-fold difference in expression, the
contribution ofDNA to the total expression level measured would be 1/64 (1/26) at a
maximum (Heart tissue) and 1/1024 (1/210) at a minimum (fibroblasts). This 0.1-
1.0% bias was deemed acceptable for the purpose of this study.
The no RT and NSC controls were also checked with the 18S primer/probe set. As
the DNA contamination seen in the no RT controls (analysed using the DNMT1
primers/probe) was considered negligible, the tissue no RT controls were pooled,
and a Taqman® PCR performed to compare the Ct value of pooled no RT controls
with pooled tissue cDNA (as described 2.15.3; optimal primer/probe conditions
described in Table 2.5). The no RT control gave an average Ct value of 29.1,
compared with a value of 16.82 from pooled cDNA. The difference in cycle
numbers corresponds to a 4000-fold (212) difference in expression, meaning that
DNA contamination would only contribute 1/4000 (0.025%) to the overall
expression level at a maximum. The NSC gave a Ct value of >35 when used in the
18S Taqman PCR, demonstrating no significant contamination. As the 18S
ribosomal RNA reagents will amplify 18S across a wide range of species, it is
difficult to gain a NSC with absolutely no 18S contamination, and Ct values of 35-
40 are widely accepted as the norm.
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Table 5.1 Average Ct values for tissue cDNA samples and controls after
amplification with DNMT1-specific primers and probe (pre-quantitation
control experiment).
The 'no sample' control and 'no template' control are indicated as NSC and NTC
respectively. Ct values are shown in the 'cDNA' or 'no RT' columns and are the
average of three triplicate PCR reactions performed simultaneously.
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Prior to quantification of DNMT1 in tissues, an additional experiment was required
to measure the relative efficiencies of the DNMT1 and 18S primer/probe sets over an
equivalent and suitable working range of cDNA dilutions. This was required in
order to validate the Comparative Ct method of quantification, which relies on the
relative efficiencies of the 'gene-of-interest' and 'endogenous control' primer/probe
sets to be equivalent. The Taqman® PCR reaction to assess relative primer
efficiency was performed (as described 2.4.12.3), with the DNMT1 and 18S PCR
reactions present on the same plate. The cDNA dilutions were prepared using
pooled cDNA from all tissue samples. The optimal primer and probe conditions
used are described in Table 2.6 (18S final primer concentration, 50nm) To measure
the relative efficiencies of the two primer/probe sets, ACt values were plotted
against the log of input cDNA dilution, and a line of best fit generated. The slope of
the line was 0.14, demonstrating relative primer efficiencies within the accepted
range (<0.1). The graph showing the relative linear efficiency of the DNMT1 and
18S primer/probe sets is presented in Figure 5.1.
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Figure 5.1 Evaluation of DNMT1 and 18S relative primer efficiency.
The Log of input cDNA dilutions are indicated on the x axis. The ACt values
(.DNMT1 Ct minus 18S Ct) are indicated on the x axis. Over a working range of
cDNA dilutions, the DNMTH18S ACt values produced a line with slope of 0.1,
demonstrating acceptable relative primer efficiencies.
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After confirmation that DNMT1 and 18S primer/probe sets performed with equal
efficiency, quantification of DNMT1 expression was performed. Dilutions of 1:10
and 1:100 for each tissue cDNA were prepared for expression analysis of DNMT1
and 18S respectively. The Taqman® PCR was performed (as described 2.12.3) with
the MBD2 and 18S PCR reactions present on the same plate. Optimal primer/probe
conditions were determined and are described in Table 2.5 (18S primer
concentration, 50 nm). The PCR was repeated, and the mean of the two ACT values
for each tissue was calculated and used in subsequent quantification of DNMT1.
The tissue found to have the lowest levels ofDNMT1 expression was liver, and was
therefore designated the 'calibrator' tissue (1-fold). The levels of DNMT1
expression in the other tissues and cells are therefore expressed as n-fold increase
relative to liver. The results of the quantification experiment are shown in Table
5.2.
The result of the quantification experiment demonstrated expression of DNMT1 in
all tissues analysed, and also in the fetal fibroblast cells. Expression was highest in
spleen and lung, whereas heart and kidney demonstrated levels similar to liver.
DNMT1 was found to be moderately expressed in fetal fibroblasts relative to
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5.3.2 Expression of DNMT3A in adult tissues and fetal fibroblast cells
Quantification ofDNMT3A in adult tissues was performed using the Comparative Ct
method as described for DNMT1. Primers and probe were designed for the sheep
DNMT3A cDNA sequence, as described 2.12.3; primer and probe sequences can be
found in Table 2.6. Sufficient template for DNMT3A expression analysis remained
in the cDNA samples described in 5.2.1. As the DNMT3A primer/probe set span a
relatively large intron (~1.2 Kb, see 4.2.1), amplification of contaminating DNA
should not contribute to the observed PCR signal. To demonstrate this, analysis of
two randomly chosen tissue samples (heart and lung) was performed, alongside
analysis of the 'no sample control' (NSC) to confirm the previous observation of no
contamination when using the DNMT1 primer/probe set. The Taqman® PCR was
performed as described in 2.12.3; optimal DNMT3A primer/probe conditions are
described in Table 2.6. Template was either a 1:10 dilution of tissue cDNA or
corresponding no RT control, or a 1:10 dilution of 'no sample control'. The results




Heart no RT 40
Lung 27.3
Lung no RT 40
Table 5.3 Average Ct values for tissue cDNA and RT-PCR controls after
Z)7VM73/l-specific amplification.
'No sample control' is indicated as NSC. Average Ct values are the mean of the Ct
values gained from the three triplicate PCR reactions performed for each sample.
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As with the DNMT1, evaluation of the relative efficiencies of DNMT3A and 18S
primers was measured over an equivalent range of cDNA dilutions prior to
quantification experiments. The Taqman® PCR reaction to assess relative primer
efficiency was performed (as described 2.4.12.3), with both DNMT3A and 18S PCR
reactions present on the same plate. Initially, the 18S primers were used at a final
concentration of 50 nm, but analysis of the relative primer efficiencies produced a
line with slope >0.1. The Taqman® PCR was repeated, limiting the final 18S primer
concentration to 25 nm. In this case, plotting of the ACt values against the log of
input cDNA dilution generated a line of best fit with slope <0.1. The graph showing
the relative linear efficiency of the two primer/probe sets is presented in Figure 5.2.
After confirmation of relative equal efficiency of the DNMT3A and 18S
primer/probe sets, quantification of DNMT3A gene expression in a range of tissues
was performed. Dilutions of 1:10 and 1:100 for each tissue cDNA sample were
prepared for expression analysis of DNMT3A and 18S respectively. The Taqman®
PCR was performed (as described 2.12.3) with both the DNMT3A and 18S PCR
reactions performed simultaneously on the same plate. Optimal primer/probe
conditions are described in Table 2.6 (18S primer concentration, 25 nm). The PCR
was repeated, and the mean of the two ACt values for each tissue was calculated and
used in subsequent quantification of DNMT3A (as described 2.12/ The tissue with
the lowest levels ofDNMT3A expression was liver, and was therefore designated the
calibrator tissue. The levels of expression of DNMT3A are expressed as n-fold
relative to liver and results of the quantification experiment are shown in Table 5.4
Analysis of DNMT3A in tissues and fibroblast cells demonstrated high levels of
expression in the lung, ovary and fibroblast. Expression levels were lowest in the
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Figure 5.2 Evaluation ofDNMT3A and 18S relative primer efficiency.
The Log of input cDNA dilutions are indicated on the x axis. ACt values (DNMT3A
Ct minus 18S Ct) are indicated on the y axis. Over a working range of cDNA
dilutions, the DNMT3AI18S ACt values produced a line with slope 0.02,
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5.3.3 Expression of DNMT3B in adult tissues and fetal fibroblast cells
Quantification ofDNMT3B expression in adult tissues and fetal fibroblast cells, was
performed using Taqman® real-time RT-PCR as previously described for DNMT1
and DNMT3A. Primers and probe were designed for the sheep DNMT3B cDNA
sequence, as described 2.12.3; primer and probe sequences can be found in Table
2.6. Sufficient template for DNMT3B expression analysis remained in the cDNA
samples described in 5.2.1, Preliminary Taqman® RT-PCR results using 1:10
dilution of tissue cDNA demonstrated no detectable DNMT3B transcripts in adult
tissues and fetal fibroblast cells after 40 cycles of PCR (Taqman® RT-PCR
performed as described 2.4.12.3; optimal primer and probe conditions described
Table 2.6). Therefore it was not possible to perform DNMT3B quantification in
these tissues using this method. The Taqman® RT-PCR was repeated to confirm the
results, and average Ct values of a typical DNMT3B expression analysis experiment
are shown in Table 5.5. As a positive control, simultaneous amplification of the
same tissue cDNA samples using 18S Taqman® primers and probes was performed
on the same plate (as described 2.4.12.3).
To further confirm these observations, DNMT3B expression was analysed in adult
tissues using standard RT-PCR methods. A 1:10 dilution of adult tissue cDNA was
used in a PCR reaction, using the DNMT3B2 primer pair (as described 2.4.1;
primer-specific PCR conditions are described in Tables 2.1 and 2.2) As a positive
control, 1:10 dilutions of fetal dl25 fetal heart, kidney or liver cDNA (synthesised
from 1 pg of RNA using the same cDNA synthesis method as described for adult
tissues (see 2.4.11.1) were used as template for the PCR reaction. D125 tissue
cDNA has previously been used successfully as a positive control for DNMT3B2
PCR reactions (see Figure 4.2, Chapter 4), and in addition, pooled dl25 fetal cDNA
was used to optimise the DNMT3B Taqman® primer and probe sets, with Ct values
<40 observed. PCR products were electrophoresed in a 2% ethidium-bromide
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stained agarose gel (as described 2.4.2); the results of this PCR are shown in Figure
5.3.
The standard DNMT3B2 PCR demonstrated no PCR amplification in any of the
adult tissues after 40 cycles; however, amplification was observed from the dl25
fetal tissue cDNA samples. This clearly indicates DNMT3B is expressed in dl25
fetal tissues, but is not detectable in adult tissues after 40 cycles of PCR, and is thus











Table 5.5 DNMT3B expression in adult sheep tissues.
'No Template control' is indicated as NTC. Average Ct values are the mean of the





Figure 5.4 DNMT3B expression in adult and dl25 fetal tissues.
Lanes 2-8 are PCR reactions containing adult heart, kidney, liver, lung, ovary,
spleen and fetal fibroblast cDNA respectively. Lanes 11-13 demonstrate PCR
products amplified from dl25 fetal heart, kidney and liver cDNA respectively.
Lanes 1 and 10 are negative (no template) controls. DNA marker sizes (Lane 9;
1 Kb Plus DNA ladder (Invitrogen Life Technologies)) are indicated to the right of
the gel image.
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5.3.4 Qualitative analysis of DNMT1, DNMT3A and DNMT3B transcripts
in sheep and mouse oocytes and preimplantation embryos
To detect DNA methyltransferase transcripts in single oocytes and preimplantation
embryos, a non-quantitative PCR method was employed. 18S was used as an
endogenous control, confirming the presence of embryonic derived cDNA in the
case of failure to amplify PCR products for the DNMT-specific primers. Briefly,
RNA was extracted from three single oocytes/embryos of the following
developmental stages: Mil oocyte, 2-cell, 8-16 cell, morula and blastocyst, and
subsequently reverse transcribed (as described 2.4.11.2). In addition, a no embryo
control (NEC) was carried through all RNA extraction/cDNA synthesis steps to rule
out any possible contamination from reagents or plastic consumables. A no RT
control was also performed, with the RNA extracted from a single blastocyst taken
through cDNA synthesis minus the reverse transcriptase. Four PCR reactions per
single oocyte/embryo were performed using the MTRA1, HDNMT3A, DNMT3B2
and Classic II 18S primers (as described 2.4.1; primer-specific PCR conditions are
described in Tables 2.1 and 2.2), and PCR reactions for all genes and embryonic
stages were performed simultaneously. As template, 2pl of cDNA was used for the
18S PCR and 4pl for the DNMT1, DNMT3A or DNMT3B PCR reactions. For the
'no embryo control' or no RT control, 4pi of cDNA was used as template, and as a
positive control, 2pl of dl25 fetal liver cDNA was used. All PCR products were
electrophoresed on the same 2.5% ethidium bromide stained agarose gel (as
described 2.4.2), results are shown in Figure 5.4 (A) and are representative of two
independent experiments. PCR amplification from the NEC control demonstrated
no contamination; a very faint band was observed as a result of PCR amplification
of the no RT control using 18S primers, demonstrating a slight but tolerable
contamination.
143
A parallel experiment was performed analysing Dnmtl, Dnmt3a and Dnmt3b
transcript levels in mouse embryos. This experiment was performed firstly, to
demonstrate the applicability of the PCR method to single embryo/oocyte analysis in
the mouse, where the amount of starting RNA is even lower than in sheep.
Secondly, analysis of Dnmt3a and Dnmt3b transcript levels has not previously been
described in mouse oocytes or preimplantation embryos. RNA was extracted from
oocytes and embryos and reverse transcribed (as described 2.4.11.2), with the same
controls (NEC and no RT) as described for sheep embryos. PCR reactions were
performed as described for single sheep embryos (5.2.4), using the same primer-
specific PCR conditions (as described Tables 2.1 and 2.2). Template (samples and
controls) was as described for DNMT expression analysis in sheep embryos (5.2.4).
All PCR products were electrophoresed on the same 2.5 % ethidium bromide stained
agarose gel (as described 2.4.2), results are shown in Figure 5.4 (B). The results are
representative of two independent experiments. The MTRA1, HDNMT3A and
DNMT3B2 PCR products amplified from mouse-derived cDNA were subcloned and
sequenced (DNMT3B2), as described 2.4.3, or digested with sequence-specific
restriction enzymes (MTRA1 (Hpa II) and HDNMT3A (Taq I)) to verify insert
identity (as described 2.4.5).
In the sheep, the apparent increase of 18S at the 2-cell stage, relative to the oocyte,
could be explained by incomplete lysis of the oocyte, possibly due to a difficulty in
rupturing the zona pellucida of the sheep oocyte at this stage. The same observation
was made when the RNA extraction, cDNA synthesis and PCR were repeated.
DNMT1 was detected at all stages analysed, with apparently higher levels of
expression in oocytes and 2-cell embryos followed by an apparent decrease at the 8-
16 cell stage. This probably corresponds to the destruction of maternally-inherited
RNA. DNMT3A and DNMT3B were also detected at all stages analysed, again with
an apparent decrease at the 8-16 cell stage (more evident with DNMT3A); however,
DNMT3A transcript levels appeared to increase at the blastocyst stage.
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In the mouse, similar patterns were observed. Dnmtl was detected at all stages, with
high levels in the oocyte, an apparent reduction at the 2-cell stage and similar levels
observed henceforward. Dnmt3a was also highly expressed in oocytes, relative to
Dnmt3b, and detectable at all stages, although the apparent increase seen after the
onset of zygotic genome activation (2-cell stage in the mouse) was not as marked as
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Figure 5.4 DNMT1, DNMT3A and DNMT3B transcripts in single sheep and
mouse oocytes or preimplantation embryos.
Results for sheep oocytes and preimplantation embryos are shown in gel image A;
results for the mouse are shown in gel image B. Gene-specific PCR products are
indicated to the left of the gel image. Lanes are labelled with the origin of the
template cDNA and are as follows; + (positive control; liver cDNA); - (no embryo
control); RT (no RT control); O (oocyte cDNA); 2 (2-cell embryo); 8 (8-16 cell
embryo); M (morula stage embryo) and B (blastocyst stage embryo). The four gene-
specific PCR products amplified from cDNA derived from a single oocyte/embryo
are shown within the same lane column.
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5.4 Discussion
Semi-quantitative Taqman® real-time RT-PCR experiments demonstrated
expression ofDNMT1 in all adult sheep tissues and cell types analysed. Expression
levels were measured and were found to be highest in spleen (8.1-fold increase),
lung (5.8-fold increase) and ovary (5.5-fold increase), moderate in fetal fibroblast
cells (3.9-fold increase), and lowest in heart (2-fold increase) and kidney (2-fold
increase) relative to liver. These observations fit with the requirement for high
levels of DNMT1 expression in tissues with high cellular turnover, in order to
methylate newly replicated DNA and mirror the patterns observed in the human and
mouse where known (Yen et al., 1992; Bestor et al., 1988). The high levels of
expression in ovary tissue may reflect the acquisition of large stores of Dnmtl in
growing oocytes (Mertineit et al., 1998) in addition to the high cell turnover.
Analysis of DNMT3A expression in sheep adult tissue samples, using the same
quantification method as for DNMT1, demonstrated high levels of expression in fetal
fibroblasts (5.7-fold increase), ovary (5.4-fold increase) and lung (5.1-fold increase),
moderate in spleen (3.4-fold increase), and lowest in heart (2.3-fold increase) and
kidney (1.6-fold increase) relative to liver. The relatively high levels of DNMT3A
expression observed in ovary tissue was particularly interesting, and may indicate an
important role for DNMT3A in oocyte growth. To further support this notion,
analysis of DNMT3A in mature oocytes and early stage sheep preimplantation
embryos demonstrated significant levels of expression (see 5.3.4),
DNMT3A expression in sheep tissues was very similar to patterns observed in both
the human and mouse. DNMT3A was also found to be highly expressed in sheep
fetal fibroblasts (cells derived from d25 fetuses). This observation correlates with
findings in the mouse, where Dnmt3a is ubiquitously expressed in the developing
fetus, but downregulated in adult tissue relative to undifferentiated ES cells (Okano
et al., 1999; Okano et al., 1998a).
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DNMT3B expression analysis indicated very low levels, or potentially absent
expression in all adult tissues and fetal fibroblast cells. However, DNMT3B was
found to be expressed in heart, kidney and liver tissue from dl25 fetuses. The
expression of de novo methyltransferases in adult sheep tissues described here
reflects findings in the human, where DNMT3A is expressed at high levels in most
tissues (although at slightly lower levels than DNMT1), and DNMT3B is expressed
at much lower levels than either DNMT1 or DNMT3A (Okano et al., 1999). Adult
human tissues in which DNMT3B is detectable include testis, thyroid and bone
marrow (Okano et ah, 1999), tissue types that were not available for analysis in this
study.
It was not possible to accurately determine whether DNMT1 or DNMT3A is the most
abundant DNA methyltransferase transcript in adult sheep tissues. The Taqman®
real-time PCR quantification technique requires gene-specific primers/probes of
equal efficiency and the DNMT3A primer/probe were found to be more efficient
than those designed for DNMT1. However, Ct values for both genes appeared to be
within a similar range, suggesting comparable levels of expression, although
different tissue-specific patterns of expression were observed for each gene.
Analysis of DNMT1, DNMT3A and DNMT3B transcripts in sheep oocytes and
preimplantation embryos was also performed. DNMT1 was shown to be expressed
in oocytes and 2-cell embryos, followed by an apparent decrease at the 8-16 cell
stage, most likely corresponding to the degradation of maternally-derived
transcripts. As RT-PCR only measures steady-state transcripts, it could not be
determined in this experiment as to whether DNMT1 is actively transcribed from the
embryonic genome at the morula or blastocyst stages, or whether detection of
transcripts is due to residual maternal stores ofDNMT1. The relative abundance of
DNMT1 transcripts in sheep oocytes and early preimplantation embryos cannot be
disputed, demonstrating significant similarities with the mouse. It remains to be
determined whether this similarity extends to protein levels, and due to the apparent
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lack of an oocyte-speciflc DNMT1 in sheep, it would be surprising to see the unusual
nuclear trafficking of DNMT1, as observed in the mouse preimplantation embryo
(Carlsson et al., 1992)
DNMT3A was shown to be expressed in the oocyte, followed by an apparent
decrease to the 8-16 cell stage. However, in contrast with DNMT1, there is a
marked increase in DNMT3A at the blastocyst level, perhaps suggesting transcription
of DNMT3A from the embryonic genome has occurred at, or prior to, this stage.
DNMT3B was detected in oocytes and all embryo stages analysed, although, as with
DNMT1, it is unclear as to the origin of transcripts at the later stages of
preimplantation development.
Analysis of Dnmtl, Dnmt3a and Dnmt3b expression in mouse oocytes and
preimplantation embryos allowed direct comparison with the sheep. Previous results
have demonstrated significant species-specific differences in DNMT1 isoform
expression in mouse and sheep oocytes (Chapter 3) and it was of particular interest
to see if species-specific expression patterns of other de novo methyltransferases
also exist. The Dnmtl transcript was present at all embryo stages and was
apparently high in oocytes and 2-cell stage embryos, with levels decreasing
gradually from this point onwards. Dnmt3a transcripts levels were similar to Dnmtl
in oocytes, with a gradual decrease through later stages, and no marked increase at
the morula/blastocyst stage, as observed in the sheep. Dnmt3b transcripts were
detected at all stages of mouse preimplantation development, with no clear
transcriptional origin during later stages.
This is the first reported investigation of de novo methyltransferase expression in
mammalian oocytes or preimplantation embryos. It is likely from these findings,
that DNMT3A in particular, may have an active role in de novo methylation in
oocytes or early stages of preimplantation development. There are known de novo
methylation activities occurring in the growing mouse oocyte, with the
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establishment ofmethylation imprints occurring at this time (Obato & Kono, 2002).
Furthermore, de novo methylation may also occur post-fertilisation in the absence of
Dnmtl (Rougier et al., 1998; Walsh et al., 1998). The observation in this thesis that
Dnmt3a is apparently highly expressed in both sheep and mouse oocytes make this
gene a potential candidate for establishing maternal imprints in the oocyte.
Examination of its expression in different stages of oocyte growth would deduce any
such role. As both Dnmt3a and Dnmt3b are expressed in early stage
preimplantation embryos, either protein could be involved in de novo methylating
activities occurring at this time.
It was noticed that transcript levels were sometimes inconsistent between sheep or
mouse oocytes and embryos of the same stage. This apparent variability of gene
transcript levels in similar stage embryos may be biologically significant, although it
is also possible that differences could be due to unequal PCR amplification between
tubes. The small amounts of template used in individual PCR reactions (cDNA
comprising 1/4 of a single oocyte or embryo's RNA) could certainly account for
inconsistent amplification between PCR tubes. To further back this hypothesis,
inconsistencies in gene transcript levels were more obvious in oocytes and earlier
stage preimplantation embryos, when RNA isolation may be problematic. The
inconsistencies may also reflect the efficiency of the primer pair used for
amplification; for example, DNMT1 transcript levels appear to be more consistent
between same stage embryos than DNMT3A or DNMT3B transcript levels. Thus,
the DNMT1 primer set (MTRA1) may be more efficient than those used to amplify
DNMT3A and DNMT3B. These differences were reproduced in repetitions of the
mouse and sheep PCR experiments. This apparent difference in primer efficiency
also justifies why it was deemed inappropriate to assign significance to the
differences observed between DNMT1, DNMT3A and DNMT3B transcript levels
within a single embryo. Overall, the analysis of larger numbers of oocytes and
embryos will allow more confident interpretation of these results.
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The analysis ofDNMT expression levels in fetal fibroblasts presented an opportunity
to investigate the quantities of DNMT transcripts in cells used as SCNT donors.
Inappropriate transfer of the 'somatic' form of Dnmtl within a somatic cell donor
nucleus has been postulated as a possible reason for increased methylation levels
observed in SCNT produced sheep blastocysts (Kang et al., 2001; Bourc'his et al.,
2001; Dean et al., 2001). This could indeed be an important factor, when
considering the observed long retention of mouse Dnmtl in oocyte cytoplasm
(Cardoso & Leonhardt, 1999; Carlson et al., 1992). Indeed, expression levels of
DNMT1 were found to be moderately high in sheep fetal fibroblast cells, the cells
commonly used as nuclear donors for SCNT at Roslin Institute (R.I) and for the
SCNT embryos analysed in this thesis (reported in Chapter 7). If the expression
levels of DNMT1 in sheep fetal fibroblast cells are indicative of protein levels, this
could lead to the introduction of 'somatic' DNMT1 into nuclei of SCNT-derived
preimplantation embryos. However, as sheep oocytes already contain large
quantities of 'somatic' DNMT1 mRNA, and presumably DNMT1 protein,
introduction of large quantities of DNMT1 from the SCNT donor nuclei may have
little, or no consequence. It may, however, be a potential source of aberrant
methylation reprogramming in other mammalian species.
The significance of high levels ofDNMT3A expression in fibroblast cells, in relation
to SCNT, is unclear. If DNMT3A protein levels are similarly high in fetal fibroblast
nuclei, the developing SCNT embryo may be inappropriately exposed to large
quantities of this protein. DNMT3A mRNA appears to be present in significant
quantities in the sheep and mouse oocyte and therefore the protein may also be
present in significant amounts. However, as nothing is known of the roles or
localisation of DNMT3A in oocytes or preimplantation embryos, presumptions
cannot be made regarding the effects of an SCNT-caused increase in protein levels.
151
Chapter 6
Cloning and characterisation of the gene encoding
the methyl-CpG-binding protein MBD2 in sheep
6.1 Introduction
Methyl-CpG-binding protein 2 (Mbd2) is a mammalian protein that demonstrates
affinity for methylated DNA, and shares homology with other known methyl-CpG
binding proteins (Hendrich & Bird, 1998) including Methyl-CpG Binding Protein 2
(MeCP2). This protein, alongside Mbdl, Mbd3 and Mbd4, was initially identified
during a database search for proteins containing the methyl-CpG binding domain
first identified in the transcriptional repressor, MeCP2 (Nan et al., 1993). The
methyl-binding proteins interact with methylated DNA via the highly conserved
MBD (Methyl-CpG-binding domain) motif, and all MBD-containing proteins, aside
from Mbd3, demonstrate high affinity for methylated DNA (Hendrich & Bird,
1998). These MBD-containing proteins are of significant interest due to their
potential involvement in methylation-mediated transcriptional repression. Of the
four recently identified MBD proteins, Mbd2 is best characterised, and more
interestingly, has generated controversy over its putative roles in response to the
DNA methylation signal
Structurally, the human and mouse MBD2 genes are similarly organised, comprising
7 exons and a sex-specific exon located in intron 2 with undetermined function
(Hendrich et al., 1999b). In addition, the mouse has two forms of Mbd2. Mbd2a
encodes a protein of 414 aa whilst Mbd2b encodes a smaller protein of 262 aa
(Hendrich & Bird, 1998). Mbd2b is closely related to Mbd3 and shares significant
sequence identity. Figure 6.1 highlights the structures of Mbd2 and Mbd3,








Figure 6.1 Structural comparison of Mbd2 and Mbd3 proteins.
All three proteins share the highly conserved MBD domain, highlighted as a black
rectangle. The size of each protein is indicated at the right hand side of the diagram.
As mentioned previously, the involvement of Mbd2 in transcriptional repression has
been studied in the mouse, but has not been a straightforward case. In early 1998, a
paper identified the human MBD2B as a protein with inherent demethylating
activity, the elusive mammalian CpG 'demethylase' (Bhattacharya et al., 1999).
Previous studies aiming to identify mammalian demethylases had failed to isolate
any convincing candidate genes (Weiss et al., 1996; Swisher et al., 1998). As
demethylation is a fundamental event in reprogramming methylation patterns during
post-fertilisation development, the identification ofMBD2B as a demethylase was a
potentially significant discovery. However, subsequent reports implicated Mbd2 in
transcriptional repression, as part of the MeCPl-HDAC (Histone deacetylase)
complex involved in silencing methylated DNA (Ng et al., 1999). As demethylation
is a process expected to be associated with gene activation, not gene-silencing, this
discovery cast doubts over the initial 'demethylase' study. Moreover, attempts to re¬
create the experiments described by Bhattacharya and colleagues, demonstrating the
demethylating activity of Mbd2, failed when attempted in another laboratory (Ng et
al., 1999; Boeke et al., 2000).
In the light of these observations, it was suggested that Mbd2 could be a protein with
dual silencing and activating activities, possibly acting as a molecular switch
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between active and silenced chromatin states (Ng et al., 1999). However, recent
experiments have ruled out the involvement ofMbd2 in active demethylation during
mouse development. Santos and colleagues (2001) demonstrated normal
demethylating activities in embryos derived from mouse oocytes carrying a targeted
deletion of Mbd2. Moreover, mice carrying a targeted deletion ofMbd2 develop to
term and demonstrate no difference in global methylation levels when compared to
their normal counterparts (Hendrich et al., 2001).
Mbd2 is expressed in a wide range of adult tissues, but is significantly down-
regulated in ES cells (Hendrich & Bird, 1998), Even though ES cells generally
maintain high levels of genomic methylation, ES cells carrying a targeted deletion of
Dnmtl are viable (Lei et al., 1996), demonstrating a non-requirement for the
maintenance of DNA methylation and subsequently may not require Mbd2 activity.
The requirement for Mbd2 in preimplantation development is unknown and no
investigations into Mbd2 expression during preimplantation development have been
reported to date.
During the initial stages of this project, the identification of Mbd2 as a demethylase
provided a candidate gene for analysis in sheep development. By the time reports
implicating Mbd2 in transcriptional repression became available, substantial
progress had been made in the cloning of the sheep homologue ofMBD2. Given the
new information, it was decided to continue with analysis of Mbd2 as an interesting
component of the sheep DNA methylation repressor system.
In this study, the partial cloning of a sheep homologue of MBD2, using a
combination of RT-PCR and cDNA library screening is described. Pairwise and
multiple sequence alignments were generated analysing the conservation of the
MBD2 sequence between sheep, humans and mice, and assessing similarities with
other closely related methyl-CpG binding proteins. Expression analysis of the
MBD2 gene in adult sheep tissues was performed using Taqman® real-time RT-PCR
to determine its requirement in differentiated tissues. Analysis of MBD2 transcript
levels was also performed in sheep preimplantation embryos, being the first reported
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6.2.1 Generation of partial sheep MBD2 clones by RT-PCR
Pairwise alignments of the human (Accession No. AF072242) and mouse
(Accession No. NMO10773) MBD2 cDNA sequences were generated and primers
were designed within highly conserved regions between the human and mouse
cDNA sequences. Partial cDNA clones were generated from pooled heart and
kidney cDNA in a standard PCR reaction performed (as described 2.4.1.1). PCR
products were electrophoresed in a 2% ethidium bromide stained agarose gel (as
described 2.4.2), results are shown in Figure 6.2. PCR products of expected size
were observed (MBD 116 bp; DMT 168 bp) and were subsequently cloned and
sequenced (as described 2.4.3) to confirm identity. In addition to amplification of
PCR products from cDNA, genomic DNA was used as the template to indicate the
presence of exon-intron boundaries within the partial cDNA sequence. PCR
reactions were performed as previously described. The MBD primers generated a
400 bp product from genomic DNA, indicating the primers spanned a small intron of
approximately 280 bp. No PCR product was detected for DMT primers on genomic
DNA, suggesting the presence of a larger intron within the region. Table 6.1 lists
the primers used and the location within the source sequence.
Gene Primer Direction of
primer




MBD2 MBDF Forward AF072242 700-719
MBD2 MBDR Reverse AF072242 815-796
MBD2 DMTF Forward AF072242 1040-1058
MBD2 DMTR Reverse AF072242 1208-1190
Table 6.1 PCR primers used to amplify partial MBD2 cDNA sequences in
sheep.














Figure 6.2 Amplification of partialMBD2 cDNA clones by RT-PCR.
Gel image A demonstrates PCR products amplified using the MBD primers, image
B demonstrates PCR products amplified using the DMT primers. In both images,
lane 1 is a no template (negative) PCR control and lanes 2 and 3 are PCR products
amplified from dl25 fetal heart and liver cDNA respectively. Lane 4 is the PCR
product amplified from genomic DNA. DNA marker sizes (Lane 5) are indicated to
the right of the gel image.
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6.2.2 Isolation of partial MBD2 clones from an adult sheep lung cDNA
library
The partial cDNA clones generated by the MBD and DMT primers were used to
probe an adult sheep lung cDNA library purchased from Stratagene (as described
2.4.7). The primary screen identified three positive clones, 4a, 5a and 6a, which
were re-plated for the secondary screen. After the secondary screen, three positive
plaques were identified from the initial positive clones 4a (4a. 1, 4a.2 and 4a.3) and
one positive plaque from the positive clone 5a (5a. 1). These 5 single colonies were
isolated and the pBluescript phagemids excised from the Uni-ZAP® XR vector (as
described 2.4.7.7). DNA minipreps were established from 4 single colonies for each
positive clone and digested with EcoR I and Xho I to release and ascertain the vector
insert size (as shown in Figure 6.3) Clones 4a.l-4a.3 were found to be identical,
containing an insert of approximately 0.8 Kb, clone 5a. 1 contained an insert of
approximately 1.3 Kb.
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Figure 6.3 EcoR A/Xho I digestion of DNA minipreps prepared from the
Uni-ZAP® XR clones 4a.l, 4a.2, 4a.3 and 5a.l
Lanes 1-4 represent minipreps established from clone 4a. 1, lanes 5-7 and 9 represent
minipreps established from clone 4a.2, lanes 10-13 represent minipreps established
from clone 4a.3 and lanes 14-17 represent minipreps established from clone 5a. 1.
DNA marker sizes are indicated to the right of the gel image.
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A single miniprep originating from the clone 4a.2, and a single miniprep originating
from clone 5a. 1 were ethanol precipitated and sequenced as described (2.4.6; 2.4.3),
After sequence editing of the two clones, and assembly using the Staden fragment
assembly program, 1224 bp of sequence corresponding to the sheep MBD2 cDNA
sequence was obtained, with substantial overlapping of the two clones. The
sequence contained the PolyA tail and corresponded to nucleotides 749 to 1964 of
the human MBD2 sequence (Accession No. AF072242). The partial MBD2 cDNA
sequence can be found in Appendix III. Pairwise alignment of the sheep and
human or mouse cDNA sequences were performed using the 'Gap' application
(default parameters) of GCG10. The partial sheep MBD2 cDNA sequence was
found to be 90% homologous to the human MBD2 sequence and 87% homologous
to the mouse MBD2 cDNA sequence (Accession No. NMO10773). The complete
pairwise alignment for the sheep and human MBD2 cDNA sequences can be found
in Appendix III. Translation of the partial MBD2 sequence was performed using
the 'translate' application on GCG10, and an open reading frame was identified,
terminating at a TAA stop codon at nucleotide 724. A multiple protein sequence
alignment was generated using the Tocalpileup' application (default parameters) of
GCG10, comparing the predicted sheep MBD2 protein sequence with the known
human MBD2 (Accession No. AAD56597) and closely related human MBD3
(Accession No. NP003917) protein sequences. Shading of the multiple sequence
alignment was added using the GeneDoc program (default settings). The multiple
sequence alignment is shown in Figure 6.4 and highlights the conserved methyl-
CpG binding domain (MBD).
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6.2.3 Expression of MBD2 in adult sheep tissues and fetal fibroblast
cells
To quantify MBD2 gene expression in adult sheep tissues and differentiated cells,
Taqman® real-time PCR employing the Comparative Ct method of relative
quantification was used, with 18S rRNA acting as the endogenous control. MBD2-
specific primers and Taqman® probe were designed from the sheep MBD2 sequence
(as described 2.4.12.3); primer and probe sequences can be found in Table 2.6.
Sufficient template for MBD2 expression analysis remained in the cDNA samples
derived from heart, kidney, lung, liver, ovary, spleen and fetal fibroblast cells
described in the previous chapter (for analysis of DNMT1, DNMT3a and DNMT3b
expression). As the no RT controls for each of these tissue/cell samples were
checked for DNA contamination in the previous chapter, with no significant
contribution of DNA contamination to the PCR signal demonstrated, it was decided
to compare a pooled no RT control (of all the adult sheep tissue controls) with a
pooled tissue cDNA sample, to prevent wastage of tissue cDNA stocks and the
expensive Taqman reagents and consumables. The Ct values for MBD2 expression
in pooled cDNA tissue and the pooled no RT control are demonstrated in Table 6.2.
Well Dye Sample Ct
1 FAM NTC 40
2 FAM NTC 40
3 FAM NTC 40
4 FAM cDNA 23.68
5 FAM cDNA 23.07
6 FAM cDNA 23.81
7 FAM no RT 32.86
8 FAM no RT 32.65
9 FAM no RT 32.11
Table 6.2 Average Ct values for tissue cDNA and RT-PCR controls after
MBD2-specific amplification.
Samples are clearly designated as cDNA (pooled cDNA), no RT (pooled no RT
RNA samples) and NTC (no template control).
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The no RT sample Ct value of 32 indicated some DNA contamination, but as this
value is significantly higher (9-10 cycles = -500-1000 fold difference in expression
and corresponds to a 0.1-0.2% bias) than the Ct value of the pooled cDNA sample
itself, it was deemed acceptable.
Prior to quantification experiments, the relative efficiencies of the MBD2
primers/probe and 18S primers/probe sets were measured over a suitable working
range of cDNA dilutions (using pooled cDNA from all tissue samples). The
Taqman PCR reaction to assess relative primer efficiency was performed (as
described 2.4.12.3), with all reactions performed simultaneously on the same plate.
The optimal primer and probe conditions used for both genes are described in Table
2.6. ACt values were plotted against the log of input cDNA dilution and a line of
best fit generated. The slope of the line was 0.08, demonstrating relative primer
efficiencies within the accepted range (<0.1). The graph showing the relative linear
efficiency of the two primer/probe sets in presented in Figure 6.5
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MBD2 v 18S delta Ct
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Figure 6.5 Evaluation ofMBD2 and 18S relative primer efficiency.
The Log of input cDNA dilutions are indicated on the x axis, and the delta Ct values
(MBD2 Ct minus 18S Ct) are indicated on the y axis. Over a suitable working range
of cDNA dilutions, the MBD2/18S delta Ct values produced a line with slope of










After confirmation of equal relative efficiency of the MBD2 and 18S primer/probe
sets, quantification of gene expression in a range of tissues was performed.
Dilutions of 1:10 and 1:100 for each tissue cDNA were prepared for expression
analysis of MBD2 and 18S respectively. The Taqman PCR was performed (as
described 2.12.3) with the MBD2 and 18S PCR reactions performed simultaneously
on the same plate. Optimal primer/probe conditions are described in Table 2.6. The
PCR was repeated, and the mean of the two ACt values for each tissue was
calculated and used in subsequent quantification of MBD2 by the comparative Ct
method (as described 2.12.2), The tissue with lowest expression was liver, and was
therefore designated the 'calibrator' tissue (1 fold). The levels of expression of
MBD2 in the other tissues analysed are therefore expressed as n-fold increase
relative to liver. The results of the quantification experiment are shown in Table 6.3
The Taqman® PCR results demonstrated expression of MBD2 in all adult tissues
analysed and the fetal fibroblast cells. MBD2 expression is high in lung and spleen
relative to liver, whereas heart and kidney tissue demonstrate similar levels to liver.
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6.2.4 MBD2 expression in preimplantation embryos.
To assess the importance ofMBD2 expression in preimplantation development, RT-
PCR was performed on cDNA derived from either single 2-cell or morula stage
embryos. These stages were chosen as they represent stages pre- and post- zygotic
genome activation. RNA was extracted from 5 single in vitro fertilised and cultured
2-cell embryos or morulae, and reverse-transcribed (as described 2.4.11.2). In
addition, a 'blank' sample (No Embryo Control) was carried through the RNA
extraction and cDNA synthesis steps, to ensure the reagents and plastic consumables
were not contaminated. Half of the single embryo cDNA was used as template in
the subsequent PCR reaction using the 'MBD' M8D2-specific primers (as described
2.4.1.1) that would in theory amplify all forms ofMBD2. As the MBD primers span
an intron, DNase treatment of the embryos was not required as any DNA
contamination would produce an alternative PCR product. Primer-specific PCR
conditions are described in Tables 2.1 and 2.2. PCR products were electrophoresed
in a 2% ethidium bromide stained agarose gel (as described 2.4.2), results are shown
in Figure 6.6.
Results of the PCR indicated the presence of MBD2 mRNA in 2-cell and morula
stage sheep embryos, albeit barely detectable at both stages.
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A
Figure 6.6 MBD2 mRNA transcripts in single 2-cell and morula stage sheep
embryos.
Gel A shows PCR products generated from 2-cell embryos, Gel B shows PCR
products generated from morula stage embryos. In both images, Lane 1 is a
negative 'no template control' PCR reaction. Lane 2 is a positive control PCR
product amplified from 2 pi of dl25 fetal kidney cDNA. Lane 3 is a second
negative control, with the No Embryo Control used as template in the PCR reaction.
Lanes 4-8 are PCR products amplified from cDNA derived from 5 single 2-cell
stage embryos (gel image A) or 5 single morula stage embryos (gel image B). DNA




This study has described the isolation of a sheep partial cDNA clone homologous to
the MBD2 gene through a combination of RT-PCR and cDNA library screening.
The cDNA clone corresponds to nucleotides 749 to 1964 of the human cDNA
sequence, and includes the 3' UTR and PolyA tail. Pairwise alignments of the
partial sheep MBD2 cDNA clone with the known human and mouse MBD2
sequences demonstrated high levels of conservation. The sheep MBD2 clone shared
90% homology with the human MBD2 cDNA sequence, and 87% sequence identity
with the mouse Mbd2 cDNA. Conceptual translation of the sheep MBD2 cDNA
sequence identified an open reading frame, terminating at a TAA codon located at
nucleotides 724-726. The predicted sheep MBD2 protein sequence was compared
with the human MBD2 and MBD3 sequences in a multiple sequence alignment.
The predicted sheep MBD2 protein appears to be very highly conserved with the
human MBD2, with 235/241 amino acid residue sequence identity (98% homology).
As the full-length cDNA sequence was not gained for the sheep homologue of
MBD2, it is possible that the sheep clone isolated from the cDNA library could
correspond to either Mbd2a or Mbd2b. These isoforms are identical aside from the
extended N-terminal region of Mbd2a and both perform simliar functions.
However, as the main aim of this study was to gain sufficient sequence to be
confident of the sheep Mbd2 identity, to assess general conservation levels and
subsequently perform expression analysis, it was decided not to pursue full-length
cloning ofMBD2.
Comparison of the MBD2 sequences with MBD3 demonstrates high levels of
conservation between these two closely related methyl-CpG binding proteins. It was
important to rule out the possibility that the clone isolated from the sheep lung
cDNA library could actually be Mbd3, as the predicted sheep MBD2 protein
sequence was of a similar size to MBD3 and the human MBD2B and MBD3
proteins are known to share 70% homology (Hendrich & Bird, 1998). Protein
sequence comparison of the sheep MBD2 and human MBD3 demonstrates high
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levels of conservation within the methyl-binding domain, but the extreme c-terminal
regions are very different, with the sheep MBD2 demonstrating strong similarities
with the human MBD2.
The similarity of Mbd2 and Mbd3 at the protein level does not denote identical
roles. Firstly, the two proteins differ in their ability to bind methylated DNA (Mbd2
can bind methylated DNA, Mbd3 does not) even though they both contain the MBD
motif (Hendrich & Bird, 1998). In terms of development, Mbd3 appears to be
essential, with mice carrying a targeted deletion ofMbd3 failing to progress through
early stages of embryogenesis (Hendrich et al., 2001). On the contrary, mice
carrying a targeted deletion of Mbd2 are viable, although demonstrate maternal-
related behavioural defects (Hendrich et al., 2001). However, a certain extent of
cooperation between these two proteins has been demonstrated, with biochemical
analysis indicating an indirect interaction between the two proteins, such as Mbd2
recruiting the Mbd3-containing NuRD complex (involved in transcriptional
repression) to methylated DNA (Zhang et al., 1999).
To further characterise the sheep homologue of MBD2, gene expression was
quantified in sheep adult tissues using real-time PCR methodology, and measured in
relation to liver, the tissue demonstrating lowest levels of expression. All adult
tissues and fetal fibroblast cells analysed demonstrated MBD2 expression, with
levels varying between tissues. Lung and spleen tissue demonstrated the highest
levels of expression, with a 4-fold increase relative to liver. Heart and kidney
demonstrated levels comparable to liver, whilst ovary tissue and fetal fibroblasts
demonstrated moderate levels of expression. In relation to Mbd2 expression
observed in the mouse, the expression patterns in sheep appear to be similar. Spleen
and lung demonstrate high levels of expression in both species, whilst liver
demonstrates low levels, suggesting functional conservation. MBD2 expression data
for human tissues was not available for comparison.
Comparisons of MBD2 and DNMT1 expression in adult tissues were also made
(DNMT1 expression analysis results can be found in Chapter 5), with similar
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patterns of expression observed. Tissues with high levels of MBD2 also
demonstrated high levels of DNMT1 and vice versa. As Mbd2 binds to and
mediates the transcriptional repression of methylated DNA, differentiated tissues
with high levels of methylation and cellular turnover (indicated by high DNMT1
expression levels) may require similarly high levels of Mbd2. A more direct
interaction of Dnmtl and Mbd2 has also been suggested by Tatematsu and
colleagues (2000) with a MBD2/MBD3 complex recruiting Dnmtl to the replication
fork, allowing maintenance of transcriptionally repressed chromatin after DNA
replication. Comparison ofDNMT1 and MBD2 expression in ovary tissue provided
the one exception to the rule. Although the ovary demonstrates high levels of
Dnmtl expression, a significant proportion of this may be located in the growing or
non-growing oocytes. These cells are not dividing, and the Dnmtl is laid down as a
store (non-functioning), thus Mbd2 may not be required to 'interpret' the
methylation signal as for differentiated or somatic cells.
In addition to analysis of adult tissues, MBD2 transcript levels were also analysed in
sheep preimplantation stage embryos to determine its requirement during early
stages of development. Embryos from the 2-cell and morula stages of development
were chosen for analysis due to their timing pre- and post- zygotic genome
activation at 8-16 cell stage. MBD2 was detected in all 2-cell embryos analysed,
albeit at apparently low levels. MBD2 was barely detectable in morulae, and
analysis of blastocyst cDNA using an alternative primer pair (the DMT primers; data
not shown) resulted in a similar observation.
Since MBD2 is observed at the 2-cell stage, before embryonic genome activation, it
must have been present as a maternal store in oocytes. This suggests a possible
requirement for this protein during the late stages of oocyte maturation or the very
early stages of preimplantation development. The barely detectable presence of
MBD2 at the morula and blastocyst stages would suggest MBD2 is not expressed
from the embryonic genome prior to the blastocyst stage; detected transcripts are
most likely from residual maternal stores. The very low levels ofMBD2 seen at the
morula/blastocyst stages of development fits well with observations made in the
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mouse where MBD2 is downregulated in ES cells, or cells lacking the requirement
for DNA methylation. As MBD2 is a methylation-mediated transcriptional
repressor, it would most likely not be required in preimplantation development when
methylation patterns are undergoing significant changes, and totipotency is required.
By cloning and characterising a component of the DNA methylation repressor
system, further insights have been gained into the role of DNA methylation in sheep.
As shown with the DNA methyltransferases, the MBD2 gene and predicted protein
sequence are highly conserved between mammals, as are indeed the expression
patterns in adult tissues. These results have also indicated a possible requirement for




Analysis of genomic DNA methylation levels in normal
preimplantation development: comparisons with cloned
(SCNT) and in vitro fertilised (IVF) embryos
7.1 Introduction
DNA methylation levels are known to change significantly during mouse
preimplantation development (Monk et al., 1987; Howlett & Reik, 1991; Rougier et al.,
1998), reprogramming gamete-specific methylation patterns to support embryonic
development. More recently, investigations performed in several other mammalian
species (cow, pig and rat) indicated conservation to a certain extent of methylation
reprogramming events during preimplantation development (Dean et al., 2001). All
species investigated demonstrate an active demethylation of the paternal genome post-
fertilisation, with different extents of further demethylation and de novo methylation
occurring during later stages of preimplantation development
The recent surge of interest in somatic cell nuclear transfer (SCNT) technology has led
many to question the epigenetic reprogrammability of an adult nucleus when fused with
an enucleated oocyte. The low success rates of SCNT and high incidence rates of fetal
overgrowth, fetal abnormalities and pre-natal death (reviewed in Young & Fairburn,
1999), are widely blamed on the failure of the oocyte to correctly reprogram the somatic
cell nuclei, thus preventing normal embryonic development. As DNA methylation is a
key epigenetic modification undergoing significant changes post-fertilisation, it is
possible that 'aberrant' methylation patterns acquired or maintained in the very early
stages of development after SCNT may be recapitulated during subsequent stages of
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development, and hence contribute to the unusual phenotypes observed in animals
generated using this technology. Indeed, recent studies have demonstrated incorrect
methylation patterns in cloned cow and pig preimplantation embryos (Dean et al., 2001;
Bourc'his et al., 2001; Kang et al., 2001a and Kang et al., 2001b).
A major aim of this thesis was to determine whether the DNA methylation events
described in mouse preimplantation development are conserved in sheep. An important
application of these studies is to determine whether DNA methylation patterns of SCNT-
derived embryos are equivalent to those seen in embryos produced in vivo or by IVF.
Techniques were developed to analyse DNA methylation status of repetitive DNA
sequences in single oocytes and preimplantation embryos. These methods were then
employed to compare DNA methylation status in in vz'vo-derived, IVF or SCNT
produced embryos. This chapter describes the design of the DNA methylation assay,
observations made of DNA methylation status in 'normal' embryos and comparisons of




7.2.1 Methods of DNA methylation analysis
There are several commonly reported methods of performing genomic DNA methylation
analysis for specific DNA sequences. One of the simplest methods involves a combined
approach of restriction enzyme analysis of DNA with methylation sensitive
isoschizomeric enzymes (e.g., Hpa ll/Msp I) and PCR (Singer-Sam et al., 1990), to
analyse the methylation status of specific cytosine residues within a known DNA
sequence. This technique has been widely used in the past, but is limited by the number
of residues analysed in a single experiment. Currently, the most commonly used
techniques involve bisulfite treatment of DNA, a process that converts unmethylated
cytosine residues to uracil (Frommer et al., 1992). The methylation status of multiple
specific CpG dinucleotides can then be assessed using a number of different methods.
Bisulfite treated DNA can be amplified by PCR to obtain specific regions of genes, and
these PCR products are then cloned and sequenced to determine the methylation status
of the cytosine residues within the sequence. This method is labour intensive as it
requires the sequencing of many clones to differentiate between the normal variability
within a population of cells and possible incomplete conversion of bisulfite treated
DNA.
An alternative method using bisulfite treatment involves the design of PCR primers that
will amplify only 'converted' (unmethylated) DNA, allowing the assessment of the
methylation status for a number of CpG dinucleotides within the primer sequence itself.
Bisulfite treatment of DNA can also be combined with restriction enzyme analysis,
using enzymes that will only recognise the converted DNA sequence (COBRA; Xiong
& Laird, 1997). However, all bisulfite techniques have inherent problems. Attainment
of complete conversion of the sequence of interest is clearly desirable, but is known to
be problematic, especially within CpG rich sequences and DNA containing unusual
secondary structures (Rother et al., 1995). Quantification of methylation levels can also
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be problematic when using primers to amplify converted C-rich sequences. It has been
demonstrated that primers used for this form of methylation analysis do not always
amplify methylated and unmethylated DNA proportionately (Wamecke et al., 1997).
For this particular study it was desirable to perform genomic methylation analysis on
single embryos and oocytes to take into account the variability expected within a
population. By pooling embryos, the variations that exist between individual embryos
are not measurable and therefore the data provides a less accurate picture of the typical
situation. Thus, greater numbers of embryos are required for methylation analysis.
Instead, a method combining the use of a methyl-sensitive restriction enzyme Hha I
(digests only unmethylated cytosine residues) and PCR, was adapted to allow
quantification of methylation status for repetitive DNA sequences in single embryos and
oocytes.
7.2.2 Selection of sheep repetitive sequences for methylation analysis
Two repetitive sequences were chosen for analysis; the sheep Satellite I sequence and an
sheep homologue of the sheep SINE element BOV-2 (henceforth referred to as OV-2).
The sheep Satellite I is found predominantly in centromeric regions of acrocentric
chromosomes, but is also found to a much lesser extent on metacentric and sex
chromosomes (Kurnit et al., 1978; Novak 1984; Burkin et al., 1996). The BOV-2 SINE
element is known to have approximately 100,000 copies (Lenstra et al., 1993) and is
dispersed throughout the genome. The OV-2 SINE has not been characterised in terms
of copy number and location, although the ability to amplify the OV-2 SINE element
from small amounts of DNA at very low PCR cycle numbers (24 cycles when using
1/10th of a blastocyst's DNA) would indicate a relatively high copy number. SINE
elements are a form of non-autonomous transposable element known to habituate
multiple locations throughout the genome (Prak & Kazazian, 2000). The different
locations of these two sequences allowed determination of methylation levels of two
very different repetitive sequences within the sheep genome. This was aimed to indicate
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whether different compartments of the genome are methylated at different levels during
sheep preimplantation development, giving us an insight into the global methylation
events occurring at this time.
Finally, DNA methylation analysis of a single CpG dinucleotide within a sequence will
not give an accurate representation of the methylation status of the entire Satellite I or
SINE element DNA sequence. However, it will allow comparison of the methylation
status of the single site to be made between different embryonic stages and different
embryo treatments.
7.2.3 Methyl-sensitive PCR (MS-PCR) method
The method chosen for analysis of OV-2 SINE and the sheep Satellite I DNA sequences
utilised the design of primers spanning a single Hha I site for methylation analysis. The
method was developed in order that each embryo had a 'standard' (the undigested DNA
PCR product, representing 100% methylation) to directly compare the Hha I digested
PCR product with. Figure 7.1 outlines the complete method from DNA extraction to
the quantification of the resultant PCR products.
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DNA extracted from single
embryos by repeat freeze-




and resuspended in 6pl dH20.
-Hha I +Hlta I
1
-H +H -H +H -H +H
DNA divided into two aliquots;
one digested with Hha I (+Hha I;
20pl volume), the second aliquot
remains undigested {-Hha I; Hha I-
free 20pl digest).
Sequence-specific MS-PCR: 4 replicate
PCR reactions per digested/undigested
single embryo DNA were performed, each
using 2 pi template DNA. The intensity of
the Hha I-digested DNA PCR product was
directly compared to the undigested DNA
PCR product (representing 100%
methylation), to ascertain the %
methylation of the Hha I site within the
DNA sequence.
Figure 7.1 Outline of methyl-sensitive PCR method.
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7.3 Development and optimisation of MS-PCR assay
7.3.1 Restriction mapping and primer design for the sheep Satellite I
sequence
The sheep Satellite I sequence (Accession No. Z18540), was mapped for Hha I sites
using the Map function on GCG10 and primers spanning a single Hha I site were
designed using the Prime function of GCG10. Figure 7.2 shows the DNA sequence of
the sheep Satellite I, highlighting the Hha I site used for methylation analysis, and the
position ofMS-PCR primers. Initial PCR products generated using the Satellite-specific
primers (OVSAT1A), were subcloned and sequenced (as described 2.4.3) to verify insert
identity.
7.3.2 Cloning, restriction mapping and primer design for the OV-2 SINE
DNA sequence
The OV-2 SINE element was isolated during a genomic library screen intended to clone
a differential methylated region of the sheep IGF2R gene (an experiment performed
independently of this thesis). Sequencing of a 4 Kb sub-clone isolated during this screen
demonstrated the presence of a 556 bp sequence highly homologous to the BOV-2 SINE
(Accession No. X64125.1) element. The OV-2 sequence was restriction mapped using
the 'Map' application of GCG10 identifying the characteristic Pst I sites flanking the
SINE element, and a single Hha I site for potential use in later methylation analysis
experiments. The 'Prime' application of GCG10 was used to identify PCR primer
positions flanking the Hha I site and the primers named BOVB forward and reverse.
The sequence obtained is demonstrated in Figure 7.3 and highlights the Pst I and Hha I
cutting sites, and the positions of PCR primers. The initial PCR products generated by




301 + + + + + 350
GTACGCTCAAGGAGCCCCCGGAAAGCCTTAAGGAGAGGGCGACTACGGCC
GGCCTAAGACCTTGTGTGAACTCAGGGCCGGAACCTGAGGATTCCTCTCC
351 + + + + + 400
CCGGATTCTGGAACACACTTGAGTCCCGGCCTTGGACTCCTAAGGAGAGG
AGTGCTGACATGGATCTTGGGGTACTTCTGAAGTCTCCCCAGGGGAGTCA




451 + + + + + 500
CAGGAGCAGAGCTTACGCCCGTACGTGAACGCGAAAGGAGGTCTCGCCAT
GCAGCAGTGTCACGCAGTCCGCCCCGTGGATCAAAGCATCTATGGTTTTC
501 + + + + + 550
CGTCGTCACAGTGCGTCAGGCGGGGCACCTAGTTTCGTAGATACCAAAAG
CCTCGTGTCTTTCCCACGGGGCTTTCCCACGAGGCTTTCCCACAGGGCTG
551 + + + + + 600
GGAGCACAGAAAGGGTGCCCCGAAAGGGTGCTCCGAAAGGGTGTCCCGAC
TCCCACGTGCACACGTGGTGGGAGTCGATCCTCGGCTTGAACGTCAAGGC
601 + + + + + 650
AGGGTGCACGTGTGCACCACCCTCAGCTAGGAGCCGAACTTGCAGTTCCG
AGTGCAGGGAAAACAGGTTCCTCTGGAATGGACTGACACATCTGGGGGAC
651 + + + + + 700
TCACGTCCCTTTTGTCCAAGGAGACCTTACCTGACTGTGTAGACCCCCTG
TCTTGGAATGGTGGCACGACCCTGGAGTTCCTCTCGCCTTTCCTGTGGAG
701 + + + + + 750
AGAACCTTACCACCGTGCTGGGACCTCAAGGAGAGCGGAAAGGACACCTC
Figure 7.2 Sheep Satellite I DNA sequence highlighting Hha I enzyme cutting
sites and positions of OVSAT1A MS-PCR primers. The Hha I restriction enzyme
cutting sites are highlighted in blue text. The MS-PCR primer (OVSAT1A) positions
are highlighted in red text and labelled with arrows. Other CpG sites are underlined,




X + + + + + 55
GTGACGTCGGTACTTTAATTTTCTACGACCGAGGAACCTTCTCTTCAATACTGGT
ACCTAGATAGCATATTCAAAAGCAGAGACATTACTTTGCCAACAAAGGTCCGTCT
56 + + + + + + 110
TGGATCTATCGTATAAGTTTTCGTCTCTGTAATGAAACGGTTGTTTCCAGGCAGA
AGTCAAAGCTATAGTTTTTCCAGTGGTCATGTATGGATGTGAGAGTTGGACTATA




166 1 1 + H 1 H 220
TTCTTTCGACTCGCGGCTTCTTAACAACGAAAACTTTACACCACAACCTCTTCTG
TCTGAGAGTCCCTTGGACTGCAAGGAGATCCAACCAGTGCATTCTAAAGGAAATC
221 + - --- + + + + 275
AGACTCTCAGGGAACCTGACGTTCCTCTAGGTTGGTCACGTAAGATTTCCTTTAG
AGTCCTGAATATTCATTGGAAGGACTGATGCAGAAGCTGAAACTCCAATACTTTG
276 + H H H + 330
TCAGGACTTATAAGTAACCTTCCTGACTACGTCTTCGACTTTGAGGTTATGAAAC
GCCACCTGATGCAAAGAGCTGACTCATTGGAAAAGACTCATGCTGGGAAAGATTG
331 - + + + + + 385
CGGTGGACTACGTTTCTCGACTGAGTAACCTTTTCTGAGTACGACCCTTTCTAAC
AGGGCAGGAGGAGAAGGGGACGACAGAGGATAAAATGGTTAGATGGCATCCCCGA
386 + + + + + + 440
TCCCGTCCTCCTCTTCCCCTGCTGTCTCCTATTTTACCAATCTACCGTAGGGGCT
CTCAATGGACGTGAGTTTGAGTAAACTCTGGGAGTTGGAGGTGGACAGGGAGGCC











Figure 7.3 OV-2 DNA sequence indicating Hha I cutting sites and positions of
BOVB MS-PCR primers. The Pst I and Hha I restriction enzyme cutting sites are
highlighted in blue text. The MS-PCR primer (BOVB) positions are highlighted in red
text and labelled with arrows. Other CpG sites are underlined, indicating the density of
CpG dinucleotides within the Satellite I DNA sequence.
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7.3.3 MS-PCR controls and assessment of reproducibility
Several controls were performed for each MS-PCR experiment relating to various steps
of the method. Firstly, a No Embryo Control (NEC; dFEO) was initiated at the DNA
extraction step and carried through the entire method, to ensure the reagents and plastic
consumables were not contaminated. Controls were also required to ensure that the
Hha I enzyme (present in excess), completely digested the unmethylated DNA. An
unmethylated PCR product amplified by either the OVSAT1A1A or BOVB primers, and
then gel extracted and purified (see 2.4.3), was used for this particular control. To
ensure the Hha I enzyme was not digesting methylated DNA, a plasmid containing
either the Satellite I or OV-2 SINE PCR product was methylated in vitro using Sss I
methylase (as described 2.4.10.4). Both the unmethylated and methylated controls were
digested alongside the embryo/oocyte DNA and subsequently used as template in a PCR
reaction with the appropriate primer pair. The PCR products were visually checked to
confirm complete digestion of unmethylated controls and no digestion of methylated
plasmid DNA. Controls established for Satellite I and OV-2 SINE MS-PCR analysis are
demonstrated in Figure 7.4.
It was decided to perform 3-4 PCR replicates per digested/undigested single embryo
DNA sample for each primer set, and the reproducibility of the MS-PCR method was
found to be very high. Figure 7.5 demonstrates the reproducibility for PCR replicates
(performed at 19 cycles) for a single blastocyst undergoing methylation analysis of the
Satellite I and OV-2 SINE sequences. Data derived from single replicates was only
removed when a clear difference was observed between triplicate/quadruplicate values,
for example, due to pipetting errors.
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Figure 7.4 PCR analysis of controls used for (A) Satellite I or (B) OV-2 SINE
methylation analysis.
The -H or +H above each lane indicates the absence or presence (respectively) of Hha I
in the digestion step of the MS-PCR method. Lanes 1 and 2 are PCR reactions
demonstrating no amplification of the No Embryo Control. Lanes 3 and 4 are PCR
products generated from the methylated control template. Lanes 5 and 6 are PCR
products generated from the unmethylated controls template. DNA marker sizes (Lane














Figure 7.5 PCR replicates for DNA derived from a single blastocyst using the
Satellite 1 (OVSAT1A; gel image A) or OV-2 SINE (BOVB; gel image B) primers.
Lanes 1-4 are PCR products generated from undigested blastocyst DNA. Lanes 5-8
contain PCR products generated from Hha I digested blastocyst DNA. DNA marker
sizes (Lane 9; 1 Kb plus DNA ladder; Invitrogen), are indicated to the right of the gel
image.
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7.3.4 Generation of standard curves for MS-PCR analysis
To define the linearity of the MS-PCR amplification within the PCR cycle used for
quantification, standard curves were established to analyse DNA standards representing
various levels ofmethylation. Standard curves were generated for both sets of primers,
and for each embryo stage analysed, using DNA extracted and pooled from 3-4 oocytes,
8-16 cell embryos, morulae or blastocysts, as appropriate (DNA extraction performed as
described 2.4.10.1), The PCR was performed at the same cycle number as the embryo
MS-PCR, using standards containing known quantities of undigested DNA equivalent to
2pi embryo/oocyte DNA (the amount of template used in a MS-PCR reaction) down to
0.4pl, at 0.4pl intervals and with 4 replicates per specified DNA quantity. As the DNA
template was undigested, each DNA standard represented a known methylation level
from 100% (2 pi DNA) down to 20% methylated (0.4pl DNA). To predict the observed
methylation level value from the known standard, the intensity of the PCR products was
divided by the '100% methylation' or 2pl standard PCR product intensity, thus
replicating the method of quantification used for individual embryo analysis. The
observed values were plotted against the predicted methylation level values to generate
the standard curves specific to each embryo stage and primer set, and are shown in
Figure 7.6.
Standard curves generated using OVSAT1A primers for all embryo stages/oocytes, were
found to be reproducible, and the curves were of a quadratic nature. There was a clear
correlation between decreasing amounts of template, and increased curvature of standard
curve lines. In addition, as template levels decreased, the standard deviation between
replicates of the same DNA standard increased, suggesting a loss of PCR sensitivity at
lower DNA concentrations. Generation of standard curves using BOVB primers for 8-
16 cell stage embryos and oocytes failed to provide reproducible standard curves with
simple linear or quadratic properties, suggesting the BOVB primers were inefficient
when used to amplify template of decreased concentration. Therefore, the small amount














































Input DNA (pi) or 'known'
methylation levels
100%
Figure 7.6 Standard curves for calculating methylation status of Satellite I
(OVSAT1A) and OV-2 SINE (BOVB).
Input DNA for the MS-PCR reaction is indicated on the x-axis, with the 'known' %
methylation levels also shown. For generation of the blastocyst standard curves for both
OVSAT1A and BOVB primers, two additional standards of 0.6 p.1 (30% methylated)




7.4.1 Methylation analysis of sheep heart and fetal fibroblast DNA
The DNA methylation status of the Satellite I and OV-2 SINE sequences were analysed
to ascertain methylation levels for a fully differentiated tissue (adult heart), and also for
the cells used in SCNT (fetal fibroblast cells). DNA was extracted from heart tissue and
cultured fetal fibroblast cells (cell line B1WF1P5), as described 2.4.9. Two (heart), or
three (fetal fibroblast), DNA samples per tissue/cell type were analysed and the
equivalent amount of DNA as in one blastocyst (~1 ng), was split into aliquots for
incubation with or without Hha I (as described 2.4.10.2), The PCR reactions were
performed at the same cycle number as for blastocyst DNA (as described 2.4.10.3) and
the methylation values obtained from direct comparison of PCR product intensities were
standardised against the pooled blastocyst-generated standard curves (refer to Figure
7.6). The mean of three values for each tissue sample was calculated and the results are
demonstrated in Figure 7.7.
DNA methylation levels were found to be similar for both Satellite I and OV-2 SINE
DNA sequences in the cell and tissue types analysed. Methylation levels were highest in
heart tissue (Satellite I: 101%; OV-2: 107%), and moderately lower in fibroblast cells
(Satellite I: 77%; OV-2: 71%). The values gained for heart tissue are both higher than
100%, an impossible event, and the values demonstrate the potential range of error in
calculating methylation values using this method. The raw PCR data and calculated








Tissue/cell type DNA sequence Mean S.E of Mean
Heart Satellite I 101 12
OV-2 SINE 106.5 2.5
Fetal Fibroblast Satellite I 77 9
OV-2 SINE 70.7 3.38
Figure 7.7 DNA methylation levels of Satellite I and OV-2 SINE DNA sequences
in Heart tissue and Fetal fibroblast cells.
Methylation level of heart tissue and fetal fibroblast cells are indicated as percentage
values and are representative of three samples for fetal fibroblast DNA, and two samples
for heart DNA. The mean ofmethylation levels for each tissue type was calculated, and
the standard error of the mean is indicated as bi-directional error bars. The numerical
values of the mean and standard error calculated for each sample type are shown in the
table below the chart.
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7.4.2 Methylation analysis of gametic DNA
DNA was extracted from 10 single superovulated Mil oocytes, as described 2.4.10.1.
The DNA was split into aliquots for incubation with or without Hha I, then MS-PCR
analysis of the Satellite I DNA sequence was performed (as described 2.4.10.2 and
2.4.10.3). Previous experiments had demonstrated non-reproducible results using the
BOVB primers on very small amounts of DNA (less than the equivalent of blastocyst
DNA), therefore, analysis of the OV-2 SINE element was not performed. Satellite I
methylation values were normalised against the relevant standard curve (refer to Figure
7.6). DNA was extracted from frozen sperm (as described 2.4.9) and three DNA
samples with the equivalent amount of DNA as in one blastocyst (~lng), were removed
from the original sample. The three 1 ng DNA samples were split into aliquots for
digestion with or without Hha I, as described 2.4.10.2. MS-PCR was performed (as
described 2.4.10.2; 2.4.10.3), at the same cycle number as for blastocyst DNA and the
percentage gained from direct comparison of PCR product intensities was standardised
against the relevant blastocyst-generated standard curve. Analysis of both the Satellite I
and OV-2 SINE sequences was performed on sperm DNA.
The mean methylation levels of Satellite I for each gamete type was calculated and the
results are shown in Figure 7.8. The raw PCR data and calculated methylation values
for individual samples of the different gamete types can be found in Table A4.2,
Appendix IV. Oocytes and sperm demonstrated similar levels of Satellite I DNA
methylation (25% and 30% respectively), and analysis of the methylation status of the















1 1 ^ 1
Oocyte Sperm Sperm
(n=9) (n=3) (n=3)
DNA source DNA sequence Mean S.E of Mean
Oocyte Satellite I 25 2.6
Sperm Satellite I 30.3 6.3
Sperm OV-2 27.3 3.4
Figure 7.8 DNA methylation levels of Satellite I and OV-2 DNA sequences in
gametes.
DNA methylation levels of oocyte or sperm DNA are indicated as percentage values on
the y-axis. The numbers of oocytes/pooled sperm DNA samples used are indicated on
the x-axis. The mean ofmethylation levels for each gamete type was calculated and the
standard error of the mean is indicated as bi-directional error bars. The numerical values
of the mean and standard error of the mean are shown in the table below the chart.
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7.4.3 DNA methylation levels of Satellite I in multi-stage in vivo derived
embryos
DNA was extracted from in v/vo-derived embryos at the following stages (as described
2.4.10.1): 8-16 cell (15), morula (8) and blastocyst (15). The DNA was subsequently
incubated with or without Hha I (as described 2.4.10.2), and then subjected to PCR
amplification, with embryo stage and primer-specific conditions (as described 2.4.10.3
and Table 2.5). The methylation values obtained from direct comparison of PCR
product intensities were standardised against the relevant standard curves (refer to 7.6).
After removal of single embryo data, due to defective PCR amplification or complete
failure of the PCR (no embryo in tube), the number of embryos providing acceptable
MS-PCR data were as follows: 8-16 cell (12), morula (6) and blastocysts (15). The
mean of methylation levels of Satellite I for each embryo stage was calculated and the
results are shown in Figure 7.9. The raw PCR data and methylation values for
individual embryos can be found in Tables A4.3-A4.5, Appendix IV. Variations in
methylation levels of individual embryos at the same embryo stage were evident,
sometimes deviating substantially from the mean. The mean methylation level for each
embryo stage demonstrated a slight decrease in DNA methylation levels between the 8-
16 cell and morula stages, followed a by a slight increase at the blastocysts stage.
However, statistical analysis using student's t-tests (95% C.I.), demonstrated the
differences in methylation levels observed between different embryo stages were not
statistically significant (P>0.05). This may be due to the small numbers of embryos






8-16 cell Morula Blastocyst
(n=12) (n=6) (n=15)
Embryo stage Mean S.E of Mean
8-16 cell 33.7 5.0
Morula 25.8 5.2
Blastocyst 36.8 2.9
Figure 7.9 DNA methylation levels of Satellite I during preimplantation stages
of development.
DNA methylation levels of embryos are indicated as percentage values on the y-axis.
The stage and number of embryos used are indicated on the x-axis. The mean of
methylation levels from embryos of a single stage was calculated, and the standard error
of the mean is indicated as bi-directional error bars on the chart. The numerical values
of the mean and standard error of the mean are shown in the table below the chart.
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7.4.4 Comparison of DNA methylation levels in in vivo, IVF and SCNT
derived sheep embryos
MS-PCR analysis of Satellite I DNA was performed (as described 2.4.10) on the
following embryos: IVF blastocysts (18), NT blastocysts (25), IVF 8-16 cell embryos
(10) and 8-16 cell NT embryos (10). The numbers of embryos chosen reflects
availability. The results already gained for in v/vo-derived embryos (blastocysts (15)
and 8-16 cell embryos (12)) were used for comparison with the results generated from
IVF and NT embryos of the same developmental stage. It was possible to combine
results collected in separate experiments, as methylation levels of single embryos are
measured relative to an 'internal' standard, then undergo standardisation using the
appropriate standard curve. MS-PCR of the OV-2 SINE element was also collected (as
described 2.4.10) for the following embryos; in vz'vo-derived blastocyst (10), IVF
blastocyst (10) and NT blastocyst (20). The methylation values obtained from direct
comparison of PCR product intensities were standardised against the relevant standard
curves (refer to 7.6).
After removal of single embryo data due to defective amplification, or failure of the
PCR, the number of embryos providing acceptable MS-PCR data was as follows: IVF
blastocysts (17), NT blastocysts (21), IVF 8-16 cell embryos (7) and NT 8-16 cell
embryos (9). All of the embryos used for OV-2 SINE methylation analysis provided
acceptable data except one NT blastocyst. The mean of methylation levels of the
Satellite I or OV-2 SINE sequence was calculated for each group of same-stage embryos
produced by the same treatment, the results are shown in Figures 7.10 (8-16 cell data)
and Figure 7.11 (blastocyst data). The raw PCR data and methylation values for all of
the individual embryos can be found in Tables A4.3, A4.5 and A4.6, Appendix IV.
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In vivo IVF NT
(n=12) (n=7) (n=9)
Embryo source Mean S.E of Mean
In vivo 33.7 3.5
IVF 12.9 5.8
NT 10.3 4.1
Figure 7.10 Comparison of Satellite I DNA methylation levels in in vivo, IVF and
SCNT derived 8-16 cell embryos.
DNA methylation levels of embryos are indicated as percentage values on the y-axis.
The source and number of embryos used are indicated on the x-axis. The mean of
Satellite I DNA methylation levels from embryos of a single source was calculated, and
the standard error of the mean is indicated as bi-directional error bars on the chart. The




















In vivo IVF NT In vivo IVF NT
(n=15) (n=17) (n=21) (n=10) (n=10) (n=19)
Source of Embryo DNA sequence Mean S.E of Mean
In vivo Satellite 1 36.8 3.9
OV-2 64 5.7
IVF Satellite 1 17.7 1.8
OV-2 14.4 2.6
NT Satellite 1 36.4 4.6
OV-2 26.4 5.3
Figure 7.11 Comparison of Satellite I and OV-2 SINE DNA methylation levels in
in vivo, IVF and NT derived blastocysts
DNA methylation levels of embryos are indicated as percentage values on the y-axis.
The source and number of embryos used are indicated on the x-axis. The mean of
sequence-specific DNA methylation levels (Satellite I or OV-2) from embryos of a
single source was calculated, and the standard error of the mean is indicated as bi¬
directional error bars on the chart. The numerical values of the mean and standard error
of the mean are shown in the table below the chart.
Satellite I OV-2 SINE
T *
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Methylation levels of the Satellite I DNA sequence differed substantially between the
groups of 8-16 cell embryos derived from different embryo technologies. Methylation
levels were highest in in v/vo-derived embryos (33.7%), whilst embryos produced by
IVF or SCNT demonstrated very low levels of methylation at the Hha I site (10-12%).
In blastocysts, methylation levels of Satellite I also differed between embryos derived
from the different embryo technologies, but did not correlate with the differences seen at
the 8-16 cell stage. In vz'vo-derived and SCNT blastocysts demonstrated similar DNA
methylation levels (~36%), whilst IVF blastocysts demonstrated low levels of DNA
methylation (14.4%). Analysis of the OV-2 SINE DNA sequence in blastocysts also
demonstrated differences between embryo groups. In vivo blastocysts demonstrated
high levels ofmethylation (64%), whilst IVF and SCNT-derived embryos demonstrated
lower levels ofmethylation (14.4% and 26.4% respectively).
To assess whether the differences observed were statistically significant, one-way
analysis of variance (ANOVA) was performed. As the methylation data collected from
individual embryos did not demonstrate equal variance between the treatment groups, a
square root transformation was performed to achieve approximate equal variance. The
one-way ANOVA was performed post-transformation. To calculate the statistical
significance of methylation level differences observed between different treatment
groups, pairwise comparisons were made using the Tukey simultaneous test (95%
confidence intervals). P values were calculated from T-values generated from the Tukey
tests, using a t-distribution table. Figures 7.12, 7.13 and 7.14 demonstrate the output of
the one-way ANOVA for Satellite I methylation levels in 8-16 cell embryos, Satellite I
in blastocysts and OV-2 SINE in blastocysts respectively.
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All Pairwise Comparisons among Levels of C5
C5 = 1 subtracted from:
Level Difference SE of
C5 of Means Difference T-Value P-Value
2 -2.426 0.7604 -3.191 <0.005
3 -2.786 0.7050 -3.951 <0.001
C5 = 2 subtracted from:
Level Difference SE of
C5 of Means Difference T-Value P-Value
3 -0.3597 0.8057 -0.4464 >0.300
Figure 7.12 Statistical analysis of differences in Satellite I DNA methylation level
sobserved between in vivo, IVF and SCNT derived 8-16 cell embryos.
Level 1 are the in v/vo-derived embryos, level 2 are the IVF produced embryos, and
level 3 are the SCNT embryos. The Minitab program did not calculate p-values; T-
values were used to calculate P-values using a t-distribution table. The number of
degrees of freedom was 25 (n-2).
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C2 8 = 1 subtracted from:
C2 8 Lower Center Upper + + +
2 -3.017 -1.879 -0.7406 (-- * )i
3 -1.309 -0.223 0.8634 (--■ * )
+ + +
-1. 6 oo 1.1
C2 8 = 2 subtracted from:
C2 8 Lower Center Upper — + + +





All Pairwise Comparisons among Levels of C28
C28 = 1 subtracted from:
Level Difference SE of
C28 of Means Difference T-Value P-Value
2 -1.879 0 .4706 -3.992 <0.001
3 -0.223 0 .4491 -0.496 >0.300
C28 = 2 subtracted from:
Level Difference SE of
C28 of Means Difference T-Value P-Value
3 1.656 0 .4334 3 . 821 <0.001
Figure 7.13 Statistical analysis of differences in Satellite I DNA methylation level
observed between in vivo, IVF and SCNT derived blastocysts.
Level 1 are in vz'vo-derived embryos, level 2 are the IVF produced embryos, and level 3
are the SCNT embryos. The Minitab program did not calculate p-values; T-values were
used to calculate P-values using a t-distribution table. The number of degrees of
freedom was 50 (n-2).
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C19 = 1 subtracted from:
CI 9 Lower Center Upper
2 -5.630 -4.005 -2 .379
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Tukey Simultaneous Tests
Response Variable C20
All Pairwise Comparisons among Levels of C19
C19 = 1 subtracted from:
Level Difference SE of
CI 9 of Means Difference T-Value P-Value
2 -4.005 0 . 6644 -6.028 0.0000
3 -3.483 0 . 5804 -6.001 0.0000
C19 = 2 subtracted from:
Level Difference SE of
CI 9 of Means Difference T-Value P-Value
3 0.5219 0.5804 0.8993 >0.100
Figure 7.14 Statistical analysis of differences in OV-2 SINE DNA methylation
level observed between in vivo, IVF and SCNT derived blastocysts.
Level 1 are in v/vo-derived embryos, level 2 are the IVF produced embryos, and levels 3
are the SCNT embryos. The Minitab program did not calculate p-values; T-values were
used to calculate P-values using a t-distribution table. The number of degrees of
freedom was 50 (n-2).
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For the Satellite I sequence of 8-16 cell embryos, statistically significant differences in
methylation levels were observed between in v/vo-derived and IVF embryos, and in vivo
and SCNT embryos. There was no difference observed between embryos produced by
IVF or SCNT. Methylation levels of the Satellite I sequence of blastocysts was
significantly different between in vivo and IVF embryos, and IVF and SCNT embryos.
There was no significant difference observed between in vz'vo-derived and SCNT
blastocysts. Finally, methylation levels of the OV-2 SINE sequence were significantly
different between in vivo and IVF embryos, in vz'vo-derived and SCNT embryos, but not
between IVF and SCNT blastocysts.
Analysis of methylation data from single blastocysts provided additional information
(individual embryo data can be found in Tables A4.5-A4.6, Appendix IV). When
analysing Satellite I methylation data of SCNT blastocysts, 9/21 embryos demonstrated
methylation levels comparable to IVF blastocysts (10-30%). The remaining embryos
demonstrated substantially increased methylation levels (30-74%). Considering that
IVF and SCNT embryos are comparable in terms of the equivalent period of in vitro
embryo culture, it would appear that some embryos are correctly reprogrammed, whilst
other embryos maintain high levels of methylation. When performing a similar
comparison of the OV-2 SINE element, many of the SCNT embryos retain similar
methylation levels to IVF derived blastocysts, whilst only 2/20 embryos demonstrate
significantly higher levels of methylation (52-73%).
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7.5 Discussion
A technique to analyse the methylation status of repetitive DNA sequences in tissues,
cells, single oocytes and embryos was devised and employed to assess DNA methylation
status in embryos produced by different embryo technologies. The method was found
to be reproducible for Satellite I DNA methylation analysis for all embryo stages and
oocytes, but not reproducible when analysing the methylation status of the OV-2 SINE
element at specific embryo stages.
The DNA methylation status of a Hha I site within the Satellite I and OV-2 SINE
sequences was first analysed in heart tissue and fetal fibroblast cells. Adult heart tissue
DNA was used to obtain DNA methylation values for a fully differentiated tissue, and
fetal fibroblast cell DNA was analysed to ascertain methylation levels of the Satellite I
and OV-2 SINE sequences in SCNT donor cells. The Hha I sites within the Satellite I
and OV-2 SINE sequences were found to be highly methylated in heart DNA (mean of
>100%), with fetal fibroblast cells demonstrating slightly lower mean levels of
methylation (77% Satellite I; 71% OV-2 SINE). The high levels of DNA methylation
observed in heart tissue are possibly indicative of the degree of cellular differentiation of
this somatic cell type. The slightly lower levels of methylation of Satellite I and OV-2
SINE in fetal fibroblast DNA may be due to the 'less differentiated' state of fibroblast
cells.
The DNA methylation status of the Hha I site within the sheep Satellite I sequence was
analysed in oocytes and sperm. As the OV-2 SINE MS-PCR method was not
reproducible in oocytes, the methylation status of the Hha I site within this repetitive
sequence was analysed only in sperm. Both sperm and oocytes demonstrated relatively
low mean levels of methylation at the Hha I site of Satellite I (25% and 30%
respectively), and the Hha I site within the OV-2 SINE sequence in sperm presented
comparable levels of methylation (27%).
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In general, investigations of DNA methylation levels of repetitive DNA sequences in
mouse oocytes and spermatazoa have demonstrated high levels of methylation in sperm,
and undermethylation in oocytes (Sanford et al., 1987, Howlett & Reik, 1991). The
observation of undermethylated Satellite I DNA sequences in sheep oocytes fits well
with these findings, however, the relatively low levels of DNA methylation seen in
sheep sperm Satellite I and OV-2 SINE sequences is in disagreement with previous
observations in the mouse. There are several possible explanations for this apparent
difference. Firstly, only a few repetitive sequences (including the LI LINE, MUP
(Major urinary protein) and IAP (Intracistemal A particle) sequences) have been
analysed in mouse gametes, and may not be representative of all genes and DNA
sequences (Sanford et al., 1987; Howlett & Reik, 1991). Secondly, the MS-PCR
analysis of OV-2 SINE and Satellite I only analyses the methylation status of a single
CpG site, which may not be representative of the entire DNA sequence. Closer
inspection of the Hha I site in Satellite I demonstrates localisation within a cluster of
CpG residues, whereas the OV-2 SINE Hha I site is isolated.
DNA methylation status of the Hha I Satellite I sequence was compared in sheep
preimplantation embryos of different stages and was not found to vary significantly
between 8-16 cell, morula and blastocyst stages. A slight decrease was observed at the
morula stage, although this may be compounded by the small number of embryos
analysed at this stage (n = 6). In the mouse, centromeric heterochromatin (containing
Satellite DNA) is not demethylated until the blastocyst stage of preimplantation
development. The results collected from sheep embryos suggest no demethylation of
Satellite I DNA at the Hha I site occurring between the 8-16 cell and blastocyst stages.
It is possible that demethylation may occur prior to the 8-16 cell stage in sheep embryos,
but analysis of sheep 2-cell and 4-cell embryos was not possible due to the combined
problem of time constraints and difficulties in obtaining significant numbers of in vivo-
derived embryos. However, taking into consideration that the relatively low methylation
values of oocyte and sperm Satellite I DNA (25% and 30% respectively), are
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comparable to those seen in 8-16 cell, morula and blastocyst stage embryos, any
demethylation occurring at the single CpG site prior to the 8-16 cell stage would most
likely have to follow a post-fertilisation de novo methylation event.
Direct comparison of Satellite I DNA methylation status was performed in 8-16 cell
embryos or blastocysts produced in vivo, by IVF or SCNT. In addition, analysis of the
OV-2 SINE was also performed for individual blastocysts produced by the three embryo
technologies. At the 8-16 cell stage, the DNA methylation status of the single Hha I site
in Satellite I was comparable in IVF or SCNT-derived embryos (means of 3% and 10%
respectively), but in vivo embryos demonstrated significantly higher methylation status
(mean of 34%). In blastocysts, the DNA methylation status of Satellite I was high in in
v/vo-derived embryos (mean of 36.8%), with comparable levels seen in SCNT
blastocysts (mean of 36.4%). The DNA methylation status of Satellite I was
considerably lower in IVF produced embryos (mean of 17.7%), when compared to in
v/vo-derived and SCNT produced blastocysts. Differences in OV-2 SINE DNA
methylation status were also observed between in v/vo-derived, IVF and SCNT
blastocysts, with in v/vo-derived embryos demonstrating the highest levels of
methylation (mean of 64%), when compared to IVF and SCNT produced blastocysts
(means of 14.4% and 26.4% respectively).
The apparent difference in methylation status observed between in v/vo-derived and IVF
embryos is intriguing, as both of these embryo production techniques generally produce
a high proportion of 'normal' offspring (De Sousa et al., 2001). When comparing the
DNA methylation status of Satellite I or OV-2 SINE in embryos produced by different
techniques (in v/vo-derived, IVF or SCNT produced), the following points should be
taken into consideration. Firstly, SCNT embryos are comparable to IVF produced
embryos in terms of in vitro embryo culture, although they are not wholly comparable,
as they are produced using oocytes of different origin (superovulated Mil oocytes
(SCNT) or in vitro matured (IVM) oocytes (IVF)), and may also develop to the
blastocyst stage at different rates. It cannot be assumed that superovulated oocytes
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would be comparable to in vitro matured (IVM) oocytes in respect of methylation status
and the required complement of 'methylation-reprogramming factors'. The period of
embryo culture common to IVF and SCNT embryos may also lead to differences in
sequence-specific DNA methylation status, as observed in large offspring syndrome
(Young et al., 2001).
If comparisons of Satellite I methylation status are made between in vz'vo-derived and
SCNT embryos, the following methylation reprogramming scenario is apparent. A
significant demethylation of the SCNT embryos occurs prior to the 8-16 cell stage,
followed by an increase in DNA methylation to levels equivalent to those observed in in
v/vo-derived embryos at the blastocyst stage. This would require hypomethylation of
DNA in 8-16 cell SCNT embryos, whilst their in vivo counterparts remain moderately
methylated. Recent studies investigating DNA methylation patterns in cloned sheep
embryos all described abnormally high methylation levels in embryonic nuclei,
purportedly reflecting the difficulties in reprogramming somatic nuclei methylation
patterns (Kang et al., 2001a; Dean et al., 2001; Bourc'his et al., 2001). It would be most
unexpected to observe undermethylated DNA as a result of SCNT and this may
therefore be an effect of in vitro culture, rather than aberrant reprogramming. In this
respect, comparison of SCNT embryos with IVF embryos may be more suitable. At the
8-16 cell stage, the methylation status of the Hha I site of Satellite I in IVF and SCNT
produced embryos are very similar, however, at the blastocyst stage, Satellite I
methylation levels in both IVF and SCNT embryos have increased, with a more marked
increase in SCNT blastocysts. This produces a statistically significant difference
between the two groups of embryos (P<0.001).
Overall, this creates a picture of correct methylation reprogramming up to the 8-16 cell
stage, followed by establishment of aberrant methylation patterns prior to the blastocyst
stage. These results agree in kind with those of Dean et al. (2001), whom observed
partial demethylation up to the 8-cell stage in cloned embryos, followed by spurious de
novo methylation. Closer inspection of Satellite I DNA methylation values for
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individual embryos demonstrated that a proportion of SCNT embryos (9/21) retained
methylation levels similar to their IVF produced counterparts (10-30%), whilst the
remainder demonstrated increased methylation levels (30-70%). This would suggest
some SCNT blastocysts are reprogrammed correctly, but a larger proportion fail to
recapitulate 'normal' DNA methylation patterns, and may partially account for the low
success rates observed in large animal SCNT.
When analysing DNA methylation status of the OV-2 SINE sequence observed between
IVF and SCNT produced blastocysts, the observed mean levels of methylation (14.4%
and 26.4% respectively), were not found to be statistically significant (P>0.1). When
inspecting individual blastocyst DNA methylation values, only 2/20 SCNT blastocysts
demonstrated significantly higher levels of methylation than their IVF produced
counterparts. This contrasts with the observations made for Satellite I methylation
levels, where a large proportion of the SCNT blastocysts demonstrated aberrant Satellite
I methylation when compared with IVF blastocysts. This suggests sequence-specific
methylation reprogramming errors occurring in SCNT produced embryos. These results
agree in kind with the observations of Bourc'his et al., where DNA methylation levels
appear to be increased in heterochromatin regions (the location of Satellite I) of
chromosomes derived from SCNT blastocysts relative to those derived from IVF
blastocysts, but are similar in euchromatin regions (where the OV-2 SINE sequence is
likely to reside).
It must be noted that the differences in DNA methylation levels observed between in
v/vo-derived, SCNT and IVF blastocysts may also be influenced by embryo collection
methods. In vivo blastocysts were collected from superovulated and naturally mated
ewes, and it is notoriously difficult to synchronise ovulation in sheep, although PMSG
(pregnant mare serum gonadotrophin) was administered to control this as much as
possible. In any one collection, blastocysts of different stages may be observed (e.g.
early, expanded or hatching), as the timing of ovulation and fertilisation may differ by
several hours. IVF and SCNT produced blastocysts are potentially more comparable in
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this respect, as they are fertilised or fused in the space of 3-4 hours, cultured in vitro, and
frozen down at the time of expansion. However, for the 'stage' of blastocyst collected to
influence the results in terms of methylation, significant methylation changes
(demethylation/r/e novo methylation) must occur at the blastocyst stage in sheep, an as
yet undetermined event.
Also, worthy of note was the observation that Satellite I and OV-2 SINE methylation
values for individual in vz'vo-derived embryos of the same stage varied substantially. For
example, methylation of the Hha I site of Satellite I in 8-16 cell embryos varied from 18-
80%. This may reflect methylation differences between 8-cell and 16-cell embryos,
although other possibilities exist. When taking into consideration that not all in vivo-
derived embryos will be able to sustain normal development, (i.e. not all 8-16 cell
embryos will progress to later stages of development), it is possible that this may be
indicated by widely varying methylation levels. If this hypothesis is true, the later stages
of development should demonstrate smaller variation within a same-stage group of
embryos. Indeed, there was a marked decrease in individual embryo variation between
8-16 cell embryos and blastocysts. However, a certain extent of variation within a
population of single-stage embryos is still likely, reflecting both naturally occurring
variation and that induced experimentally.
Overall, the DNA methylation data generated from in vz'vo-derived, IVF and SCNT
produced embryos is not clear-cut due to the aforementioned experimental constraints.
However, valuable preliminary information has been obtained. Sequence-specific
inconsistencies in reprogramming are apparent when comparing IVF and SCNT
embryos. Furthermore, it is possible that in vitro culture may lead to the
hypomethylation of repetitive DNA sequences, reflecting previously described
anomalies in imprinted gene methylation status of in vitro cultured sheep and mouse
embryos (Young et al., 2001; Doherty et al., 2000). Analysis of global methylation
reprogramming in normal and cloned preimplantation embryos (using indirect
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immunoflourescence) alongside examination of the reprogramming capacity of oocytes
derived from different sources, will help to address the issues raised in this initial study.
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Chapter 8
Dynamics of DNA methylation in normal and cloned
sheep development: summary and discussion
8.1 Aims of thesis
The primary aim of this thesis was to initiate a study of DNA methylation in sheep, in
particular, its dynamics during the early stages of normal and cloned embryo
development.
Specific aims were as follows:
1. To clone sheep homologues of genes encoding DNA methyltransferases and
methyl-CpG-binding proteins and evaluate their conservation with mouse and
human homologues.
2. To investigate expression levels of these genes in adult sheep tissues.
3. To determine whether an oocyte-specific form of DNMT1 exists in sheep
oocytes.
4. To determine expression patterns of DNMT1, DNMT3A and DNMT3B genes in
oocytes and preimplantation embryos.
5. To optimise techniques for DNA methylation analysis of specific sequences in
single oocytes and embryos, and quantify changes in methylation levels between
different stages of sheep preimplantation development.
6. To determine whether DNA methylation of specific sequences is equivalent in in
vivo produced, in vitro fertilised and SCNT embryos.
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8.2 Summary of key results
The sheep homologues of DNA methyltransferases DNMT1, DNMT3A and DNMT3B,
and the methyl-CpG-binding protein MBD2, were cloned fully or partially, using a
combination of RT-PCR, cDNA library screening, and 5' RACE methods. Analysis of
predicted protein sequences demonstrated high levels of conservation within and outwith
functional domains.
Attempts to identify an oocyte-specific form of DNMT1, known to exist in the mouse,
were unsuccessful. Instead, a form identical to that isolated from adult tissues was
detected in oocytes. These results imply there is little or no oocyte-specific form of
DNMT1 in sheep oocytes, which may be indicative of species-specific differences
during early epigenetic reprogramming events.
Analysis of DNMT1, DNMT3A, DNMT3B and MBD2 expression in adult tissues using
Taqman® RT-PCR, demonstrated similar patterns to those observed in the human, where
previously reported. Qualitative expression analysis of DNMT1 expression in sheep
oocytes and preimplantation embryos of various stages, suggested comparable
expression patterns to those observed in the mouse, with depletion of maternal stores
observed between the 1 -cell and blastocyst stages. Expression analysis of DNMT3A
demonstrated a reciprocal increase between these stages in the sheep but not the mouse,
and analysis of DNMT3B expression indicated similar patterns in sheep and mouse.
MBD2 was not found to be highly expressed in 2-cell or morula stage embryos.
A methyl-sensitive PCR method, optimised for use in single oocytes and embryos, was
employed to assay DNA methylation status of a sheep Satellite sequence, and a sheep
SINE element. Oocytes and sperm demonstrated similar Satellite I DNA methylation
status. No significant changes were detected in the Satellite sequence of in vivo derived
embryos between the 8-16 cell and blastocyst stages of development, contrasting with
the significant decrease in Satellite I DNA methylation levels observed in the mouse.
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However, comparisons between in vivo, in vitro fertilised (IVF) and SCNT blastocysts
demonstrated differences, with the IVF and SCNT embryos (both of which undergo
equivalent periods of in vitro culture) relatively undermethylated within Satellite I and
the OV-2 SINE element. In addition, SCNT blastocysts appeared to demonstrate
increased methylation levels relative to their IVF counterparts within the Satellite I
sequence, but not the OV-2 SINE element, suggesting sequence-specific reprogramming
errors.
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8.3 Key components of the DNA methylation repressor system in
sheep: an insight into functional conservation
By cloning complete or partial cDNA sequences encoding sheep homologues of DNA
methyltransferases and a methyl-CpG-binding protein, insights into the general levels of
conservation of the sheep DNA methylation machinery were obtained. Firstly, all
cDNA sequences cloned in sheep demonstrated high levels of homology with human
and mouse sequences, with sheep sequences consistently demonstrating more homology
with their human counterparts. This similarity reflects evolutionary events, as sheep
genomes are more closely related to the genomes of primates than those of rodents (Burt
et al., 1999). Conceptual translation of the sheep DNMT1 and DNMT3A cDNA
sequences demonstrated functional integrity of key motifs and domains (identified in
both human and mouse protein sequences) within predicted protein sequences. This
would further suggest conservation of the activities and functions of these DNA
methyltransferases within mammalian species. Unfortunately, only limited DNMT3B
cDNA sequence (51 bp) was obtained, therefore suggestions for the function or activity
of the encoded protein in sheep could not be made confidently.
The finding that identical forms of DNMT1 exist in sheep-derived somatic cells and
oocytes was of significant interest. Whether the apparent lack of an oocyte-specific
isoforms extends to humans, remains undetermined. As mentioned previously, the
genomes of primates are closely related to ruminants in evolutionary terms, and in this
respect, the human genome may lack oocyte-specific DNMT1 sequences. Indeed,
database searching of human chromosome 19 (the location of DNMT1) failed to identify
sequences sharing homology with mouse Dnmtl exonlo. However, this does not
completely disprove the existence of variant DNMT1 proteins in humans (or sheep), as
similarly truncated Dnmtl isoforms have been identified in rat brain, and these are
evidently produced using splicing strategies that do not require an alternative 1 st exon.
Investigations ofDNMT1 isoforms (RNA and protein) in other mammals are required to
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determine whether Dnmtl proteins lacking the N-terminal sequences of the somatic
form are restricted to rodent species.
To further characterise the components ofDNA methylation machinery cloned in sheep,
expression analysis of mRNA transcripts in adult tissues was performed. DNMT1 was
found to be ubiquitous in all tissues examined, with tissue-specific expression patterns
demonstrating similarity with those in the human where reported. DNMT3A was also
expressed ubiquitously in adult tissues, and DNMT3B was not detectable in any of the
adult sheep tissues analysed, but was found to be expressed in dl25 fetal tissues. Again,
these patterns are very similar to those reported in the human (Xie et al., 1999).
All three DNA methyltransferases were found to be expressed in dl25 fetal tissues (data
presented only for DNMT3B in this thesis), demonstrating a requirement in developing
fetuses. The significant downregulation of DNMT3B in adult sheep tissues relative to
dl25 fetal tissue clearly demonstrates an important role for this gene in fetal
development. Indeed, Dnmt3b is essential for normal development in the mouse, with
lethality occurring at mid-gestation in embryos carrying a targeted deletion of the gene
(Okano et al., 1999).
In the mouse, Dnmt3a is also downregulated in adult tissues relative to undifferentiated
cells (Okano et al., 1998a), but this is not observed in adult sheep (described in this
thesis) or human tissues (Xie et al., 1999), with ubiquitous expression comparable to
DNMT1 in both species. The differences observed imply important roles for DNMT3A
in both adult tissues and embryos of sheep and humans, but mice evidently only require
significant Dnmt3a expression in developing systems. This discrepancy may represent
alternative roles for DNMT3A in different mammalian species. As the specific
sequences targeted by DNMT3A are not yet clearly defined in either the mouse or
human, it is not possible to speculate how these roles may differ.
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MBD2 was shown to be expressed ubiquitously in adult sheep tissues, and mimicked
tissue-specific patterns of DNMT1 expression in all tissues except ovary. Expression
data for MBD2 is not available for adult human tissues, but MBD2 expression patterns
did not differ substantially from those observed in the mouse (Hendrich & Bird, 1998).
MBD2 was found to be expressed abundantly in all tissues, with levels significantly
higher than any of the DNA methyltransferases. This would suggest a significant role in
methylation-mediated transcriptional repression for this gene, although a certain extent
of functional redundancy for this protein has been demonstrated in the mouse (Hendrich
et al., 2001).
The similar tissue-specific patterns of MBD2 and DNMT1 lend further weight to the
recent observation of direct interaction between DNMT1 and MBD2 (Tatematsu et al.,
2001). A simple explanation of this observation would be that interaction between
DNMT1 and MBD2 provides a direct link between DNA methylation and immediate
transcriptional silencing in actively dividing cells, an idea reinforced by the previous
demonstration of the interaction of DNA methyltransferases with histone-deacetylase
silencing complexes (Fuks et al., 2000; Rountree et al., 2000).
The apparent high levels of conservation ofDNA methylation machinery components in
sheep, especially with the human, demonstrates the important nature of DNA
methylation in several distinct classes of mammalian species (primates, rodents and
ruminants). In addition, the tissue-specific expression patterns reported in this thesis,
and the conservation of functional domains within sheep DNMT and MBD2 sequences,
suggest the function and specific roles ofDNA methylation in adult sheep tissues would
be similar to known roles in other mammalian species. However, little is known about
the methylation status of genes or DNA sequences in sheep, aside from information
acquired in this thesis and a previous study of a differentially methylated region (DMR)
within the sheep IGF2R gene (Young et al., 2001). Studies of other imprinted and non-
imprinted gene promoter regions and their correlation with gene expression, will
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determine the extent of involvement ofDNA methylation in transcriptional repression in
sheep.
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8.4 Dynamics of DNA methylation in normal sheep preimplantation
development
Methylation analysis of a single CpG site in sheep Satellite I DNA between the 8-16 cell
and blastocyst stages of preimplantation development, demonstrated no significant
changes in DNA methylation levels. The DNA methylation status of this site was also
found to be similar in mature oocytes and sperm. Assuming no increases in DNA
methylation occurs between fertilisation and the 8-16 cell stage, and that the single site
is representative of the entire Satellite I DNA methylation status, this would suggest no
significant demethylation of Satellite I occurs between fertilisation and blastocyst
formation.
This finding contrasts with observations made in the mouse, where pericentromeric
heterochromatin (containing Satellite DNA) is known to remain highly methylated
until just prior to the blastocyst stage (Rougier et al., 1998). However, the DNA
methylation status of pericentromeric Satellite I DNA is not indicative of all DNA
sequences, coding or non-coding. Demethylation appears to takes place to different
extents, with some sequences demethylated rapidly after fertilisation, whilst others
remaining methylated throughout preimplantation development. In addition, differential
demethylation of the maternal and paternal genomes takes place shortly after fertilisation
(Mayer et al., 2000; Oswald et al., 2000).
The MS-PCR technique used in this study did not allow assessment of general genomic
methylation levels, only sequence-specific. Therefore, a clear picture of global
methylation changes and in particular, observations of any differential demethylation
events, was not permitable. However, parallel to this study, immunolocalisation
techniques using an antibody directed against m5C were employed to assess changes in
global methylation patterns in sheep preimplantation embryos (N. Beaujean, R.I.).
These experiments demonstrated that the global demethylation observed in mouse
embryos does not occur to the same extent in sheep, and furthermore, the genome
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appears to be de novo methylated after the 8-16 cell stage of development. Secondly,
the differential demethylation of paternal and maternal genomes observed post-
fertilisation in the mouse, rat, pig and cow (Mayer et al., 2000; Dean et al., 2001) does
not appear to occur in the sheep.
These findings are exceptionally interesting, and have major implications for theories
devised to explain the maternal and paternal differences in demethylation occurring
post-fertilisation. The rapid and active demethylation of the paternal genome is thought
to be required for the re-setting (or removal) of paternal methylation imprints, whereas,
the maternal genome retains DNA methylation levels, with maternal methylation
imprints remaining intact (Oswald et al., 2000). This theory is supported by the
observation that most maternally imprinted genes require DNA methylation to silence
paternal alleles, whereas paternally imprinted genes are often associated with anti-sense
transcripts to silence maternal alleles (Reik & Walter, 2001). The imprinting status of
several genes in sheep has been confirmed, including IGF2, IGF2R and H19 (McLaren
& Montgomery, 2000; Feil et al., 1998). So if sheep have imprinted genes, and
differential demethylation of paternal genomes is required for the correct re-setting of
paternal imprints, why is there no differential demethylation of paternal genomes in
post-fertilisation sheep embryos? In this respect, it is likely that sheep have evolved an
alternative developmental mechanism for correctly establishing imprints. During the
course of this study, it was noticed that sheep gametes shared similar methylation status
within Satellite I, and a comparably low methylation status was also observed in the OV-
2 SINE element in sperm DNA. This contrasts with the generally high methylation
status of DNA sequences in mouse sperm (Sanford et al., 1987; Howlett & Reik, 1991).
If the relatively low methylation status of Satellite I and OV-2 SINE are indicative of the
entire sperm genome, then this may explain why no paternal demethylation is required
post-fertilisation.
Analysis of DNA methyltransferases transcripts in sheep preimplantation embryos can
lend possible answers to the unusual observations made in sheep. Firstly, a significant
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finding in this thesis was that sheep express an identical form ofDNMT1 in both somatic
cells and oocytes. This contrasts with the mouse, where an 'oocyte-specific' truncated
form of Dnmtl (Dnmtlo) is found in oocytes and preimplantation embryos. In the
mouse, transcription and translation of this alternative Dnmtl isoform leads to unusual
localisation of the protein in the cytoplasm of oocytes and preimplantation embryos
(Carlsson et al., 1992; Cardoso & Leonhardt, 1998), and therefore does not interfere
with the processive demethylation of the embryonic genome. The presence of somatic
DNMT1 in sheep oocytes, if translated, could result in the nuclear localisation of
DNMT1 protein, thus maintaining methylation levels of both maternal and paternal
genomes, and explaining the lack of differential demethylation in sheep preimplantation
development. Further to this, DNMT1 transcripts were found to be abundant in sheep
oocytes, leading to the possibility of translation of significant amounts of somatic
DNMT1 protein, contributing further to the maintenance ofmethylation levels.
In the mouse, the 'oocyte-specific' Dnmtl protein enters the nucleus at the 8-cell stage
of development, where it maintains methylation imprints for one cell cycle, then returns
to the cytoplasm (Howell et al., 2001). This leads to an unusual pattern of imprinting,
with some cells retaining methylation imprints and others not. This presumably could
also lead to a general variation in the DNA methylation status between individual cells.
Differences in DNA methylation exist between the embryonic and extraembryonic
lineages (Chapman et al., 1984; Rossant et al., 1986) and it has been tentatively
suggested that the action of the oocyte-specific Dnmtl at the 8-cell stage (the stage prior
to compaction in the mouse) may contribute to the establishment of these differences
(Dean & Ferguson-Smith, 2001).
Again, why this elegant mechanism is potentially absent in sheep is perplexing. The
continual presence of DNMT1 transcripts in sheep preimplantation embryos has been
demonstrated in all stages from 2-cell embryos to blastocysts. If this correlates to the
presence of somatic protein, then DNMT1 would most likely be localised in the nucleus
throughout preimplantation development, albeit to varying extents. IfDNA methylation
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is required for marking inner cell mass and trophectoderm lineages, has the sheep
evolved an alternative mechanism of performing this? A process which may also be
inextricably linked to the differential methylation of the two cell lineages is X-
inactivation. In the mouse, X-inactivation requires DNA methylation in embryonic
(ICM derived) tissues, but not for the imprinted X-inactivation event occurring in
extraembryonic (trophectoderm-derived) tissues (Sado et al., 2000). In humans, random
X-inactivation occurs in both the fetus and trophectoderm, however, it is not known if
this is linked to the (unknown) methylation status of extraembryonic and embryonic
lineages in the human peri-implantation embryo. The methylating mechanisms in
human oocytes and preimplantation embryos also remain undetermined. In order to
determine whether regulation of DNMT1 activity is linked with lineage-specific
methylation in the sheep embryo, analysis of DNMT1 protein forms in sheep oocytes
and embryos must be made to confirm the apparent presence of somatic DNMT1.
In addition to DNMT1, the presence of de novo methyltransferase transcripts in sheep
oocytes and preimplantation embryos was also performed, in order to understand the
DNA methylation changes occurring at this time. Dnmt transcripts were also analysed
in mouse oocytes and preimplantation embryos, in order to define any significant
species-specific differences. As mentioned previously, an increase in methylation most
likely corresponding to de novo methylation was observed at the 8-16 cell stage in sheep
(N. Beaujean, unpublished data). This correlates with the early de novo methylation
observed in cow embryos (Dean et al., 2001), and contrasts with findings in the mouse,
where de novo methylation occurs post-implantation.
Analysis of DNMT3A transcripts in sheep oocytes and embryos demonstrated abundant
transcripts in oocytes, followed by an apparent decrease and culminating in an increase
at the morula/blastocyst stage. Analysis of Dnmt3a transcripts in the mouse
demonstrated a similar pattern, although no increase in transcripts was apparent at the
blastocyst stage. This is the first reported demonstration of de novo methyltransferase
expression in mammalian preimplantation development. These results may suggest a
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correlation between DNMT3A expression and the early onset of de novo methylation in
the sheep preimplantation embryo. Unfortunately, expression data for DNMT3B was not
conclusive in terms of such correlations, most likely due to experimental constraints.
The overall significance of the unusual methylation dynamics observed in the sheep is
unclear. However, the unexpected observed changes in DNA methylation are reinforced
by experimental evidence demonstrating species-specific DNA methyltransferase
regulation. The question of why sheep have evolved such different mechanisms in
relation to other mammalian species, including other closely related ruminants, remains
to be determined.
Finally, the general function of DNA methylation in mammalian preimplantation
development remains largely undetermined. It is likely that the differential methylation
of maternal and paternal genomes characterised in the mouse are associated with the
erasure and establishment of imprints. However, the involvement of DNA methylation
in global transcriptional repression during preimplantation development remains unclear.
Studies correlating expression and the methylation status of gene promoters in
preimplantation embryos have been largely inconclusive (Walsh & Bestor, 1999).
Furthermore, embryonic stem (ES) cells do not appear to require DNA methylation to
survive unless induced to differentiate (Li et al., 1992), and key components of the DNA
methylation repression system, including MeCPl, MeCP2 and MBD2 are barely
detectable in ES cells when compared to adult tissues (Meehan et al., 1992; Hendrich &
Bird, 1998). This would suggest DNA methylation is not extensively required for
transcriptional repression of stage-specific genes in mammalian preimplantation
embryos, but is required in subsequent stages as differentiation occurs. This contrasts
with findings in Xenopus, where direct correlations between DNA methylation and the
expression of stage-specific genes has been demonstrated (Stancheva et al., 2002).
Further work is clearly required to determine the precise requirements for DNA
methylation in mammalian preimplantation development.
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8.5 DNA methylation in cloned (SCNT) embryo development and the
effects of in vitro embryo culture
Methods established to analyse DNA methylation in single oocytes and preimplantation
embryos were also used to make comparisons between in vivo, IVF and SCNT-derived
embryos. Although unavoidable experimental constraints prevented the drawing of firm
conclusions, valuable information was obtained from these preliminary results.
To recap, it was demonstrated that sequence-specific reprogramming errors appeared to
occur in SCNT blastocysts when compared with their IVF-derived counterparts. This
manifested as increased levels ofmethylation in Satellite I sequence (heterochromatin),
but not the OV-2 SINE (euchromatin). Furthermore, these reprogramming errors would
appear to have occurred after the 8-16 cell stage of development, and thus may have
resulted from inappropriate genome activation, rather than incomplete erasure of somatic
methylation patterns. Also, comparisons of in v/vo-derived and IVF-produced embryos
appeared to show DNA methylation differences induced by in vitro embryo culture.
Several studies of reprogramming in large animal species have now been described, with
differing extents of reprogramming observed (Dean et al., 2001; Bourc'his et al., 2001;
Kang et al., 2001a; Kang et al., 2001b; Kang et al., 2002). In addition, there was
general disagreement on whether the active demethylation of DNA took place post-
fusion, with Dean et al. (2001) observing a partial demethylation immediately after
fusion, whilst the remaining studies failed to observe this. The reasons for this may lie
in the different methods used by the different groups. Firstly, each of the cow studies
used different cytological or molecular techniques to analyse DNA methylation patterns,
which may have resulted in the analysis of different DNA sequences in each study.
Also, there was no uniformity regarding the choice or treatment of donor cells used for
SCNT. Dean et al. (2001) used non-serum starved fetal fibroblasts whilst Kang et al.
(2001a; 2002) and the experiments described in this thesis were performed with serum-
starved fetal fibroblasts. In contrast, Bourc'his et al. (2001) used serum-starved adult
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skin fibroblasts. Finally, the numbers of embryos used for the cytological studies, were
very low and no statistical analysis of differences observed in methylation were
described. When taking into consideration these points, the overall picture of
methylation reprogramming in large animal clones is far from clear.
More specific reprogramming analysis in mouse SCNT embryos has been recently
described (Humpherys et al., 2001; Inoue et al., 2002). Both of these studies focused on
the expression of imprinted genes in both the fetus and placenta, as mis-expression of
these genes causes phenotypes similar to the fetal overgrowth and placental defects often
observed as a result of SCNT (reviewed in Young & Fairbum, 2000). The study by
Humpherys et al. (2001), described a range of imprinted gene expression anomalies in
clones produced from ES cells. However, abnormal expression patterns were also
observed in the ES clones from which donor nuclei were derived, leading to the
suggestion that intrinsic errors within the donor cell nuclei were more likely to cause
aberrant expression rather than inefficient reprogramming (Rideout et al., 2001).
Indeed, it has previously been shown that in vitro culture of ES cells can lead to aberrant
methylation and expression of imprinted genes (Dean et al., 1998).
The study described by Inoue et al. (2002) analysed imprinted gene expression in mice
cloned from somatic cells, demonstrating comparable expression of imprinted genes in
normal and cloned fetuses and no fetal overgrowth. Analysis of the unusually large
placenta of these cloned fetuses, however, demonstrated aberrant expression of specific
imprinted and non-imprinted genes, including Pegl/Mest, Igf2bp and Vegfr2. This
would suggest firstly, that imprints in somatic nuclei are more faithfully capitulated than
those in ES cells after nuclear transfer. Secondly, gene expression appears to be
dysregulated on a wide scale in the placenta of cloned mice, as opposed to the fetus. As
many genes involved in placental development will be tightly repressed in somatic
lineages, it is feasible that this repression is difficult to reverse after nuclear transfer,
resulting in maintained silencing of these important genes. The finding that methylation
patterns are abnormal in the trophectodermal cells of sheep NT blastocysts would
223
correlate with this hypothesis (Kang et al., 2002). The high incidence of placental
defects associated with clones of several mammalian species provides further support to
this theory (De Sousa et al., 2001; Humpherys et al., 2001; Hill et al., 2000). It would
clearly be of interest to differentiate the fetal abnormalities in cloned mammals caused
by placental defects, and those that occur independently.
The variations in aberrant gene expression of clones generated from ES cells or somatic
cells raises the question of cell reprogrammability. The apparent observation that
embryos cloned from ES-cells were more likely to develop abnormally than somatic
clones was surprising, as the undifferentiated, totipotent nature of ES cells should make
them easier to reprogram. However, as mentioned previously, these abnormalities are
thought to be attributed to epigenetic instability in ES cells, rather than reprogramming
errors. To date, studies of epigenetic reprogramming in large animals have analysed
clones generated using fetal or skin fibroblasts (Kang et al., 2001a; Bourc'his et al.,
2001; Dean et al., 2001; work described in this thesis). It is very possible that the
methylation reprogramming errors reported in these studies are not representative of all
cell types. For example, would a highly specialised heart cell be more difficult to
reprogram than a fetal fibroblast? Results described in this thesis found both Satellite I
and OV-2 SINE sequences to be more highly methylated in heart cells than fetal
fibroblasts. If this reflects the overall status of these cell types, are heart cells more
highly methylated and thus more difficult to reprogram than fibroblasts? The number of
different somatic cell types used to produce cloned animals to date is limited (refer to
Table 1.2) and generally reflects the use of less specialised cell types for SCNT. A
recent report described the cloning of mice from highly differentiated B- and T-cells
(Hochedlinger & Jaenisch, 2002). However, this required a modified process, with
isolation of ES cells from initially cloned blastocysts, and subsequent injection into a
tetraploid blastocyst to produce embryos. This, and the very low success rate (10 times
lower than when using fibroblasts or cumulus cells as donors) would suggest that
terminally differentiated cells are inherently difficult to reprogram.
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The studies of DNA methylation and gene expression patterns are only the tip of the
iceberg in terms of investigating aberrant reprogramming in clones. As well as the
oocyte failing to recognise and demethylate the chromatin of somatic nuclei, the donor
cell may also carry a host of proteins that could potentially interfere with normal
reprogramming mechanisms. For example, several components of the DNA methylation
repression system, including MeCPl and MeCP2 are barely detectable in ES cells
(Meehan et al., 1992; Hendrich & Bird, 1998) and work described in this thesis
demonstrated barely detectable levels ofMBD2 in the preimplantation embryo. As these
genes are expressed at relatively high levels in adult tissues, the SCNT process could
introduce large amounts of these proteins into the fused embryo. In addition to this,
aberrant expression of 'somatic'-specific genes could also occur within the fused SCNT
embryo, or be activated at an inappropriate stage of development. Considering the
observations made in SCNT-derived sheep embryos, where methylation levels increased
after the 8-16 cell stage relative to their 'normal' counterparts, premature activation of a
de novo methyltransferase gene may be responsible. Finally, it should be reiterated at
this point, that DNA methylation is not the only epigenetic modification likely to be
reprogrammed incorrectly. Studies of other modifications such as histone methylation
or changes in chromatin structure will give further insights to the global reprogramming
events in cloned embryos.
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A final note
Assumptions that the mouse is a representative model of mammalian epigenetic
reprogramming must now be faltering. Even though differential demethylation of
paternal and maternal genomes is conserved in most mammalian species examined
(Dean et al., 2001), it cannot be assumed that other epigenetic regulation mechanisms
are identical in all mammals. This is also highlighted by previous and continuing
attempts to clone various mammalian species, where species-specific epigenetic
differences may contribute to the ease of cloning. In light of this, any claims that one or
another species is a good model for epigenetic reprogramming in the human cannot be
regarded as accurate. The lessons learned from sheep should be taken into heed and
widespread studies of epigenetic reprogramming mechanisms should be initiated in a
diverse range of mammalian species.
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8.6 Future work
The work described in this thesis and parallel experiments using an antibody directed
against m5C (performed by N. Beaujean), have demonstrated unexpected methylation
changes in sheep preimplantation development. To further investigate this, techniques
such as bisulfite sequencing should be employed to gain more detailed sequence-specific
methylation data at different stages of development. As well as assessing the
methylation status ofmultiple CpG sites within Satellite I DNA sequences (to see if the
levels observed in this study are indicative of the entire sequence), the methylation status
of other repetitive sequences, or promoters of developmentally-regulated genes could be
analysed. Furthermore, the methylation status of differentially methylated regions of
imprinted genes could be analysed at different stages of development to see if they are
maintained, demethylated or de novo methylated at specific stages. Similar experiments
should also be performed using IVF or SCNT-derived preimplantation embryos,
allowing more detailed analysis of the sequence-specific reprogramming errors and in
vitro culture effects hinted at in this study.
The presence of somatic DNMT1 in mature sheep oocytes also presented a potentially
significant species-specific difference. It must be a high priority to ascertain whether
these transcripts are translated in the oocyte, corresponding to an abundant presence of
somatic DNMT1 protein in the early preimplantation embryo. Western blots should be
performed to analyse any protein variants present in adult tissues and
oocytes/preimplantation embryos. In addition, the localisation of DNMT1 protein in
oocytes and preimplantation embryos should be analysed by immunolocalisation
techniques to see if the presence of somatic DNMT1 correlates with nuclear localisation,
or whether the sheep has evolved an alternative form of DNMT1 regulation.
It would also be of great interest to see if the somatic DNMT1 is present in mature cow
oocytes. The differential demethylation ofpaternal and maternal genomes is observed in
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the cow; it would interesting to see if the methylation differences so far observed
between the cow and sheep extend to the regulation ofDNMT1.
To investigate the role of aberrant methylating activity in cloned embryo development,
techniques should be developed to assess DNMT transcript or protein levels in cloned
embryos. Quantitative RT-PCR would allow relative expression levels ofDNMTs to be
compared in normal and cloned embryos, whilst immunolocalisation studies would
allow determination ofwhether somatic nuclei introduce large quantities of DNMTs into
the embryo, or whether the genes are inappropriately expressed from the cloned embryo
genome.
Finally, the comparison of in vivo derived, in vitro fertilised and SCNT-derived embryos
was limited by experimental constraints. As well as effects of in vitro culture, the
oocytes used in these methods may differ considerably in terms of developmental
capacity depending on the source (superovulation, in vivo maturation, in vitro
maturation) and the stage of follicle the oocyte was derived from. Transcript levels of
DNA methyltransferases and associated proteins could be analysed (using RT-PCR) in
oocytes derived from different sources, to see if levels differ substantially. Also, as
imprints are known to be established in growing and maturing oocytes, the methylation
status of key imprinted genes should be analysed in oocytes derived from different
sources to see if this may also contribute to poor developmental capacity.
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Sheep DNMT1 cDNA sequence. Length: 5233 bp
1 GGCGAAAAGC CAGGGCTGCC TGTGCTGCTG CCGCCTCTGC TGCACCTTCC
51 AAGATGCCTG CCCGTACCGC CCCGGCGCGG GTGCCTGCGC TGGCCTCCCG
101 GGCCTTCTCA CTGCCTGACG ATGTCCGCAG GCGGCTCAAA GATTTGGAAA
151 GAGATAGTTT GACAGAAAAG GAATGTGTGA AGGAGAAACT GAATCTCTTG
201 CACGAATTTC TGCAGACAGA AATAAAGAAT CAGTTATGTG ATTTGGAAAC
251 CAAACTACAT AAAGAGGAAT TATCTGAGGA GGGCTACCTG GCTAAAGTCA
301 AATCCCTTTT AAATAAAGAT TTGTCCTTGG AGAACGGAGC TCATGCTTTC
351 AGTCGGGAAG CGAATGGATG TCTAGAGAAC GGGAGCCAGA CAAGTGGTGA
401 GGATTGCAGA GTGGTAATGG CAGAGAAAGG CAAGCCCCCC AAACCTGTCT
451 CCAGACTTTA CACGCCCAGG AGAAGCAAGT CTGATGGAGA AACAAAGTCT
501 GAAGTCTCTT CTAGCCCCAG GATTACAAGG CAGACTACCA GGCAGACCAC
551 CATCACATCT TATTTTGCAC AGGGCCCTGC CAAACGAAAA CCCGAGGAAG
601 AACCTGAAAA AGTGAAGTCA GACGATTCTG TTGATGAAGA AAAAGACCAG
651 GAGGAAAAGA GACGTCGAGT TACATCCAGA GAACGAGTTG CTGGGCTGCT
701 CCCTGCAGAA GAACCAGGAA GAGTAAGACC AGGAACACAC ATGGAAGAAG
751 AAGGAAGAGA TGATAAAGAA GAAAAGAGAC TCAGAAGTCA AACCAAAGAA
801 CCGACACCTA AACAGAAAGC TAAGGAGGAG CCAGACAGAG ATGCGAGGCC
851 TGGAGGAGCT CAGGCTGAAA TGAATGAAGG AGAAGACAAA GATGAAAAGA
901 GGCACAGAAG TCAACCCAAA GATCTAGCTA GCAAGCGGAG ACCAGAAGAG
951 AAAGAGCCTG AAAGAGCAAA ACCACAAGTC TCTGATGAGA AAGATGAAGA
1001 TGAAAAGGAG GAGAAGAGAC GCAGAACTAC ATACAGAGAA CTAACTGAGA
1051 AGAAAATGAC TCGAACCAAA ATAGCAGTGG TGTCCAAGAC CGATCCTCCG
1101 AAGTGCACCG AGTGCTTGCA GTACCTGGAC GACCCCGAGC TGAGATACGA
1151 GCAACACCCC CCTGATGCGG TGGAAGAGAT ACAGATACTG ACCAACGAGA
1201 GGTTGTCCAT CTTCGACGCT AACGAATCTG GCTTTGAGAG TTATGAGGAT
1251 TTGCCCCAAC ACAAACTAAC CTGCTTCAGC GTGTACTGTA AACGCGGCCA
























































































































































































































































































































































































































































































Pairwise alignment of sheep and human (Accession No. NM001379) DNMT1
cDNA sequences (generated using Gap; GCG10)
Sheep 1 GGCGAAAAGCCAGGGCTG 18
1111111111 Mil




11! 1111 II MINIM I INN II Mil MM Mill
251 CCGCCCCAGCCCGGGTGCCCACACTGGCCGTCCCGGCCATCTCGCTGCCC 300
117 GACGATGTCCGCAGGCGGCTCAAAGATTTGGAAAGAGATAGTTTGACAGA 166
I I I II I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II Mill
301 GACGATGTCCGCAGGCGGCTCAAAGATTTGGAAAGAGACAGCTTAACAGA 350
167 AAAGGAATGTGTGAAGGAGAAACTGAATCTCTTGCACGAATTTCTGCAGA 216





I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
451 GAATTATCCGAGGAGGGCTACCTGGCTAAAGTCAAATCCCTTTTAAATAA 500
317 AGATTTGTCCTTGGAGAACGGAGCTCATGCTTTCAGTCGGGAAGCGAATG 366
111111111111111111111 11 11111111 II 111111 I Mill
501 AGATTTGTCCTTGGAGAACGGTGCTCATGCTTACAACCGGGAAGTGAATG 550
367 GATGTCTAGAGAACGGGAGCCAGACAAGTGGTGAGGATTGCAGAGTGGTA 416
II 1111111 III11II III MM MM I I 1111111 I
551 GACGTCTAGAAAACGGGAACCAAGCAAGAAGTGAAGCCCGTAGAGTGGGA 600
417 ATGGCAGAGAAAGGCAAGCCCCCCAAACCTGTCTCCAGACTTTACACGCC 466
11111111 II 11111111111 I MM II I Mill
601 ATGGCAGATGCCAACAGCCCCCCCAAACCCCTTTCCAAACCTCGCACGCC 650
467 CAGGAGAAGCAAGTCTGATGGAGAAACAAAGTCTGAAGTCTCTTCTAGCC 516
llllll I I I I I I I I I I I I I I I I I III Mill II IMIII
651 CAGGAGGAGCAAGTCCGATGGAGAGGCTAAGCCTGAACCTTCACCTAGCC 700
517 CCAGGATTACAAGGCAGACTACCAGGCAGACCACCATCACATCTTATTTT 566
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I Mill
701 CCAGGATTACAAGGAAAAGCACCAGGCAAACCACCATCACATCTCATTTT 750
567 GCACAGGGCCCTGCCAAACGAAAACCCGAGGAAGAACCTGAAAAAGTGAA 616














III III Mill II 111IIIII Mil MINIMI
1051 GCTGACGAGGACGAAGATGGAGACGAGAAAGATGAGAAGAAGCACAGAAG 1100
911 TCAACCCAAAGATCTAGCTAGCAAGCGGAGACCAGAAGAGAAAGAGCCTG 960





11II11II11111 III II II Mill Ml Mill III111 I
12 01 GAGAAGAGACGCAAAACGACCCCCAAAGAACCAACGGAGAAAAAAATGGC 12 50
1061 TCGAACCAAAATAGCAGTGGTGTCCAAGACCGATCCTCCGAAGTGCACCG 1110
III Mill! I! II III111111 I Mill 111II11
1251 TCGCGCCAAAACAGTCATGAACTCCAAGACCCACCCTCCCAAGTGCATTC 1300
1111 AGTGCTTGCAGTACCTGGACGACCCCGAGCTGAGATACGAGCAACACCCC 1160
Mill 11111111IIII111111 II II I Ml I III Mill
1301 AGTGCGGGCAGTACCTGGACGACCCTGACCTCAAATATGGGCAGCACCCA 1350
1161 CCTGATGCGGTGGAAGAGATACAGATACTGACCAACGAGAGGTTGTCCAT 1210
ii ii 11ii1111 mi linn mil ii mm i iii1111
1351 CCAGACGCGGTGGATGAGCCACAGATGCTGACAAATGAGAAGCTGTCCAT 1400
1211 CTTCGACGCTAACGAATCTGGCTTTGAGAGTTATGAGGATTTGCCCCAAC 1260
II! II II Mill 1111111111II1111II11II I IMII I
1401 CTTTGATGCCAACGAGTCTGGCTTTGAGAGTTATGAGGCGCTTCCCCAGC 1450
1261 ACAAACTAACCTGCTTCAGCGTGTACTGTAAACGCGGCCACCTTTGCCCG 1310













15 61 AGATCTACATAAGTAAGATAGTGGTTGAGTTCCTGCAGAGCAACCCTGAC 1610
MINIUM II Mill Mill IIIIIIIIIIII111II I III






MM I I I I I I I I I I I II I I I I I II I I I I III I I I I I I I II I I
1901 AGTTTGTGGTGGAGCAGGTGGAGAGTTATGACGAGGCCGGGGACAGTGAT 1950
1761 GAGCAGCCCATCTTCCTGAGCCCCTGCATGAGAGACCTCATCAAGCTGGC 1810
1111111II111111II11 111111111 I Mill 11111111111
1951 GAGCAGCCCATCTTCCTGACGCCCTGCATGCGGGACCTGATCAAGCTGGC 2000
1811 CGGGGTCACCCTGGGAAAAAGGCGAGCC...GAAAAGCGGCAGACCATCC 1857
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II
2001 TGGGGTCACGCTGGGACAGAGGCGAGCCCAGGCGAGGCGGCAGACCATCA 2050
1858 GGCAACCCGCCAAGGAGAAGGACAAGGGCCCCACCAAGGCCACCACCACC 1907
MM I III IIIIIIIIIII III Mill II 11II11111111
2051 GGCATTCTACCAGGGAGAAGGACAGGGGACCCACGAAAGCCACCACCACC 2100
1908 AAGCTGGTCTACCAGATCTTCGACACTTTCTTTGCGGACAAATTGAGGAA 1957
I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I II II II I II
2101 AAGCTGGTCTACCAGATCTTCGATACTTTCTTCGCAGAGCAAATTGAAAA 2150
1958 GGTTGCCAGGGAGGCCAGGGGGATTGCTTTCAGGGGCGGGGGTTGTGGCG 2007












Mill IMII II I I II II II I I II I I I I I I I I I I I II II IMII
2401 AAGAAGAAGAAACAGAACAAGAATCGCATCTCTTGGGTCGGAGAAGCCGT 2450
2258 CAAGACTGACGGGAAGAAGAGTTACTACAAGAAGGTATGCATTGACTCGG 2307
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I III
2451 CAAGACTGATGGGAAGAAGAGTTACTATAAGAAGGTGTGCATTGATGCGG 2500
2308 AAACCCTGGAAGTGGGGGACTGTGTTTCTGTAATTCCAGACGACTCTTCA 2357
I I I I I I I I I I I I I I I I I I I I I I I I I IMII I I I I I I I I II II III
2501 AAACCCTGGAAGTGGGGGACTGTGTCTCTGTTATTCCAGATGATTCCTCA 2550
2358 AAACCACTGTATCTAGCAAGGGTCACGGCGCTGTGGGAGGACAGCAGCAA 2407
IMII 111111IIII1111 111111 111III 11111 III111111 1111
2551 AAACCGCTGTATCTAGCAAGGGTCACGGCGCTGTGGGAGGACAGCAGCAA 2600
2408 TGGGCAGATGTTCCACGCCCACTGGTTCTGTGCTGGGACGGACACGGTCC 2457
11111111111 11111111111111111 11111111 Mill MM
2601 CGGGCAGATGTTTCACGCCCACTGGTTCTGCGCTGGGACAGACACAGTCC 2650
2458 TCGGGGCCACTTCGGACCCCCTGGAGCTATTCCTGGTTGACGAATGTGAG 2507
III1111111 11111111 11111111 III MM II 1111111II
2651 TCGGGGCCACGTCGGACCCTCTGGAGCTGTTCTTGGTGGATGAATGTGAG 2700
2508 GATATGCAGCTCTCGTACATCCACAGCAAGGTGCAGGTCATCTATAAGGC 2557





II I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II III
2801 TGGAGGGGGACGACGGGAAGACCTACTTCTACCAGCTGTGGTATGATCAA 2850
2658 GACTACGCGAGATTTGAGTCCCCTCCGAAAACTCAGCCAACAGAGGACAA 2707














































I I I I I I I I I II I I I I I I I II II I I I I I I I I I I I I I I I I I I I
TGAGCCCTACCGAATTGGCCGGATCAAAGAGATCTTCTGTCCCAAGAAGA 3250
GCAACGGCCGGCCCAATGAGACAGACATCAAGATCAGGGTCAACAAGTTC 3107
I I I I I I I I I I I I I I I I I I I II I I I I I I I I III I I I I I I I I I I I I I I
GCAACGGCAGGCCCAATGAGACTGACATCAAAATCCGGGTCAACAAGTTC 3300
TACAGGCCGGAGAACACACACAAGTCTACCCCAGCCAGTTACCATGCAGA 3157
I II I II II I I II I I I I I I I I I I I I II II II I II I I II I I I II I
TACAGGCCTGAGAACACCCACAAGTCCACTCCAGCGAGCTACCACGCAGA 3350
CATCAACCTGCTCTACTGGAGCGATGAGGAGGCCGTGGTGGACTTCAAGG 3207
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I
CATCAACCTGCTCTACTGGAGCGACGAGGAGGCCGTGGTGGACTTCAAGG 3400
CTGTGCAGGGCCGCTGCACCGTGGAGTACGGAGAGGACCTGCCTGAGTGC 3257
I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II I I I I I I I I I I I I I I I
CTGTGCAGGGCCGCTGCACCGTGGAGTATGGGGAGGACCTGCCCGAGTGC 3450
CTCCAGGACTTCTCTGCTGGTGGCCCCGATCGCTTCTACTTTCTCGAGGC 3307
I I I I II I III II I I I I I I I I I I I I I I I I I I I I I I I I I I
GTCCAGGTGTACTCCATGGGCGGCCCCAACCGCTTCTACTTCCTCGAGGC 3500
CTATAACGCCAAGAGCAAAAGCTTTGAAGATCCTCCGAACCACGCCCGGA 3357






















I I I I I I I I I I I I I I I I I Mill I I II II I I I I I I I I I I I I I I I I I I
3951 CACCTACTCCAAGTTCAAAAACTCTCTGGTGGTTTCCTTCCTCAGCTACT 4000
3808 GTGACTACTACCGGCCCCGCTACTTCCTCTTGGAGAACGTTCGAAACTTC 3857
I 1111111111111111 I I 1111111 II1111 I II I Mill
4001 GCGACTACTACCGGCCCCGGTTCTTCCTCCTGGAGAATGTCAGGAACTTT 4050
3858 GTCTCCTTCAAGCGCTCCATGGTCCTGAAGCTGACGCTGCGCTGCCTGGT 3907
I I I I I I I I I I I I I II I I I I I II I I I II I II II II II I I I I I I I II I I
4051 GTCTCCTTCAAGCGCTCCATGGTCCTGAAGCTCACCCTCCGCTGCCTGGT 4100
3908 CCGCATGGGCTACCAGTGCACCTTCGGCGTGCTGCAGGCTGGTCAGTACG 3957
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I
4101 CCGCATGGGCTATCAGTGCACCTTCGGCGTGCTGCAGGCCGGTCAGTACG 4150
3958 GCGTGGCCCAGACTCGGAGGCGAGCCATCATCCTGGCTGCAGCCCCTGGG 4007
I I I I II I I I II I I I I I I I I I I I II I I I II I I I I I I I! I I I I I I I I
4151 GCGTGGCCCAGACTAGGAGGCGGGCCATCATCCTGGCCGCGGCCCCTGGA 4200
4008 GAGCCACTCCCTCTGTTCCCCGAGCCGTTGCACGTGTTCGCGCCCCGGGC 4057
III 111111111II111 Mill 1111111111 II 11111111
4201 GAGAAGCTCCCTCTGTTCCCGGAGCCACTGCACGTGTTTGCTCCCCGGGC 4250
40 5 8 CTGCCAGCTGAGCGTCGTGGTGGACGACAAGAAGTTTGTCAGCAACATCA 4107
4251 CTGCCAGCTGAGCGTGGTGGTGGATGACAAGAAGTTTGTGAGCAACATAA 4300
4108 CCAGGTTGAGCTCAGGTCCCTTCCGAACCATCACCGTGCGGGACACCATG 4157
I I I I I I I I I I I II Mill Mill I I I I I I I I Mill Mill III
4301 CCAGGTTGAGCTCGGGTCCTTTCCGGACCATCACGGTGCGAGACACGATG 4350
4158 TCCGACCTCCCCGAGATCCGGAATGGGGCCTCGGCACTGGAGATCTCATA 4207











lllllll I I Mil MM 1111111III 111IIIII I II III
4601 TGCGGTATACCCACCATGACAGGAAGAACGGCCGCAGCAGCTCTGGGGCC 4650
4458 CTCCGCGGGGTCTGCTCCTGTGTGGAA...GGCAAGCCCTGTGAGCCTGC 4504





II I I I I I I I I I I I I I I I I I I I I I I II I II I II I I I I I I I I I I I I
4751 ACCGGCACAACCACTGGGCTGGCCTCTATGGAAGGCTCGAGTGGGACGGC 4800
4605 TTCTTCAGCACAACTGTCACCAACCCTGAGCCCATGGGTAAGCAGGGCCG 4654
I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I
4801 TTCTTCAGCACAACCGTCACCAACCCCGAGCCCATGGGCAAGCAGGGCCG 4850
4655 CGTGCTCCACCCCGAGCAGCACCGAGTGGTGAGCGTGCGGGAGTGTGCCC 4704
I I I I I I I I II M I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I
4851 CGTGCTCCACCCAGAGCAGCACCGTGTGGTGAGCGTGCGGGAGTGTGCCC 4900
4705 GCTCCCAGGGCTTCCCTGACACCTATCGGCTGTTCGGCAACATCCTGGAC 4754
II I I I I I I I II I I I I I I I I I II I I I Mill I I I I I I I I I II I I I I I I I
4901 GCTCCCAGGGCTTCCCTGACACCTACCGGCTCTTCGGCAACATCCTGGAC 4950
4755 AAGCACCGGCAGGTGGGTAATGCTGTGCCGCCACCACTGGCCAAAGCCAT 4804


















5151 TTAAGACTTTATGTAGTTTTTATATGTTGTAATATTTCTTCAAATAAATC 52 00
11111111111111111111!1111111111II11111111111111111
5346 TTAAGACTTTATGTAGTTTTTATATGTTGTAATATTTCTTCAAATAAATC 5395
52 01 TCTCCTATAAATCAAAAAAAAAAAAAAAAAAAA 523 3
5396 TCTCCTATAAACCAAAAAAAAAAAAAAAAAAAAAAAAAA 5434
257
Pairwise alignment of Sheep and mouse (Accession No. X14805) DNMT1
cDNA sequences generated using Gap (GCG10)
Sheep 1 GGCGAAAAGCCAGGGCTGCCTGTG 2 4




I! II I I I I I I I I I II I I I I I I I III III II II III Mil
101 GCCCGAGTGCCTGCGCTTGCCTCCCCGGCAGGCTCGCTCCCGGACCATGT 150
125 CCGCAGGCGGCTCAAAGATTTGGAAAGAGATAGTTTGACAGAAAAGGAAT 174
II I I I I I II I I I I I I I I I I I I I I I I I I I II I II llllllllll! I
151 CCGCAGGCGGCTCAAAGACTTGGAAAGAGATGGCTTAACAGAAAAGGAGT 200
175 GTGTGAAGGAGAAACTGAATCTCTTGCACGAATTTCTGCAGACAGAAATA 224
MINI MINI I II I INI Mill INN MINIM
201 GTGTGAGGGAGAAATTAAACTTACTGCATGAATTCCTGCAAACAGAAATA 250
225 AAGAATCAGTTATGTGATTTGGAAACCAAACTACATAAAGAGGAATTATC 27 4
II I Mill Mill IIIII11111II lllllllllllllllllll
251 AAAAGCCAGTTGTGTGACTTGGAAACCAAATTACATAAAGAGGAATTATC 300
275 TGAGGAGGGCTACCTGGCTAAAGTCAAATCCCTTTTAAATAAAGATTTGT 324
mm ii111111111111111111 mil iiiiim Mm
301 TGAGGAAGGCTACCTGGCTAAAGTCAAGTCCCTCTTAAATAAGGATTTGT 350
325 CCTTGGAGAACGGAGCTCATGCTTTCAGTCGGGAAGCGAATGGATGTCTA 374
III11111 1111 I I I II II III II MM II II MM
351 CCTTGGAGAACGGAACACACACTCTCACTCAAAAAGCCAACGGTTGTCCC 400
375 GAGAACGGGAGCCAGACAAGTGGTGAGGATTGCAGAGTGGTAATGGCAGA 424
I 111II111 I I I III II MM I 111111 111




II11111 II I II II I MM II MM II I I
492 GCAAGTCGGACAGTGACACCCTTTTTGAAACTTCACCTAGTTCCGTGGCT 541
525 ACAAGGCAGACTACCAGGCAGACCACCATCACATCTTATTTTGCACAGGG 574
ii iii ii 1111111111111ii11111 ii i ii i MM
542 ACGAGGAGAACCACCAGGCAGACCACCATCACGGCTCACTTCACGAAGGG 591
575 CCCTGCCAAACGAAAACCCGAGGAAGAACCTGAAAAAGTGAAGTCAGACG 624











































I II III II II III II I III II II I
GGACGAGGACGGAAAAAAGGATAAAAGAAGTTCCAGACCCAGGAGCCAGC 935
CCAAAGATCTAGCTAGCAAGCGGAGACCAGAAGAGAAAGAGCCTGAAAGA 965
III Mill MM III IIMIIII III III
CCAGAGATCCAGCTGCCAAACGGAGACCCAAGGAAGTCAGAGCCAGAGCA 985
GCAAAACCACAAGTCTCTGATGAGAAAGATGAAGATGAAAAGGAGGAGAA 1015





I I MM III III II Mill III I I
AGAGCAGATCGGAGAGAAAAGCCGCTCAAAGCAAAA...GTGTGATCCCG 1132
AAGACCGATCCTCCGAAGTGCACCGAGTGCTTGCAGTACCTGGACGACCC 1135





I Mill MM 111111111 MM I II I I III
TGTTGACCAGTGAGAAACTGTCCATCTACGACTCCACCTCGACCTGGTTT 1282
GAGAGTTATGAGGATTTGCCCCAACACAAACTAACCTGCTTCAGCGTGTA 12 85
II I Mill MM III III I II I Mill Mill
GATACTTATGAAGATTCTCCCATGCATAGGTTCACTTCCTTCAGTGTGTA 1332
CTGTAAACGCGGCCACCTTTGCCCGATCGACACCGGCCTCATTGAGAAAG 1335










153 3 CCACTGCATTTGCTGAATACATTTTGATGGAGCCCAGCAAAGAGTATGAG 15 82
1536 CCACTATTCAGCGTGATGCAGGAGAAGATCTACATAAGTAAGATAGTGGT 1585
II! Mil I MINIMUM II Mill II Mill II II
1583 CCAATATTTGGGCTGATGCAGGAGAAAATTTACATCAGCAAGATTGTTGT 1632
1586 TGAGTTCCTGCAGAGCAACCCTGACTCCACCTACGAAGACCTGATCAATA 1635
I I I I I I I I I I I I I II! IMII I II I I I I I I I I I I I I I I I I
1633 TGAGTTCCTGCAAAACAATCCTGATGCTGTATATGAAGACCTGATCAATA 16 82
1636 AGATTGAGACCACTGTTCCTCCTTGTATGCTCAACTTGAATCGATTCACA 1685
11111II11111111111 1111II I! I II MM II 111III
1683 AGATTGAGACCACTGTTCCTCCTTCTACCATTAATGTGAACCGGTTCACA 1732
1686 GAGGATTCTCTCCTGCGGCATGCCCAGTTCGTGGTGGAGCAAGTAGAGAG 1735
Mill II III I II II 111IIIII I! III I! 11111111
1733 GAGGACTCCCTCTTACGCCACGCCCAGTTTGTAGTGAGCCAGGTAGAGAG 1782
1736 TTATGATCGGGCTGGGGACAGTGACGAGCAGCCCATCTTCCTGAGCCCCT 1785





II II III I II I I I I I I I I I I II I II I I I I


















llll III Mil I I I Mil II! I III I I MINI
2277 TCTCCTGGCTTGGGCAGCCTATGAAGATTGAAGAGAATAGAACTTACTAT 2326
2286 AAGAAGGTATGCATTGACTCGGAAACCCTGGAAGTGGGGGACTGTGTTTC 2335










II II I I I I I III II II I I I I I I II I II I I I I I I I I I I I I I
2527 GTTCCTGGTGGGCGAGTGCGAAAACATGCAGCTTTCCTACATCCACAGCA 2576
2536 AGGTGCAGGTCATCTATAAGGCCCCCTCGGAGAACTGGGCCTTGGAGGGA 2585





Mill Mill Mill MM II Mill II Mill Mill I
2677 CTTCTTCCAGCTCTGGTACAACCAGGAGTACGCAAGGTTTGAATCCCCAC 2726
2683 CGAAAACTCAGCCAACAGAGGACAACAAGTACAAGTTCTGTGTGAGCTGT 2732
I II I! Mill I! II11IIIIIIII 1111111III I III
2727 CCAAGACCCAGCCGACCGAGGACAACAAGCACAAGTTCTGCCTATCTTGT 2776
2733 GCACGTCTGGCCGAAATGAGGCAGAAGGAAATCCCCAGGGTCATGGAGCA 2782












llllllllll II MINIUM! II I I I I I I I I II I II II
3027 ACATCAAGGGGAGAAACCTGGATGCTCCAGAGCCCTATCGCATCGGTCGG 3076
3030 ATAAAGGAGATCTTCTGCAGCAAGAAGAGCAACGGCCGGCCCAATGAGAC 3079
Mill MINI III 11111111 I! III I II III I
3077 ATAAAAGAGATCCACTGTGGCAAGAAG...AAAGGCAAGGTGAACGAGGC 3123
3080 AGACATCAAGATCAGGGTCAACAAGTTCTACAGGCCGGAGAACACACACA 3129
1111111111 I III II 1111111111111111 Mill II MM
3124 AGACATCAAGCTGAGGCTCTACAAGTTCTACAGGCCTGAGAATACCCACA 3173
3130 AGTCTACCCCAGCCAGTTACCATGCAGACATCAACCTGCTCTACTGGAGC 3179











111111111111 II I I III III! II Mill I I
3424 GAAGGGGAAAGGGAAGGGGAAGGGGAAGCATCAGGTGTCAGAGCCCAAAG 3473
3430 AACTGGAGACAGAAATCAAACTGCCAAAGCTGCGGACCCTGGACGTGTTT 3479
I I III III 111 11111111 Mill 1111111 1111 Mill
3474 AGCCTGAGGCAGCCATCAAACTGCCCAAGCTCCGGACCCTGGATGTGTTT 3523
3480 TCCGGCTGTGGGGGACTGTCAGAAGGCTTCCACCAAGCAGGCATCTCGGA 3529












I I I I I I I I I I I I I I I I I I I I I I I ! I II II I I I I I I I II I I I I I III
3774 TCAGTGGCATGAACCGCTTCAACTCCCGCACTTACTCCAAGTTCAAAAAC 3823
3780 TCCCTGGTGGTCTCCTTCCTCAGCTACTGTGACTACTACCGGCCCCGCTA 3829
IMII III11II111111111111II11111111111II1111 II I
3824 TCCCTAGTGGTCTCCTTCCTCAGCTACTGTGACTACTACCGGCCTCGGTT 3873
3830 CTTCCTCTTGGAGAACGTTCGAAACTTCGTCTCCTTCAAGCGCTCCATGG 3879
MINI MINIUM I III11111 MM II 1111111111
3874 CTTCCTTCTGGAGAACGTCAGGAACTTCGTGTCCTACAGACGCTCCATGG 3923
3880 TCCTGAAGCTGACGCTGCGCTGCCTGGTCCGCATGGGCTACCAGTGCACC 3929
I I I II I I II II I I I I II I I I I II I I II I I I I I I I I I I I I II I I I I I I
3924 TGCTGAAGCTCACACTGCGCTGCCTGGTCCGCATGGGCTACCAGTGCACC 3973
3930 TTCGGCGTGCTGCAGGCTGGTCAGTACGGCGTGGCCCAGACTCGGAGGCG 3979
II II Mill IIIIIIII Mill 111 11 IIII I 111 I II III I
3974 TTTGGTGTGCTCCAGGCTGGACAGTATGGCGTGGCCCAGACACGAAGGAG 4023
3980 AGCCATCATCCTGGCTGCAGCCCCTGGGGAGCCACTCCCTCTGTTCCCCG 4029
I I I I I I I I I I I I I I I I I I I I I I II II II I I I I II I I I I I I
4024 GGCCATCATCTTGGCTGCAGCCCCAGGAGAAAAGCTGCCTCTGTTCCCAG 4073
4030 AGCCGTTGCACGTGTTCGCGCCCCGGGCCTGCCAGCTGAGCGTCGTGGTG 4079
MM MM Mill 11IIIIII 11II1111II1111111 llllll
4074 AGCCTCTGCATGTGTTTGCGCCCCGTGCCTGCCAGCTGAGCGTTGTGGTG 4123
4080 GACGACAAGAAGTTTGTCAGCAACATCACCAGGTTGAGCTCAGGTCCCTT 4129
II II1111111111II III11III II III 1111111 II Mill
4124 GATGACAAGAAGTTTGTTAGCAACATAACGAGGCTGAGCTCGGGGCCCTT 4173
4130 CCGAACCATCACCGTGCGGGACACCATGTCCGACCTCCCCGAGATCCGGA 4179
















! 11111111 Mil II Mil I II I II Mil MINI II
4524 CAGAAGGCAAGGCCTGCGACCCTGAGTCCAGGCAATTCAGCACCCTCATC 4573
4530 CCCTGGTGCCTGCCCCACACTGGGAACAGGCACAACCACTGGGCTGGCCT 4579
111 1111111111 I 111 11 111 III I NMIMI MIMllMi Mil
4574 CCCTGGTGCCTGCCGCACACTGGGAACCGGCACAACCACTGGGCTGGCCT 4623
4580 CTACGGGCGTCTTGAGTGGGACGGCTTCTTCAGCACAACTGTCACCAACC 4629
I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I I I I I
4624 CTACGGGCGTCTGGAGTGGGATGGCTTCTTCAGCACCACTGTCACCAACC 4673
4630 CTGAGCCCATGGGTAAGCAGGGCCGCGTGCTCCACCCCGAGCAGCACCGA 4679
11111II111111 MINIM II 1111111II11 11111111III
4674 CTGAGCCCATGGGCAAGCAGGGTCGGGTGCTCCACCCGGAGCAGCACCGG 4723
4680 GTGGTGAGCGTGCGGGAGTGTGCCCGCTCCCAGGGCTTCCCTGACACCTA 4729
II Mill II IMII 11111111111IIII111II II II I III
4724 GTCGTGAGTGTTCGGGAATGTGCCCGCTCCCAGGGCTTTCCAGATAGCTA 4773
4730 TCGGCTGTTCGGCAACATCCTGGACAAGCACCGGCAGGTGGGTAATGCTG 4779
III I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II
47 74 CCGGTTCTTCGGCAACATCCTGGACAGACACCGGCAGGTGGGTAATGCTG 4823
4780 TGCCGCCACCACTGGCCAAAGCCATCGGCTTGGAGATCAAGCGCTGCATG 4829
MM Mill II111111111111 III 1111111 MM MM II
4824 TGCCACCACCCCTGGCCAAAGCCATTGGCCTGGAGATTAAGCTCTGCCTG 4873
4830 TTGGCCAAAGCGCGTGAGAGCACCTCAGCTAAAATCA AGGA 4870
ii mi ii m linn i mm i i i mm
4874 CTGTCCAGTGCTCGGGAGAGCGCATCAGCTGCAGTTAAAGCAAAAGAGGA 4923
4871 GGAGGCTGCCAAGGACTAGCTCTCTCCTCCTATCACCCATGTTTCTGCCA 4920
II III I I I I I I I I I I I Mill II MM II
4924 GGCTGCTACCAAGGACTAGTGCTCTCACCCAGAGCCCCACGTGCACTGAT 4973
4921 CCAGAGATCCCCAGCGTGCACTGATATTGTTGTATTTTCACATGTCAATC 4970
I III II III II III III
4974 GTTTTTAACCCTTTGAGCCCCATCATTTGAAGTCTTGTGCTCAGTGTCTG 5023
4971 AGTCAGTTCAGGTGTGTCGTATGCGGTGTTTGTGGCCTTGGCTGACATGA 5020
5024 TGGCCATGGCTGACACTAAGCTG . TTTGTATGAGGTTTGTTTTGTGACCA 5 072
264
5021 AGCTCTTCAGTGAGATTTCCTATCGGCTAATTTGACTTAGTGATCAAACT 5070












Sheep DNMT3A cDNA sequence. Length: 1848 bp
1 GACATGTGGG TTGAACCTGA GGCAGCTGCC TATGCGCCGC CCCCACCAGC
51 CAAAAAGCCC CGAAAGAGCA CAACGGAGAA GCCTAAGGTC AAGGAGATCA
101 TTGATGAGCG CACAAGAGAG CGGCTGGTGT ACGAGGTACG GCAGAAGTGC
151 CGGAACATCG AGGACATCTG CATCTCTTGT GGGAGCCTCA ACGTCACCTT
201 GGAACACCCT CTCTTCATCG GAGGAATGTG CCAAAACTGC AAGAACTGCT
251 TCCTGGAATG CGCGTACCAG TACGATGACG ACGGCTATCA GTCCTACTGC
301 ACCATCTGCT GCGGGGGGCG CGAGGTGCTC ATGTGTGGGA ACAACAATTG
351 CTGCAGGTGC TTTTGCGTGG AGTGTGTGGA TCTCTTGGTG GGGCCAGGGG
401 CTGCGCAGGC AGCATTCAAG GAAGACCCCT GGAACTGCTA CATGTGCGGG
451 CACAAGGGTA CCTACGGGCT GCTGCGGCGG CGGGACGACT GGTCGTCTCG
501 GCTCCAGATG TTCTTCGCCA ACAACCATGA CCAGGAATTC GACCCTCCGA
551 AGGTTTACCC ACCTGTCCCA GCCGAGAAGA GGAAGCCCAT CCGGGTGCTG
601 TCTCTATTCG ATGGAATCGC TACAGGGCTT CTGGTGCTGA AGGACTTGGG
651 CATTCAGGTG GACCGCTACA TCGCCTCCGA GGTGTGTGAG GACTCCATCA
701 CAGTGGGCAT GGTGCGGCAC CAGGGGAAGA TCATGTACGT CGGGGACGTC
751 CGCAGCGTTA CACAGAAGCA TATCCAGGAG TGGGGCCCGT TCGATCTGGT
801 GATTGGGGGC AGTCCCTGCA ATGATCTCTC CATCGTCAAT CCTGCCCGCA
851 AGGGACTCTA CGAGGGCACT GGCCGGCTCT TCTTTGAGTT CTACCGCCTC
901 CTGCATGATG CGCGGCCCAA GGAGGGAGAT GACCGCCCCT TCTTCTGGCT
951 CTTTGAGAAT GTGGTGGCCA TGGGCGTTAG TGACAAGAGG GACATCTCGC
1001 GATTTCTCGA GTCCAACCCT GTGATGATTG ATGCCAAAGA AGTGTCAGCT
1051 GCGCACAGGG CCCGCTACTT CTGGGGGAAC CTTCCTGGTA TGAACAGGCC
1101 ATTGGCATCC ACTGTGAATG ATAAGCTGGA GCTGCAGGAG TGTCTGGAGC
1151 ACGGCCGAAT AGCCAAGTTC AGCAAAGTGA GGACCATTAC TACTAGGTCG
1201 AACTCCATAA AGCAGGGCAA AGACCAGCAT TTCCCCGTCT TCATGAATGA





































































Pairwise alignment of sheep and human (Accession no. AF067972)
DNMT3A cDNA sequences generated using Gap (GCG10)
Sheep 1 GACATGTGGG 10




II MINIM! I 111 I 11111 111 II11 11 I I 11 I lllllllllll
1601 CGGAAGAGCACAGCGGAGAAGCCCAAGGTCAAGGAGATTATTGATGAGCG 1650
111 CACAAGAGAGCGGCTGGTGTACGAGGTACGGCAGAAGTGCCGGAACATCG 160
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
1651 CACAAGAGAGCGGCTGGTGTACGAGGTGCGGCAGAAGTGCCGGAACATTG 1700
161 AGGACATCTGCATCTCTTGTGGGAGCCTCAACGTCACCTTGGAACACCCT 210
III M 11111111111 11111111111111 I! Ill 1111111111
1701 AGGACATCTGCATCTCCTGTGGGAGCCTCAATGTTACCCTGGAACACCCC 1750
211 CTCTTCATCGGAGGAATGTGCCAAAACTGCAAGAACTGCTTCCTGGAATG 260









411 AGCATTCAAGGAAGACCCCTGGAACTGCTACATGTGCGGGCACAAGGGTA 46 0





I I I I I I II II Mill I I II I II I I I I I II I I II I I I I I I I I I I I I
2 051 TTCTTCGCTAATAACCACGACCAGGAATTTGACCCTCCAAAGGTTTACCC 2100
561 ACCTGTCCCAGCCGAGAAGAGGAAGCCCATCCGGGTGCTGTCTCTATTCG 610












111111111II111 11111111111111 Mill 11111111 Mill
2351 AGTCCCTGCAATGACCTCTCCATCGTCAACCCTGCTCGCAAGGGCCTCTA 2400
861 CGAGGGCACTGGCCGGCTCTTCTTTGAGTTCTACCGCCTCCTGCATGATG 910
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I
2401 CGAGGGCACTGGCCGGCTCTTCTTTGAGTTCTACCGCCTCCTGCATGATG 2450
911 CGCGGCCCAAGGAGGGAGATGACCGCCCCTTCTTCTGGCTCTTTGAGAAT 960







I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II I
2601 CCCGCTACTTCTGGGGTAACCTTCCCGGTATGAACAGGCCGTTGGCATCC 2650
1111 ACTGTGAATGATAAGCTGGAGCTGCAGGAGTGTCTGGAGCACGGCCGAAT 1160




















Pairwise alignment of the sheep and mouse (Accession No. AF068625)
DNMT3A cDNA sequences generated using Gap (GCG10)
Sheep 1 GACATGTGGGTTGAACCTGAGGCAGCTGCCTATGC 35









llllll Nil MM Mill 111IIIII Mill 11111111 I
1701 CCTCAATGTCACCCTGGAGCACCCACTCTTCATTGGAGGCATGTGCCAGA 1750
236 ACTGCAAGAACTGCTTCCTGGAATGCGCGTACCAGTACGATGACGACGGC 285
MM 1111 11111111 MM II II 1111 1111 II Mill II
17 51 ACTGTAAGAACTGCTTCTTGGAGTGTGCTTACCAGTATGACGACGATGGG 1800
286 TATCAGTCCTACTGCACCATCTGCTGCGGGGGGCGCGAGGTGCTCATGTG 335
II I I I I I I I I II I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I
1801 TACCAGTCCTATTGCACCATCTGCTGTGGGGGGCGTGAAGTGCTCATGTG 1850
336 TGGGAACAACAATTGCTGCAGGTGCTTTTGCGTGGAGTGTGTGGATCTCT 385
I I I I I I I I I I II I I I I I I I I I I I I I I I I I II I I I I I I I I I II I I I I I
1851 TGGGAACAACAACTGCTGCAGGTGCTTTTGTGTCGAGTGTGTGGATCTCT 1900
386 TGGTGGGGCCAGGGGcTGcGCAGGCAGCmaTCAAGGAAGACCCCTGGAAC 435
I I I I I II I I I I I I Mill I I I I I I I I M I I I I I I II I I I M I II I I I
1901 TGGTGGGGCCAGGAGCTGCTCAGGCAGCCATTAAGGAAGACCCCTGGAAC 1950
436 TGCTACATGTGCGGGCACAAGGGTACcTACGGGCTGCTGCGGCGGCGGGA 485



















Mil 11111111111111111 II Mill MINIM 111111111
2351 TCAACCCTGCCCGCAAGGGACTTTATGAGGGTACTGGCCGCCTCTTCTTT 2400
886 GAGTTCTACCGCCTCCTGCATGATGCGCGGCCCAAGGAGGGAGATGACCG 935













II I I I I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I I I I I I I I I
2650 CAAGAGTGTCTGGAGCACGGCAGAATAGCCAAGTTCAGCAAAGTGAGGAC 2699
1185 CATTACTACTAGGTCGAACTCCATAAAGCAGGGCAAAGACCAGCATTTCC 1234
II I I II II Mill Mill I I I I I I I I I I II I I I I I I I I I I I I I I I I












147 8 . . AAAAAACACAAAACACAACAAAACACCAACAACGTGAGGATGGAGAGA 1525
3 000 CAAAAAACAAAACAAAACAATAAAACACCAAGAACGAGAGGACGGAGAAA 3 049
1526 AGTAtCAGCACCCAGAAGAGaAAAAGGAATTTAAAACAAAAcAAACAAAC 1575
III 1111II11111II11111 I 111 11 111 11 I I Mil




111111ii111111 inn 1111111 111111111111 linn
3137 ACATCATCTCCTGAGTTTTCAATGTTAACCTTCAGTCCTATCTAAAAAGC 3186
1675 AAACCAAGCTCCCTCCCTACCCCCACTACCCCCTTTTTTTCTGGTCAAAC 1724
Ml I II II MM I II II II I I II II
3187 AAAATAGGCCCCTCCCCTTCTTCCCCT...CCGGTCCTAGGAGGCGAACT 3233
1725 CTTTGTTTTCTACTC.TTTTCAGAGGGGTTTTCTGTTTGTTTGGGTTTTT 1773
I I I I I I I I I I I I I I I II I I I I I I I I I I I I I I II I I I I I I I I I II I I I I
3234 TTTTGTTTTCTACTCTTTTTCAGAGGGGTTTTCTGTTTGTTTGGGTTTTT 3283
1774 GTTTCTTGCTGTGACTGAAACAAGAGGGTTTATTGCAGCAAAAAAAAAAA 1823
I I II I I I I I I I I II I I I I I I I I I I I I I I II I I I I I I I I I I I I II
3284 GTTTCTTGCTGTGACTGAAACAAGAGAG.TTATTGCAGCAAAATCAGTAA 3332
182 4 AAAAAAAAAAAAAAAAAAAAAAAAAaCTCGAGGGGGGGCCC 1864




Sheep MBD2 cDNA sequence. Length: 1224
1 AGCGCCGGCA AGAGCGATGT CTACTACTTC AGTCCGAGCG GTAAGAAGTT
51 CAGAAGCAAA CCTCAGTTGG CAAGGTATCT GGGAAATACT GTTGACCTCA
101 GCAGTTTTGA CTTCAGAACT GGAAAGATGA TGCCTAGTAA ATTACAGAAG
151 AACAAACAGA GACTGCGGAA TGATCCTCTG AATCAGAATA AGGGTAAACC
201 AGACTTGAAT ACAACATTGC CAATTAGACA AACAGCATCT ATTTTCAAGC
251 AACCAGTAAC CAAAGTCACA AATCATCCTA GTAATAAAGT GAAATCCGAC
301 CCACAGAGAA TGAATGAACA GCCACGTCAG CTTTTCTGGG ACAACAGGCT
3 51 ACAAGGAATT AGTGCACCAG ATGTAACAGA ACAAATTATA AAAACCATGG
401 AACTCCCTAA AGGTCTTCAA GGAGTTGGTC CGGGTAGTAA CGATGAGACC
451 CTTTTATCTG CTGTCGCCAG TGCTTTGCAC ACAAGCTCTG CACCCATCAC
501 AGGGCAAGTC TCTGCTGCTG TGGAAAAGAA CCCCGCTGTG TGGCTGAACA
551 CATCTCAACC CCTCTGCAAG GCTTTCATTG TCACAGATGA AGACATTAGG
601 AAACAGGAAG AGCGAGTTCA GCAAGTACGT AAGAAATTGG AGGAGGCACT
651 GATGGCAGAC ATCTTGTCGC GAGCTGCTGA CGCGGAGGCC ATGGACCTCG
701 AAATGGACAG TGGAGATGAC GCCTAAGATT GGCATCAGGT AACTTTCGAC
751 CGACTTTCCC CGAAGAGCAA ACTCCTAGAA TTGACCAAAA ACGTTTCCAC
8 01 TGGGTTTTGC CTGTAAGAAA AAAATGTACC TGAGCACATA GAGCTTTTTA
851 ATAGCACTAA CCAATGCCTT TTTAGATGTA TTTTTGATGT ATATATCTAT
901 TATTCAAAAA TGATGTTTAT TTTGAGTCCC AGGACTTAAA ATTAGTCTTT
951 TTGTAATATC AAGCAGGACC CTTAAAATGA AGCTGAGCTT TTGATGCCAG
1001 GTGCAATCTG CTGGAAATGT AGCACTTCCA TGAAATACTT GTCCCCCCCC
1051 AATTTTCATA TGAACAGATC AGGAGTACCA AATAAATTTC ACAACGAGAA
1101 AAAAAAAAAA AAAAAAAAAA AATAAACACA AGTTTATACT TTATTGAAAG
1151 AGGACACCTG TACATTCTTC CGTCATCACT GTAAAGACAA ATAAATGATT
1201 ATATTCACAA AAAAAAAAAA AAAA
Pairwise alignment of sheep and human (Accession No. AF072242) MBD2
cDNA sequences generated using Gap (GCG10)
Sheep 1 AGCGCCGGCAA 11




I I I I I I I I I I I I I I I I I II I IMI I M I ! I I I lllllllllllllll
801 CTCAGTTGGCAAGGTACCTGGGAAATACTGTTGATCTCAGCAGTTTTGAC 850
112 TTCAGAACTGGAAAGATGATGCCTAGTAAATTACAGAAGAACAAACAGAG 161
I I I I I I I I I I I I I I I I ! I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
851 TTCAGAACTGGAAAGATGATGCCTAGTAAATTACAGAAGAACAAACAGAG 900
162 ACTGCGGAATGATCCTCTGAATCAGAATAAGGGTAAACCAGACTTGAATA 211















III I I I I I II I I I I I I I I I I I I I I I I I I I II I I I I I I I I I I I II I I I
1201 TGTTGCCAGTGCTTTGCACACAAGCTCTGCGCCAATCACAGGGCAAGTCT 1250
512 CTGCTGCTGTGGAAAAGAACCCCGCTGTGTGGCTGAACACATCTCAACCC 561
I 1111111II11111111111 Mill Mill 111111111II1111
1251 CCGCTGCTGTGGAAAAGAACCCTGCTGTTTGGCTTAACACATCTCAACCC 1300
5 62 CTCTGCAAGGCTTTCATTGTCACAGATGAAGACATTAGGAAACAGGAAGA 611













MINI II1111 llll III I III 111II M I III III 111111111 I
1551 TGTAAGAAAAAAAATGTACCCGAGCACATAGAGCTTTTTAATAGCACTAA 1600
861 CCAATGCCTTTTTAGATGTATTTTTGATGTATATATCTATTATTC . AAAA 9 09
I I I I I I II I I I I I I I I II I I I I I I I I I I I I I I I I I II I I I I I I I I Mil
16 01 CCAATGCCTTTTTAGATGTATTTTTGATGTATATATCTATTATTCAAAAA 165 0
910 ATGATGTTTATTTTGAGTCCCAGGACTTAAAATTAGTCTTTTTGTAATAT 959
II lllllllllllllllll I I III I II I I llll II I I I I I I I I II I I
1651 ATCATGTTTATTTTGAGTCCTAGGACTTAAAATTAGTC.TTTTGTAATAT 1699
960 CAAGCAGGACCCTTAAAATGAAGCTGAGCTTTTGATGCCAGGTGCAATCT 1009
I I I I I I I I I I I I III I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I
1700 CAAGCAGGACCC.TAAGATGAAGCTGAGCTTTTGATGCCAGGTGCAATCT 1748
1010 GCTGGAAATGTAGCACTTCCATGAAATACTTG.TCCCCCCCCAATTTTCA 1058
1749 ACTGGAAATGTAGCACTTACGTAAAACATTTGTTTCCCCCACAGTTTTAA 17 9 8
1059 TATGAACAGATCAGGAGTACCAAATAAATTTCACAACGAGAAAAAAAAAA 1108
II I I I I I I I I I I I I I I I I I I I I I I I I I I II llll
1799 TAAGAACAGATCAGGAATTCTAAATAAATTTCCCAGTTAAAGATTATTGT 1848
1109 AAAAAAAAAAAAAATAAACACAAGTTTATACTTTATTGAAAGAGGACACC 1158
I I I lllllll I II111II11III MM I 1111111
1849 GACTTCACTGTATATAAACATATTTTTATACTTTATTGAAAGGGGACACC 1898
1159 TGTACATTCTTCCGTCATCACTGTAAAGACAAATAAATGATTATATTCAC 1208
I I I I I I I I I I I I I I I I I I I I II I II I I I I I I I I I I I I I I I I I I I I I I I I
1899 TGTACATTCTTCCATCATCACTGTAAAGACAAATAAATGATTATATTCAC 1948
1209 AAAAAAAAAAAAAAAA.. 1224




The following pages show raw data acquired during the methyl-sensitive PCR
experiments, and subsequently used to calculate DNA methylation levels.
Each table is clearly labelled with embryo stage/tissue type and the specific DNA
sequence under analysis. The following rules apply to each table:
Sample source is indicated in the first column.
Volumes 1-4 (or Vol 1-3) are band intensities of undigested DNA PCR
products, with the average indicated as Average 1.
Volumes 5-8 (or Vol 4-6) are band intensities of Hha I digested PCR products,
with the average indicated as Average 2.
% meth is Average 2 divided by Average 1.
Real % meth is the transformed % meth value (transformed using relevant
standard curve as described in Chapter 7).
Band intensity values in Bold type were not included when calculating the average,
as they deviated substantially from the mean. These values generally correlated with
the presence of an unusually intense PCR product band, or complete absence of a




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Embryostage:bla oc stDNAsequence:OV-2SI E EmbryoVol1Vol2Vol3
Vol4
Average1
Vol5
Vol6
Vol7
Vol8
Average2
%meth.
real%meth
B1
571.79
590.08
584.79
574.31
580.2425
409.43
400.16
422.72
296.86
382.2925
66
64
B2
694.81
742.84
630.19
595.28
665.78
330.6
336.53
337.32
344.97
337.355
51
47
B3
595.03
601.05
633.92
646.5
619.125
395.14
381.21
311.32
317.23
351.225
57
54
B4
604.87
651.07
639.87
635.76
632.8925
498.18
508.7
543.88
481.67
508.1075
80
80
B5
131.07
129.89
145.43
140.12
136.6275
94.32
87.45
89.81
86.49
89.5175
66
64
B6
160.05
137.98
154.2
165.78
154.5025
113.65
143.73
121.65
138.95
129.495
84
84
B7
92.04
107.17
100.79
96.58
99.145
68.92
73.88
74.85
38.06
63.9275
64
62
B8
165.22
135.96
135.97
154.69
147.96
109.48
98.75
120.78
85.28
103.5725
70
68
B9
182.34
249.02
266.38
235.71
233.3625
113.79
119.49
108.84
112.68
113.7
49
45
B10
174.8
163.16
160.72
178.63
169.3275
53.38
41.53
54.65
32.97
45.6325
27
22
IVFB1
166.95
134.74
136.35
183.22
155.315
48.28
36.37
34.49
27.75
36.7225
24
19
IVFB2
125.65
96.7
149.54
114.71
121.65
29.56
27.23
28.76
52.21
34.44
28
23
IVFB3
174.29
163.11
149.7
133.71
155.2025
17.8
26.75
22.49
16.39
20.8575
13
8
IVFB4
120.93
100.14
93.45
107.33
105.4625
35.72
34.28
30.91
25.35
31.565
30
25
IVFB5
113.52
104.83
108.06
123.85
112.565
19.11
16.01
18.79
21.48
18.8475
17
12
IVFB6
166.4
188.14
181.66
152.52
172.18
44.85
48.99
32.4
35.85
40.5225
24
19
IVFB7
165.43
276.39
203.63
289.86
233.8275
27.89
17.12
13.87
13.85
18.1825
8
3
IVFB8
246.14
236.07
272.64
285.08
259.9825
20.75
12.18
18.2
9.98
15.2775
6
1
IVFB9
202.84
148.83
170.71
130.55
163.2325
44.16
29.25
35.39
32.56
35.34
22
17
IVFB10
82.59
79.81
87.95
52.53
75.72
23.38
14.64
16.28
13.78
17.02
22
17
NTB1
450.22
329.26
372.41
274.51
356.6
51.44
33.11
42.81
37.69
41.2625
12
7
NTB2
707.92
721.44
661.9
600.17
672.8575
144.57
145.2
136.64
141.3
141.9275
21
16
NTB3
654.73
731.36
699.69
702.85
697.1575
71.42
74.81
94.12
112.44
88.1975
13
8
NTB4
774.74
563.8
559.08
615.31
628.2325
178.77
162.6
159.59
259.33
190.0725
30
25
NTB5
169.92
165.93
140.7
171.83
162.095
16.13
25.8
24.46
23.74
22.5325
14
9
NTB6
153.78
166.53
221.52
198.24
185.0175
32.85
16.42
21.08
20.94
22.8225
12
7
NTB7
426.54
462.28
404.01
459.9
438.1825
179.34
274.27
266.13
191.15
227.7225
52
49
NTB8
83.25
112.56
148.5
147.24
122.8875
0
20.77
33.53
22.42
25.5733333
21
16
NTB9
86.91
99.28
104.16
113.54
100.9725
25.53
23.35
23.05
27.37
24.825
25
20
Embryo
Vol1
Vol2
Vol3
Vol4
Average1
Vol5
Vol6
Vol7
Vol8
Average2
%meth.
real%meth
NTB10
242.99
252.17
203.86
205.62
226.16
36.28
33.84
42.36
45.43
39.4775
17
12
NTB11
462.12
416.81
434.54
428.45
435.48
170.14
143.47
153.31
151.69
154.6525
26
21
NTB12
181.4
197.11
188.95
198.23
191.4225
64.87
62.19
46.53
57.56
57.7875
30
25
NTB13
358.08
315.05
321.9
350.76
336.4475
35.24
35.11
38.79
34.86
36
10
5
NTB15
162.08
140.99
173.41
165.04
160.38
117.71
109.82
111.48
130.64
117.4125
73
72
NTB16
344.75
458.99
401.88
462.33
416.9875
32.39
26.61
30.79
28.04
29.4575
7
2
NTB17
485.49
293.16
399.89
381.5
390.01
88.88
90.95
100.87
105.1
96.45
25
20
NTB18
213.96
225.51
220.21
231.93
222.9025
59.79
55.2
59.88
56.82
57.9225
26
21
NTB19
405.49
392.86
397.58
416.53
403.115
80.26
62.51
71.03
72.29
71.5225
18
13
NTB20
114.6
142.23
128.09
83.24
117.04
34.78
25.2
6.63
29.4
29.7933333
25
20
